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ultigene   delivery   systems   are   emerging   as   key   technologies   required   in  
diverse   research   fields   in   both   academia   and   industry.   Examples   include  
genome  editing  and  synthetic  biology,  cellular  reprogramming  and  stem  cell  
biology,   production   of   complex   proteins   in   structural   biology   and  many   others.   Many  
strategies  for  assembly  and  delivery  of  multigene  constructs  exist  but  all  of  them  have  
their   limitations.   Genetic   constructs   are   typically   introduced   into   mammalian   cells   by  
transient   transfection.   However,   the   low   efficiency   of   transient   transfection   and   its  
limited   applicability   to   a   variety   of   important  mammalian   cells   significantly   restrict   the  
utility   of   this   approach.     Viral   systems   infect   many   cell   types   but   usually   don’t   have  
enough   capacity   for   multiple   genes.   Therefore,   highly   efficient   delivery   of   multigene  
plasmid   in  a  variety  of  mammalian  cells   is  a  challenge  which  needs   to  be  addressed.  
We   developed   MultiPrime,   a   baculovirus-­mediated   multigene   expression   system,  
allowing  simultaneous  expression  of  several  genes   from  a  single  virus   for  mammalian  
cells.  MultiPrime   is  a  modular,  non-­cytotoxic,  non-­integrating  system  and  works  with  a  
variety   of   promoters.   MultiPrime   viruses   efficiently   transduced   a   wide   range   of   cell  
types,  including  non-­dividing  primary  neurons  and  induced-­pluripotent  stem  cells  (iPS).  
We   showed   that  MultiPrime   can   be   used   for   reprogramming,   and   for   genome   editing  
and   engineering   by   CRISPR/Cas9.   Moreover,   we   implemented   dual-­host-­specific  
cassettes   enabling  multiprotein   expression   like   full   length   human   antibodies   in   insect  
and   mammalian   cells   using   a   single   reagent.   Also,   MultiPrime-­infected   Zebrafish  
embryos  showed  expression  of  all  expected  genes   in  vivo.  Our  experiments  establish  
M  
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MultiPrime  as  a  powerful  and  highly  efficient   tool,   to  deliver  multiple  genes   for  a  wide  
range  of  applications  in  primary  and  established  mammalian  cells.	  
The  thesis  is  organized  in  five  chapters.  The  first  chapter  provides  an  introduction  to  
available  and  common  strategies   for  multigene  expression   in  mammalian  cells  as  well  
as  some  of  the  most  important  applications  of  multigene  delivery  in  biological  research.  
The   chapters   two,   three,   and   four   present   original   research   reports   covering   our  
established  system,  an  optimized  protocol  necessary  for  production  and  utilization  of  the  
system   and   development   of   some   software   for   analysis   of   acquired   images   by   our  
system.   In   chapter   two,   Mansouri   et   al.   (2016)   present   the   main   project   including  
establishment  of  MultiPrime  and  its  diverse  applications  in  cell  biology.  In  chapter  three,  
Mansouri  et  al.   (manuscript   in  preparation)  describe  an  optimized  protocol   to  generate  
MultiPrime  baculovirus  particles  that  harbor  complete  gene  constructs.  In  chapter  four,  
Rizk  et  al.   (2014  and  2015)  present  Squassh,  Squassh3C  and  SquasshAnalyst,   three  
user-­friendly   software   modules   that   enable   segmentation   and   quantification   of  
subcellular  structures  of  fluorescence  microscopy  images.  In  the  last  Chapter,  I  discuss  
and   summarize   our   results   and   refer   to   the   limitations   of   our   system   and   I   propose  
possible  future  directions  for  genetic  manipulation  of  cells.  
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ysteme   zum   Einbringen   von   mehreren   Genen   in   eukaryotische   Zellen   spielen  
eine  wichtige  Rolle  in  der  industriellen  und  akademischen  Forschung.  Sie  werden  
z.B   benötigt,   um   das   Genom   zu   editieren,   um   den   Zelltyp   zu   verändern,   um  
Proteinkomplexe   zu   produzieren   oder   in   der   synthetischen   Biologie.   Einige   Systeme  
existieren   bereits,   wobei   diese   Nachteile   besitzen.   Konstrukte   mit   genetischer  
Information   werden   üblicherweise   mittels   Transfektion   in   die   Zellen   gebracht.   Die  
Effizienz  ist  allerding  schlecht  und  diese  Strategie  ist  auf  wenige  Zelltypen  beschränkt.  
Virale  Systeme  können  zwar  viele  Zelltypen  infizieren,  ihre  Kapazität  für  fremde  DNAS  
ist   jedoch  beschränkt.  Deshalb   ist  die  Entwicklung  eines  Systems  mit  hoher  Kapazität  
für   fremde   DNS,   das   das   in   vielen   Zelltypen   aktiv   ist,   wünschenswert.   Wir   haben  
„MultiPrime“   entwickelt.   Dieses   System   basiert   auf   einem   baculoviralen  
Expressionsystem  und   erlaubt   die   gleichzeitige  Expression   von  mehreren  Genen   von  
einem   einzigen   Virus.   MultiPrime   ist   modular   aufgebaut,   nicht   cytotoxisch,   integriert  
nicht   ins  Genom  der  Zielzelle   uns   arbeitet  mit   verschiedenen  Promotoren.  MultiPrime  
Viren   infizieren   viele   Zelltypen  wie   z.B.   sich   nicht   teilende   primäre  Nervenzellen   oder  
induzierte   pluripotente   Stamm   Zellen.   Wir   zeigten   auch,   dass   sich   MultiPrime   zur  
Umprogrammierung   von   Zellen   eignet   und   dass   man   damit   das   Genome   mittels  
CRISPR/Cas9   editieren   kann.   Zusätzlich   verwendeten   wir   Promotoren,   die   in   zwei  
verschieden   Wirtszellen   aktiv   sind.   Damit   konnten   wir   Proteine   in   Insekten-­   und  
Säugerzellen  exprimieren.  Wir  infizierten  Zebrafisch  Embryos  um  zu  zeigen,  dass  unser  
Virus   auch   in   vivo   verwendet   werden   kann.   Diese   Experimente   zeigen,   dass   unser  
MultiPrime  System  ein  wertvolles  Werkzeug  für  zellbiogische  Experimente  ist.  
S  
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Diese  Doktorarbeit  enthält  fünf  Kapitel.  Das  erste  Kapitel  gibt  eine  Einführung  in  
bekannte  Strategien  zur  Expression  von  mehreren  Genen  und  deren  Anwendung.  Die  
Kapitel  zwei  bis  vier  enthalten  Publikationen  meiner  Arbeit.  Kapitel  zwei  beschreibt  mein  
Hauptprojekt,  die  Entwicklung  und  Validierung  von  MultiPrime   (Mansouri  et  al.,  2016).  
Kapitel  drei  beschreibt  ein  optimiertes  Protokoll  zur  Herstellung  von  Viren  (Mansouri  et  
al.,   in   preparation).  Kapitel   vier   enthält   zwei  Publikationen  an  denen   ich  mitgearbeitet  
habe   (Rizk   et   al.,   2014,   2015).   Diese   beiden   Publoation   beschreiben   Squassh,  
Squassh3C   und   SquasshAnalyst,   drei   Programme   zur   Segmentierung   und  
Quantifizierungvon   subzellulären   Strukturen   in  Mikroskopie   Bildern.   Im   letzten   Kapitel  
fasse   ich  meine  Ergebnisse  zusammen  und  diskutiere  mögliche  Einschränkungen  und  
schlage  Experiment  für  die  Zukunft  vor.  
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e   transfert  et   l'expression  de  plusieurs  gènes  dans  des  cellules  eucaryotes  
sont  des  techniques  cruciales  dans  de  nombreux  domaines  de  la  recherche  
académique  et   industrielle.  Le  transfert  de  plusieurs  gènes  est  par  exemple  
utilisé  dans   les  domaines  de   la  biologie  synthétique,  de   la   reprogrammation  cellulaire,  
pour   l’édition   du   génome   ou   pour   la   production   de   complexes   protéiques   pour   la  
biologie  structurale.  Il  existe  actuellement  de  nombreuses  techniques  pour  la  création  et  
le   transfert   de   constructions   d'ADN   contenant   plusieurs   gènes,   mais   toutes   ont   des  
limitations.   Les   constructions   génétiques   sont   habituellement   introduites   dans   les  
cellules  de  mammifères  par  transfection  transitoire.  Cependant,  ces  techniques  ont  un  
rendement   faible   et   ne   peuvent   être   utilisés   que   pour   certains   types   de   cellules.   Les  
systèmes  de   transfert  basés  sur  des  virus  sont  capables  d'infecter  de  multiples   types  
cellulaires  mais  n'ont  habituellement  pas  une  capacité  d'emport  suffisante  pour  contenir  
plusieurs   gènes.  Par   conséquent,   un   système  de   transfert   à   haute   capacité   utilisable  
dans  de  nombreux  types  de  cellules  est   très  recherché.  Nous  avons  pour  cette  raison  
développé  MultiPrime,  un  système  basé  sur   les  baculovirus  qui   permet   le   transfert   et  
l'expression   simultanée   de   plusieurs   gènes   dans   des   cellules   de   mammifères   en  
utilisant   un   unique   virus.   MultiPrime   est   un   système   modulaire,   non   toxique,   qui   ne  
s'intègre  pas  dans  le  génome  et  qui  fonctionne  avec  une  grande  variété  de  promoteurs.  
Nous  avons  montré  que  les  virus  MultiPrime  permettent  une  transduction  efficace  d'une  
grande  variété  de  types  de  cellules,  dont  les  cellules  souches  pluripotentes  induites  ou  
les  cellules  qui  ne  se  divisent  pas  comme  les  neurones.  Nous  avons  également  montré  
que   MultiPrime   peut   être   utilisé   pour   la   reprogrammation   cellulaire   ainsi   que   pour  
L  
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l'édition  du  génome  par  CRISPR/Cas9.  De  plus,  nous  avons  implémenté  des  cassettes  
d'expression   actives   dans   plusieurs   types   cellulaires   permettant   l'expression   de  
complexes  protéiques  dans  des   cellules   de  mammifères   ou  d'insectes   avec   le  même  
virus.   Enfin,   nous   avons   montré   en   infectant   des   embryons   de   poisson-­zèbre   que  
MultiPrime  peut  être  utilisé  in  vivo  et  que  tous  les  gènes  transférés  sont  alors  exprimés.  
Ces  expériences  établissent  que  MultiPrime  est  un  outil  efficace  de  transfert  de  gènes  
pour  de  nombreuses  applications  de  biologie  cellulaire.  
Cette   thèse   est   organisée   en   cinq   chapitres.   Le   premier   chapitre   présente   les  
techniques  usuelles  pour  le  transfert  et  l'expression  de  plusieurs  gènes  dans  les  cellules  
de   mammifères   ainsi   que   les   applications   les   plus   importantes   en   biologie.   Les  
chapitres   deux,   trois   et   quatre   sont   des   publications   décrivant   notre   système   et   ses  
applications.   Le   chapitre   deux   constitue   la   partie   centrale   de   ce   travail   et   présente   le  
développement,  la  validation  et  les  applications  du  système  MultiPrime  (Mansouri  et  al.  
2016).  Le  chapitre   trois  décrit  un  protocole  pour   la  production  optimisée  de  particules  
baculovirales  MultiPrime  (Mansouri  et  al.,  en  préparation).  Le  chapitre  quatre  présente  
deux   publications   résultant   d'une   collaboration   utilisant   MultiPrime   pour   créer   et  
analyser  par  microscopie  des  cellules  contenant  plusieurs  marqueurs  fluorescents  (Rizk  
et   al.   2014,   2015).   Plus   précisément   ces   publications   décrivent   Squassh   et  
SquasshAnalyst,   deux   programmes   pour   la   segmentation   et   la   quantification   de  
structures   cellulaires   dans   des   images   de   microscopie   par   fluorescence.   Le   dernier  
chapitre   est   une   discussion   sur   les   résultats   et   perspectives   futures   du   système  
MultiPrime.  
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he   introduction   of   heterologous   genetic   information,   e.g.   multiple   genes,   into  
mammalian   cells   is   a   key   technology   in   current   cell   biology.   These   genetic  
components  are   typically   introduced   into  mammalian  cells  by   transient   transfection  
or   viral   transduction.   However,   the   low   efficiency   of   transient   transfection   and   its   limited  
applicability   to   a   variety   of   important   mammalian   cells   significantly   restrict   the   utility   of   this  
approach.  On   the  other  hand,  most  of   the  common  used  viruses   for  gene  delivery  suffer   from  
low  cargo   capacity   or   inability   to   infect   dividing  and  non-­dividing  mammalian   cells.  Therefore,  
development  of  an  efficient  baculoviral   system,   termed  MultiPrime,   for   the  delivery  of  multiple  
gene   cassettes   to   mammalian   cells,   both   dividing   established   lines   and   non-­dividing   primary  
cells,   would   significantly   facilitate   genetic   manipulation   of   cells   for   multiple   cell   biological  
applications.    
My  aims  in  this  project  are  to;;  
1.   Establish  a  baculovirus-­based  multigene  delivery  system  for  mammalian  cells  
2.   Evaluate  the  capability  of  MultiPrime  viruses,  harboring  multigene  cassettes  to  transduce  
a  variety  of  mammalian  cells  such  as  established  cell  lines,  primary  cells  and  stem  cells    
3.   Assess  gene  delivery  efficacy  and  expression  duration    in  MultiPrime  transduced  cells  
4.   Develop  an  optimized  protocol  for  efficient  generation  MultiPrime  virus  stocks  
5.   Optimize  the  protocol  to  achieve  high  transduction  rates  in  cell  lines  and  primary  cells  
6.   Generate   VSV-­G   protein   pseudotyped   MultiPrime   baculovirus   vectors   and   compare  
them  to  wildtype  virus  
7.   Create   multicomponent   biosensors   for   quantitative   monitoring   of   specific   cellular  
parameters  through  snapshot  and  live-­cell  imaging    
T  
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8.   Modulate   the   gene   expression   level   with   alternative   promoters   in   MultiPrime-­infected  
mammalian  cells  
9.   Express  multiple  proteins  in  mammalian  and  insect  cells  by  a  single  MultiPrime  virus  
10.  Apply   MultiPrime   system   for   CRISPR/Cas9-­mediated   genome   editing,   reprogramming  
and  antibody  production  
11.  Deliver  multiple  genes  to  a  living  organism  like  zebrafish  
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his  chapter  aims   to  summarize  available  strategies  and  also  recent  applications  of  
multigene  delivery  systems   for  mammalian  cells.  The  chapter   contains   two   review  
articles.    
The   first   review   is   focused   on   the   most   common   strategies   for   assembly   of   multigene  
constructs.   I   describe   co-­transfection/co-­infection   strategies,   Internal   ribosomal   entry   sites  
(IRES)   systems,   polyproteins   systems,   direct   assembly   of  multiple   expression   cassettes   (e.g.  
Gibson  assembly,  BioBrick  and  etc),  and  Cre  recombination-­based  systems  such  as  MultiLabel.  
Advantages  and  drawbacks  of  each  system  are  provided  (Mansouri  et  al.,  2014).  
The   second   review,   which   is   in   preparation,   summarizes   recent   applications   of   multigene  
delivery  systems  not  only  for  cell  biology  purposes  using  RNA  polymerase  II  promoters  but  also  
for   U6-­driven   expression   cassettes   and   homology   constructs   which   are   required   for   genome  
editing  though  CRISPR/Cas9  (Mansouri  et  al.,  in  preparation).      
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a b s t r a c t
Multigene delivery systems for heterologous multiprotein expression in mammalian cells
are a key technology in contemporary biological research. Multiprotein expression is
essential for a variety of applications, including multiparameter analysis of living cells
in vitro, changing the fate of stem cells, or production of multiprotein complexes for struc-
tural biology. Depending on the application, these expression systems have to fulfill differ-
ent requirements. For some applications, homogenous expression in all cells with defined
stoichiometry is necessary, whereas other applications need long term expression or
require that the proteins are not modified at the N- and C-terminus. Here we summarize
available multiprotein expression systems and discuss their advantages and disadvantages.
! 2014 Elsevier Inc. All rights reserved.
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1. Introduction
Multigene expression systems are central tools for
many applications in biology. Therefore many new strate-
gies for multigene expression have been established in
recent years (Fig. 1). Multigene expression systems were
initially developed for production of protein complexes
needed for structural and biochemical analysis. Bacterial
and insect cell systems were mainly used for this purpose
because they are fast, cost-efficient and easy to handle
(Vijayachandran et al., 2011). Mammalian systems are of
course also suitable for protein production, but they are
mainly used to study or to manipulate physiological pro-
cesses within cells (Geisse and Kocher, 1999; Perrakis
and Romier, 2008). Therefore, additional requirements
have to be fulfilled by these systems.
The expression of multiple fluorescently-tagged sensors
is a useful strategy to monitor several parameters simulta-
neously in living cells. For example, we use our MultiLabel
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expression system to express Rab GTPases and phosphoin-
ositide sensors to follow trafficking of activated receptors
in living cells (Ballmer-Hofer et al., 2011; Kriz et al.,
2010). Sensors for monitoring protein–protein binding
are often composed of two subunits that transiently inter-
act (Massoud et al., 2007). Fluorescence resonance energy
transfer (FRET) and bioluminescence resonance energy
transfer (BRET) sensors require coexpression of two fluo-
rescent proteins or of luciferase together with a fluorescent
protein (Sun et al., 2011). For bimolecular fluorescence
complementation (BiFC) assays, two parts of a fluorescent
protein reconstitute upon binding (Kerppola, 2013). Multi-
protein expression systems allow in these assays the
expression of the two proteins in a defined stoichiometric
ratio.
The manipulation of cell fates is another interesting
application area for multiprotein expression systems. It
was shown that the expression of the transcription factors
Oct3/4, Sox2, c-Myc, and Klf4 allows the reprogramming of
somatic cells into pluripotent stem cells (Takahashi and
Yamanaka, 2006). In the meantime several other combina-
tions of transcription factors have been used for the repro-
gramming of cells. For example, it was shown that the
coexpression of Asc1, Brn2, and Myt1l allows direct con-
version of fibroblasts into functional neurons (Vierbuchen
et al., 2010). So far these studies mainly involved coinfect-
ing several Lentiviruses, but the coexpression from a single
plasmid might be an interesting strategy to overcome the
low efficiency of the process.
Drug development is another important application
field for multiprotein expression systems. First, multipro-
tein complexes themselves might act directly as potential
drugs. Virus-like particles (VLPs) consisting of components
of a virus without its genetic material can be used to pro-
duce safe vaccines (Roy and Noad, 2008). VLPs were shown
to stimulate the immune response and could replace atten-
uated viruses that are currently used for vaccination
(French et al., 1990; Gheysen et al., 1989; Noad and Roy,
2003). Second, multiprotein expression systems can be
used to develop screening platforms for drug discovery.
Libraries of small molecules are usually used to identify
new agonists or antagonists of GPCRs and receptor tyrosine
kinases. Very often, receptors form heterodimeric com-
plexes and a suitable primary cell type is not available.
For example, the serotonin receptor 2A (5-HT2A) forms
either a complex with the dopamine receptor D2 (D2DR)
or the metabotropic glutamate receptor-2 (mGluR2)
(Borroto-Escuela et al., 2010; Gonzalez-Maeso et al.,
2008). In this situation, a heterologous cell line is a suitable
tool. In such a cell line it is important that all cells express
both receptors, since otherwise a mixed response is mea-
sured in the assay.
As described above, mammalian expression systems
have to fulfill special requirements depending on the appli-
cation. Many strategies have been developed in the last
years to fulfill these requirements, and all systems have
their advantages and disadvantages. Viral systems usually
lead to high infection rates (up to 100%), but their capacity
as carriers of foreign DNA is limited and the expression is
usually transient. The translation of a polyprotein followed
by proteolytic cleavage allows a short mRNA, but the N-
and C-terminus of the mature protein are then modified
which may lead to problems with proteins that need a
native N- and C-terminus (e.g. Rab GTPases). Here we
Acceptor Donor 2Donor 1 MultiLabel Plasmid
IRES IRES Poly A
IRES-based, polycistronic
Polyprotein
2A/ TEV Poly A2A/ TEV
Gibson Fragments Gibson Assembly
A
D
C
B
Fig. 1. Strategies for multigene expression. (A) IRES-based: a single transcript can lead to multiple proteins if the coding regions (colored boxes) are
separated by an IRES element. (B) Polyprotein: a single transcript leads to a long polyprotein. The individual proteins are then released either by ‘‘self-
cleavage’’ (see text) or by a coexpressed protease such as TEV. (C) Gibson assembly allows the assembly of independent expression cassettes (colored
arrows). Assembly occurs at homologous ends of the fragments (indicated by grey-shaded circles). (D) cre/LoxP-based: Independent expression cassettes on
Acceptor and Donor plasmids are assembled by a cre/LoxP reaction to yield a single plasmid. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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review strategies for multigene expression in eukaryotic
cells and we discuss their applications in cell and struc-
tural biology.
2. Cotransfection and coinfection
The most straightforward way to obtain coexpression in
mammalian cells is by cotransfection of several vectors
each bearing a single, independent expression cassette.
The relative expression levels can be titrated by adjusting
the ratio between the plasmids or by the use of different
promoters. This approach is efficient if only three to four
genes have to be expressed and if the cell line is easy to
transfect. In our experience, the approach fails in cells that
are difficult to transfect (e.g., primary cells). The generation
of stable cell lines is possible if plasmids contain different
selection markers, but this is tedious. In addition, the
approach leads to a heterogeneous cell population with
different expression levels and it is not guaranteed that
all cells express all proteins. For example, in a co-transfec-
tion experiment containing two plasmids A and B, a frac-
tion of cells will be transfected only with either A or B,
and only a part of the cell population is transfected with
both A and B (Kriz et al., 2010). In addition, the expression
ratio between protein A and B is variable. This might be an
advantage when single cells are selected for analysis (e.g.,
by microscopy) but is a problem when the whole cell pop-
ulation is analyzed with a biochemical assay. An atypical
but successful example of this strategy is the generation
of influenza A viruses for vaccination using an eight-plas-
mid transfection system in HEK293T cells. This strategy
profits from the fact that a replication competent virus is
produced. It is therefore sufficient that only a small portion
of the cells take up all eight plasmids (Hoffmann et al.,
2000; Nakamura et al., 2008).
Coinfection with multiple lentiviruses is a similar strat-
egy. Lentiviral vectors are suitable for overexpression of a
gene of interest or for downregulation using short hairpin
RNA technology (Dull et al., 1998; Naldini et al., 1996). The
vectors stably integrate into the genome of dividing and
non-dividing cells. As for cotransfections, this yields a het-
erogeneous but stable cell population. This effect is used in
the so called RGB labeling system. Three lentiviral gene
ontology (LeGO) vectors encoding red, green or blue fluo-
rescent proteins are simultaneously used to transduce
cells. Individual cells are thereby marked by different com-
binations of inserted vectors, resulting in the generation of
numerous mixed colors. This allows monitoring clonal
expansion of cells in vitro and in vivo (Weber et al.,
2011). A similar approach was used to identify factors that
are able to convert fibroblast to neurons. Here, a library of
19 lentiviruses was used to identify combinations that
allow this conversion (Vierbuchen et al., 2010). If a homog-
enous cell population is needed, appropriate selection
markers must be used. This can be achieved by coexpress-
ing a fluorescent marker proteins followed by FACS sorting
or by coexpression of an antibiotic resistance gene (Weber
et al., 2010). Lentiviruses have the disadvantage that they
have limited capacity as carriers of foreign DNA, and that
their production is time consuming. In addition, they are
usually classified at Biosafety Level 2, which requires a spe-
cial laboratory infrastructure.
Coinfection of baculoviruses with mammalian expres-
sion cassettes (BacMam) can also be used for multigene
expression. This strategy was successfully used to replace
the generation of stable cell lines in the drug discovery
process. In contrast to retroviruses, baculoviruses do not
integrate into the genome of host cells. The expression is
therefore only transient (Davenport et al., 2009; Kost
et al., 2010).
3. Internal ribosomal entry sites (IRES)
The use of IRES sequences is the most straightforward
approach to extending the above strategy. IRES sequences
were initially identified in picornaviruses, and they allow
the translation initiation from internal sites from mRNAs
in a 5’cap independent manner (Jang et al., 1988;
Pelletier and Sonenberg, 1988). In the meantime, IRES
sequences were found in other viruses and in eukaryotic
genes (Mokrejs et al., 2006). The use of IRES elements
allows the design of polycistronic mRNAs for the expres-
sion of two or more proteins, which is rather unusual for
mammalian cells. This strategy allows relatively short con-
structs, since IRES sequences are typically 150–500 bp long
(Mokrejs et al., 2010). In comparison, an independent
expression cassette requires an additional promoter and
polyadenylation signal, which together encompass approx-
imately 1000 bp. The translation of the first ORF is cap
dependent, whereas the translation of the following ORFs
depends on IRES sequences. An advantage of IRES elements
is that they are active in situations where cap-dependent
translation is inhibited, such as in the reduction in overall
protein synthesis in response to stress during cell cycle or
apoptosis (Holcik et al., 2000). The coexpression with IRES
elements is very efficient, meaning that typically more
than 90% of transfected cells express both proteins
(Ghattas et al., 1991). However, problems arise when the
expression levels of the genes upstream and downstream
of the IRES are compared. The imbalance of protein expres-
sion seen with the use of different IRES sequences makes it
difficult to predict protein expression levels. Hotta, et al.,
showed for example that it is difficult to produce heavy
and light chains of an IgG at similar levels with an IRES-
based system (Hotta et al., 2004). Studies comparing the
expression levels of two cDNA sequences separated by an
IRES have shown that genes cloned downstream of the
IRES were expressed at significantly lower levels (10–50%
of the upstream gene, (Zhu et al., 1999). In these studies,
this appeared to be independent of the gene sequence, as
the same gene placed before the IRES resulted in high
expression. However, other groups have reported that the
coding sequence can affect IRES translation efficiency
(Hennecke et al., 2001). Mutated IRES elements were
developed that allow different expression levels (Poyry
et al., 2001).
In conclusion, IRES sequences are a useful tool for many
applications even though their effectiveness is controver-
sially discussed (see e.g. Kozak, 2005). The main applica-
tion is the coexpression of a selectable marker for the
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generation of a stable cell line or the coexpression of a fluo-
rescent protein to identify transfected cells. In both cases,
the expression level is not very important. Commercial
cloning vectors are available for this purpose. It is also pos-
sible to combine several IRES sequences to express more
than two proteins or to add elements that allow tetracy-
cline-inducible expression or direct generation of stable
cell lines (Fussenegger et al., 1997). IRES sequences are also
functional in vivo. For example, Sangiorgi et al. introduced
an IRES-CreERT2 element into the 30 untranslated region of
the Bim1 gene. Crossing these mice with an appropriate
reporter mouse line (ROSA26-LacZ) allowed lineage tracing
of Bim1-positive cells. These mice were also used to condi-
tionally express diphtheria toxin to delete this cell lineage
(Sangiorgi and Capecchi, 2008).
4. Direct assembly of multiple expression cassettes
Assembly of multiple expression cassettes by classical
cloning with restriction enzymes and ligases is another
strategy to obtain multigene expression. This approach
has two major technical disadvantages, namely that it is
difficult to find unique cloning sites in large DNA frag-
ments and that cloning with large DNA fragments is not
very efficient. The first problem can be overcome by using
homing endonucleases (e.g., I-CeuI) in combination with
restriction enzymes with compatible cohesive ends (e.g.,
BstXI). This approach also permits the reconstitution of
the homing endonuclease site, allowing iterative insertion
of additional genes (Kriz et al., 2010).
Several methods such as ligase-independent cloning
(LIC) (Aslanidis and de Jong, 1990), sequence and liga-
tion-independent cloning (SLIC) (Li and Elledge, 2007), or
Gibson assembly (Gibson et al., 2009) were developed to
allow cloning of large fragments independent of restriction
enzymes. In the Gibson isothermal assembly technique,
the exonuclease digests back the ends of each fragment,
leaving 30 single-stranded overhangs. Fragments anneal
to each other through their complementary overhangs,
the gaps are filled in by DNA polymerase, and the nicks
are sealed by DNA ligase. This strategy facilitates assembly
of multiple fragments to form large expression constructs
or even small bacterial genomes (Lartigue et al., 2009).
Based on Gibson assembly, Guye, et al., described a similar
method for assembly of complex gene circuits which is
useful particularly in synthetic biology research (Guye
et al., 2013). The method fuses different transcriptional
units (TU), each one containing a specific promoter and
termination sequence. First, every TU is cloned into an
appropriate destination vector called a ‘‘position vector’’
using Gateway recombination. Each TU in a position vector
is flanked by two different 40 bp UNSs (unique nucleotide
sequence) that are flanked in turn by two I-SceI restriction
sites. I-SceI digestion of each position vector releases a
fragment containing one TU with two different UNSs at
its ends. These TU fragments are then assembled in a Gib-
son reaction where the UNS 1/2 fragment is joined to the
UNS 2/3 fragment, which is then joined to the UNS 3/4
fragment. The final UNS (N-1)/N fragment is joined using
an adapter vector containing UNS N/X to the carrier vector
containing UNS 1/X and Escherichia coli propagation
sequences. Using their method, they could assemble 11
TUs into a single vector and they could hierarchically
assemble a 45 kb 7-TU module with 5 additional TUs to
create a 63 kb 12-TU circuit (Guye et al., 2013).
5. Release from polyproteins
Polyproteins are long protein precursors spaced by pro-
teolytic cleavage sites. This approach is inspired by certain
viruses such as corona- and retroviruses that release their
proteins from a large polyprotein precursor (Szymczak
et al., 2004). Polyprotein approaches have proven to be
particularly powerful for balancing the stoichiometry of
coexpressed proteins. Nevertheless the degradation rate
can still be different for each released protein leading to
different protein ratios under steady state conditions. In
addition, it is not possible to simultaneously express cyto-
plasmic and secreted proteins. For in vivo applications it is
necessary to coexpress the protease, because endogenous
proteases are not specific enough. Usually, proteases with
a long recognition site such as TEV protease are used for
this purpose to gain specificity (Chen et al., 2010). After
cleavage, N- and C-termini are modified compared to the
native protein, which might be a problem for certain
applications.
The most elegant method involves the use of ‘‘self-
cleaving’’ 2A peptide-based polyproteins, which cleave
via a non-protease-based cleavage mechanism and there-
fore are independent of cofactors. The basis is rather a ribo-
somal skipping effect (Donnelly et al., 2001). The best
characterized 2A peptides derive from Picornaviridae, as
for example from foot-and-mouth disease virus. The recog-
nition sequence, with an average length between 18 and
22 amino acids, encodes a highly conserved consensus
motif (Asp-Val/Ile-Glu-X-Asn-Pro-Gly-+-Pro) that has to
be placed between the two proteins. The 2A peptide
appears to disrupt translation and impair normal peptide
bond formation between the last glycine residue of the
consensus sequence and the first proline residue of the sec-
ond protein (marked by an arrow in the consensus
sequence above). There are several advantages of using
2A peptide sequences, most notably their small size and
their ability for efficient coexpression of genes that are
placed between them. Furthermore, antibodies have been
generated against the consensus 2A sequence, which thus
serves as a useful ‘tag’ for identifying proteins in biochem-
ical assays. On the other hand, a protein with modified
ends is produced, which might be a problem for certain
applications.
Szymczak, et al., showed that a single 2A peptide-linked
retroviral vector can be used to generate all four CD3 pro-
teins (CD3 epsilon, gamma, delta, zeta) and restore T cell
development and function in CD3-deficient mice
(Szymczak et al., 2004). Also, Fang, et al., described an anti-
body delivery system that allows continuous production of
a full-length antibody at high concentrations in vivo after
gene transfer. The antibody is expressed from a single open
reading frame by linking the heavy and light chains with a
2A self-processing peptide derived from the foot-and-
mouth disease virus. Using this expression system, they
generated a recombinant adeno-associated virus vector
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encoding a VEGFR2-neutralizing antibody which might be
useful for the treatment of cancer or other diseases such as
macular degeneration (Fang et al., 2005).
6. Cre recombination
The cre/loxP system can be used to fuse multiple plas-
mids bearing independent expression cassettes to produce
a single plasmid. Cre recombinase is an enzyme derived
from bacteriophage P1, and carries out site-specific recom-
bination events. It catalyzes the recombination between
two DNA recognition sites (loxP sites). A loxP site consists
of a 34 base pair sequence composed of two 13 bp palin-
dromic sequences flanking an asymmetric 8 bp spacer
region. Cre recombinase can either excise the DNA
between two loxP sites leading to an additional circular
plasmid containing the excised DNA, or fuse two DNA frag-
ments (Nagy, 2000). It is an equilibrium reaction that does
not need additional cofactors, and it works in vitro and
in vivo in a wide range of organisms. Therefore, the Cre/
loxP system has found many applications in biotechnology,
especially for tissue-specific conditional protein overex-
pression or gene knockout in mice.
MultiBac was the first system that used the cre/LoxP
strategy for multiprotein expression. This system allows
expression of up to 14 proteins in insect cells (Fitzgerald
et al., 2006). The rationale of the system was to allow com-
binatorial assembly of the different components or
mutants thereof for structural studies. The system was
used to solve structures of multiprotein complexes, e.g.,
for the structure determination of the core elements of
TFIID (Bieniossek et al., 2013). The concept was in the
meantime adapted for E. coli (Acembl, (Bieniossek et al.,
2009)) and mammalian expression (MultiLabel; (Kriz
et al., 2010)). MultiLabel consists of Acceptor and Donor
vectors. All vectors contain a typical expression cassette
(promoter – gene-of-interest – poly A signal), a loxP site,
and different antibiotic resistance genes. Acceptor plas-
mids bear a ColE1 origin of replication whereas Donor plas-
mids have a conditional origin of replication (R6Kc). One
Acceptor plasmid is then fused with up to four Donor plas-
mids by an in vitro cre/loxP reaction. Correct fusion plas-
mids are then selected by appropriate combinations of
antibiotics; unfused donor plasmids cannot propagate in
standard cloning strains due to the conditional origin of
replication. The resulting plasmid contains up to five inde-
pendent expression cassettes that can be used for transient
transfections, giving rise to homogenous cell populations
(Kriz et al., 2010, 2011). Acceptor plasmids can contain
additional features such as selection markers for the gener-
ation of stable cell lines or sites for homing endonuclease
enabling linearization prior to transfection. The system
was successfully used to generate stable cell lines with
multiple fluorescent sensors or to monitor receptor traf-
ficking (Ballmer-Hofer et al., 2011; Kriz et al., 2010).
7. Concluding remarks
Powerful technologies for the recombinant expression
of multiple proteins in mammalian cells have been devel-
oped in recent years. Reliable protocols exist for all sys-
tems, and many examples show that they work. There
are subtle differences in these systems that might be rele-
vant for diverse applications. Future users should be aware
if they need (1) transient expression, (2) stable expression,
(3) a homogenous cell population, (4) modular cloning for
screening, (5) a short construct, or (6) unmodified N- and
C-termini. The system should be chosen based on these
criteria.
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Abstract))
)
Systems& for&multigene&delivery& in&mammalian&cells&are&essential& tools& in&
current& biological& research.& Initially,& they& were& based& on& RNA& polymerase& II&
promoters& and& were& used& for& production& of& protein& complexes& and& or& for&
applications& in& cell& biology& like& reprogramming& of& somatic& cells& to& stem& cells.&&
Emerging&new& technologies& like& & &CRISPR/Cas9,&enabling&any&alteration& in& the&
genomic& level& of& an& organism,& need& additional& elements& like& U6Adriven&
expression& cassettes& for& RNA& expression& or& homology& constructs& for& targeted&
genome& editing.& For& applications& like& this,& systems& with& high& DNA& capacity,&
flexibility,&and&transfer&rates&are&needed.&In&this&article,&we&briefly&give&an&update&
on&some&of&recent&strategies&that&facilitate&multigene&assembly&and&delivery&into&
mammalian&cells.&Also,&we& review&some&of&multigene&delivery&applications& in&a&
various& fields& of& biology& such& as& genome& editing,& cellular& reprogramming,& cell&
signaling&and&trafficking,&and&many&others.&&&
&
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Introduction)
Multigene&delivery&systems&gain& increasing& importance& in&biological& research& in&
both& academia& and& industry.& Many& molecular& process& within& mammalian& cells&
such&as&DNA&replication&and&repair,&cell&division,&gene&expression,&protein&sorting&
and&trafficking&rely&on&interaction&between&many&protein&or&molecular&machines,&
which&were&also&termed&as&protein&sociology& in&the&cell&(Robinson&et&al.,&2007).&
Understanding& the& complex& functions& of& these& machines& require& the& ability& to&
manipulate& their& components& in& single& cells& by& overexpression,& repression& or&
activation&(Dominguez&et&al.,&2015).& In&addition,&manipulation&of&cells&very&often&
needs& the& introduction& of& heterologous& DNA& into& a& cell.& Examples& include&
labelling& of& living& cells&with& various& fluorescentlyAtagged& sensors& for&monitoring&
changes& in& cellular& architecture& or& metabolism& (BallmerAHofer& et& al.,& 2011)& or&
production&of&complex&protein&or& therapeutic&vectors& (Assenberg&et&al.,&2013a).&
Also,& these& systems& allow& to& engineer& mammalian& cells& on& the& genomic& level&
(Hsu&et&al.,&2014)&or&reprogram&them&through&change&of&cell&fate&(Takahashi&and&
Yamanaka,&2006).&Construction&of&multigene&circuits& in&synthetic&biology& (Guye&
et&al.,&2013),&and&gene&therapy&(Hotta&and&Yamanaka,&2015)&are&other&examples&
that&show&central&role&of&multigene&delivery&systems&in&biological&research.&
Nevertheless,& delivery& of& multiple& genes& simultaneously& to& single& cells& is& still&
challenging.&Hallmarks&of&a&good&multigene&delivery&system&are& flexible&design,&
easy& to& assembly,& and& efficient& and& reproducible& delivery& to& a& variety& of& cells&
including&diving&and&nonAdividing&cells&(Mansouri&et&al.,&2016).&&
Multigene&expression&systems&were& initially&developed& to& improve&production&of&
protein& complexes& in& E.& coli& and& insect& cells.& Although&mammalian& expression&
systems&are&of&course&also&suitable&for&protein&production,&they&are&mainly&used&
to& study& or& to& manipulate& physiological& process& within& cells& (Mansouri& and&
Berger,& 2014).& Multigene& delivery& systems& can& be& used& to& introduce& multiple&
expression&cassettes& into& immortalized&cell& lines& (Kriz&et&al.,&2010).&Established&
cell&lines,&harboring&some&alterations&that&lead&to&indefinitely&division,&are&desired&
usually& for& generation& of& biotechnological& products.& Primary& cells,& which& retain&
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many& functions& seen& in& vivo,& & since& they& express&many& protein& at& their& in& vivo&
level,& are& an& attractive& source& in& research.& Furthermore,& stem& cells,& of& either&
embryonic&or&adult&origin,&as&well&as& those&derived&from&differentiated&cells,&are&
now& an& emerging& and& reliable& source& for& investigations& (Eglen& and& Reisine,&
2011).&For&instance,&induced&pluripotent&stem&cells&(iPSC)&can&be&derived&directly&
from&patients&and&provide&a&valuable&source&of&information&(Dimos&et&al.,&2008).&
The&ability& to&delivery&of&multiple&genetic&expression&cassettes& into&mammalian&
cells& (e.g.,& established& cell& lines,& primary& cells& and& stem& cells)& make& a& great&
possibility& for& production,& research& and& therapy.& Here,& we& review& available&
methods& for& delivery& of& multigene& constructs& into& mammalian& cells.& Then,& we&
describe& some& the& most& frequent& and& efficient& strategies& for& assembling& of&
multigene&cassettes.&Finally,&we& introduce&some&field&of&biological& research&that&
benefit&from&multigene&delivery&systems.&
&
Methods)for)multigene)delivery)to)mammalian)cells)
Three& major& methods& are& used& for& multigene& delivery& (as& like& single& gene&
delivery)&to&mammalian&cells,&including&physical&methods,&chemical&methods&and&
biological&methods& (Nelson&and&Gersbach,&2016).&Physical&methods,&which&are&
also&known&as&carrierAfree&delivery&systems,&lead&to&a&temporary&disruption&of&cell&&
the&membrane&allowing&the&desired&plasmid&to&enter&the&cell&(Knutson&and&Yee,&
1987).& Electroporation,& magnetofection,& microinjection& and& sonoportion& are& the&
most& frequent& physical&methods& used& for& delivery& of& plasmids& into&mammalian&
cells& (Nelson& and& Gersbach,& 2016).& & Physical& methods& are& usually& fast& and&
simple& but& need& to& special& equipment.& In& addition,& reproducibility& of& achieved&
result&by&physical&methods&are&divers&and&their&damaging&effect&on&cells&is&high.&
ChemicalAmediated&multigene&delivery& is& the&next&method& for&gene&delivery& into&
mammalian&cells.&Liposome&(e.g.&DOTMA),&cationic& lipids&(e.g.&Lipofectamin)&or&
nonAliposomal&lipids&(e.g.&Fusion&HD)&and&polymers&(e.g.,&polyethylenimine&(PEI))&
are&the&most&common&chemical&reagents&that&have&been&pursued&to&deliver&DNA&
to& mammalian& cells.& These& reagents& are& easy& to& work& and& fast& & and& have&
moderate& toxicity& (Heiser,& 2003).& Biological& methods& include& integrating& viral&
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vectors& (e.g.,& retrovirus& and& lentivirus),& nonAintegrating& viral& vectors& (e.g.,&
Adenovirus,& AdenoAassociated& virus,&and& Baculovirus)& (Nelson& and& Gersbach,&
2016f&Smith,&1995).&Biological&methods&deliver&foreign&genes&with&high&efficiency&
to&many& cell& types.&On& the&other& hand,& they& suffer& from& low&cargo& capacity& for&
genetic&material,& and/or& possibility& to& random& integration& into& the& host& genome&
can& cause& mutations& and& tumorigenesis.& Additionally,& working& with& biological&
particles&can&raise&biosafety&issues.&Table&1&compared&some&of&the&gene&delivery&
features&by&these&three&methods.&&&&&&
)
An)update)on)strategies)for)multigene)expression)in)mammalian)cells)
Many& strategies& for& assembly& of& multigene& cassettes& and& for& delivery& to&
mammalian&cells&exist.&Here,&we&briefly&review&some&these&strategies&as&well&as&
an&update&in&the&topic.&The&most&convenient&way&to&co&express&several&genes&in&
mammalian&cells&is&either&coAtransfection&of&plasmids&using&chemical&or&physical&
methods&or& coAinfection&with&a&pool& of& virus&each&bearing& single& cassette.&This&
strategy& is& straightforward,& fast& and& easy& to& do& but& leading& to& generation& of& a&
heterologous&cell&population&or&imbalance&level&of&expression&in&every&single&cell&
(Kriz&et&al.,&2010).&Internal&ribosomal&entry&sites&(IRES)&is&a&good&choice&for&coA
expression&of& reporter/selection&genes& (e.g.,&GFP&or&antibiotic& resistance&gene)&
along&with&protein&of&interest.&This&system&ensures&expression&of&a&second&gene&
that&is&located&downstream&of&IRES&sequence.&In&this&strategy,&genes&located&up&
and& downstream& of& IRES& sequence& are& transcribed& as& a& single& polycistronic&
mRNA.&Unfortunately,& ratio&of&expressed&genes& in& the&up/down&stream&of& IRES&
sequence& are& imbalanced& and& not& predictable& (Zhu& et& al.,& 1999).& Polyprotein&
approaches& have& been& proven& to& be& particularly& powerful& for& balancing& the&
stoichiometry& of& coAexpressed& proteins.& Usually,& proteases& with& a& long&
recognition& sites& such& as& TEV& protease& are& used& for& this& purpose& to& gain&
specificity& (Chen& et& al.,& 2010).& After& cleavage,& NA& and& CAtermini& are& modified&
compared& to& the& native& protein,& which& might& be& a& problem& for& certain&
applications.& The& most& elegant& method& involves& the& use& of& ‘‘selfAcleaving’’& 2A&
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peptideAbased& polyproteins,& which& produce& multiple& proteins& via& ribosomal&
skipping.&(de&Felipe,&2004).  
Many& strategies& for& direct& cloning& of& multiple& expression& cassettes& exist.&
Examples&are&overlap&extension&polymerase&chain&reaction,&circular&polymerase&
extension&cloning,&sequence&and&ligase&independent&cloning&(Wang&et&al.,&2012f&
Ye&et&al.,&2014).&Another&approach&for&simultaneous&DNA&fragment&assembly& is&
provided&by&Golden&Gate&and&Golden&GateArelated&systems&(Engler&et&al.,&2008,&
2009f&Werner&et&al.,&2012).&A&powerful&assembly&technique&that&can&be&used&for&
joining& multiple& DNA& fragments& simultaneously& in& a& single& tube& is& Gibson&
assembly& (Gibson& et& al.,& 2009).& Gibson& assembly& allows& joining& the& DNA& via&
overlapping& ends.& One& flexible& approach& to& assemble& multigene& expression&
cassettes& to& mammalian& cells& is& based& on& in& vitro& cre/loxP& recombination&
systems.&We&have&developed& two& systems& called&MultiLabel& (Kriz& et& al.,& 2010)&
and&MultiPrime&(Mansouri&et&al.,&2016)&which&are&based&on&plasmid&transfection&
or& baculovirus& transduction.&MultiLabel& and&MultiPrime& consist& of&Acceptor& and&
Donor& vectors.& Acceptor& vectors& for&MultiLabel& contain& selection& genes& for& the&
generation&of&stable&cell&lines&whereas&MultiPrime&Acceptor&contain&elements&for&
the& generation& of& baculoviruses.& Baculoviruses& have& the& potential& to& transduce&
many& cell& types& including& primary& cells.& All& vectors& have& their& own& individual&
expression& cassette& (promoter& –& geneAofAinterest& –& poly& A& signal),& a& loxP& site,&
and&different&antibiotic&resistance&genes.&Acceptor&plasmid&can&be&fused&with&up&
to&four&Donor&plasmids&by&an&in&vitro&cre/loxP&recombination&reaction.&(Kriz&et&al.,&
2010).&Then,& recombinant&baculovirus&genome&can&be&applied& for&production&of&
baculovirus&particles&within&insect&cells.&(Mansouri&et&al.,&2016).&
Therefore,& choosing& a& rapid,& modular& and& reliable& strategy& for& assembly& of&
multigene&construct&is&an&important&step&for&efficient&cargo&delivery.&In&the&table&2&
we&have&summarized&some&features&of&each&strategy.&&
&
Application)of)multigene)delivery)in)genome)editing)
Genome& editing& refers& to& the& process& of& making& targeted& any& modifications&
(mutation,& deletion& or& insertion)& to& the& genome,& its& contexts& (e.g.,& epigenetic&
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marks),& or& its& outputs& (e.g.,& transcripts)& (Hsu& et& al.,& 2014).& Genome& editing& is&
powerful&technique&for&gene&targeting&in&biological&researches&in&order&to&study&of&
involved& genes& in& disease& (Nelson& and& Gersbach,& 2016)& and& development& of&
novel&therapeutic&medicine&(Sander&and&Joung,&2014).&Genome&editing&employs&
two& key& players:& programmable& nuclease& that& introduce& DNA& doubleAstrand&
breaks& (DSBs)& into& userAdefined& sites& in& the& genome& and& the& DSB& repair&
mechanism& in& host& cells& (Sakuma& and& Yamamoto,& 2015f& Yamamoto,& 2015).&
DSBs& are&mainly& repaired& through& two& pathways,& either& nonA& homologous& end&
joining& (NHEJ)& that& is& inherently&errorAprone&or&homologyAdirected& repair& (HDR)&
which& is& precise& compared& with& NHEJ& but& requires& a& repair& template.& In& the&
absence&of&a&donor&repair&template,&the&errorAprone&nonAhomologous&endAjoining&
(NHEJ)&pathway&fill&the&DSB&gaps&with&small&insertions&or&deletions&(Indels)&that&
can& be& used& to& disrupt& the& coding& region& of& a& gene& of& interest& by& alteration& of&
open&reading&frame&(ORF)&or&induction&a&premature&stop&codon&&(knock&out)&(Hsu&
et& al.,& 2014f& Jiang& and& Marraffini,& 2015b).& Additionally,& coAintroduction& of&
targetable& nucleases& and& exogenous& repair& donors& (or& targeting& vectors)&
increases& the&HDRA&mediated& targeted& transgene& insertion& (knock& in)& (Sakuma&
and& Yamamoto,& 2015).& Among& four& main& classes& of& targeted& DBPAbased&
genome& editing,& Clustered& regularly& interspaced& short& palindromic& repeat&
(CRISPR)/Cas9& is& more& popular& due& to& its& simplicity,& high& efficiency& and&
versatility& in& genome& editing& (Hsu& et& al.,& 2014f& Nelson& and& Gersbach,& 2016).&
CRISPR/Cas9& system,& including& the& Cas9Abased& type& II& CRISPR& system,& is& a&
part&of&adaptive&immune&systems&in&bacteria&and&archaea&against&invading&phage&
(Jiang&and&Marraffini,&2015b).&CRISPR/Cas9&system& is&composed&of& two&major&
components:&an&endonuclease&enzyme&called&Cas9&and&at&least&one&guide&RNA&
(gRNA).& Hybridization& between& gRNA& and& DNA& in& the& specific& sequence& of&
genome&leading&to&direction&of&Cas9&to&the&target&place&and&cleave&the&DNA&(Hsu&
et& al.,& 2014f& Jiang& and&Marraffini,& 2015af&Nelson& and&Gersbach,& 2016f&Sander&
and&Joung,&2014).&&
Three&types&of&Cas9&nucleases&are&available:&Cas9&and&two&mutated&forms&of&it&
including&Cas9n&and&dCas9.&Cas9&induce&double&stands&break&in&DNA&whereas&
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Cas9n&(harboring&D10A&mutation)&generate&a&single&stand&break&(nick)& in&DNA.&
dCas9& in& addition& to&D10A&bearing&H840A&mutation& that& lead& to& inactivation& of&
cleavage&activity,&but&do&not&prevent&DNA&binding&(Qi&et&al.,&2013).&
The&most&significant&challenge&for&the&clinical&translation&of&genome&editing&is&the&
development& of& a& safe& and& effective& delivery& vehicles& (Nelson& and& Gersbach,&
2016).&In&the&following&part,&we&briefly&describe&some&of&the&recent&application&of&
delivery& methods,& their& potential& issues& for& carrying& Cas9,& gRNA(s),& HDR& and&
other&related&genes&into&mammalian&cells.&&
The& largest& component&of& the&CRISPR/Cas9&system& is&Cas9&nuclease& (Nelson&
and&Gersbach,&2016).&Cas9,&originally& from&Streptococcus&pyogenes,& is&encode&
by&a&4.2&kb&DNA.&Although&gRNA& itself& is&almost&100&bp&but&along&with&a&RNA&
polymerase&III&promoter&(usually&U6&promoter)&would&be&around&330&bp&(Mali&et&
al.,& 2013).& Therefore,& carrying&Cas9& and& gRNA& on& the& same& vector& need& to& a&
robust& system& with& large& cargo& capacity.& Although,& delivery& of& Cas9& by&
transfection& can&be&quite&efficient& in&many&cell& types& (Cong&et& al.,& 2013)&but& in&
hardAtoAtransfect& cells& (e.g.,& primary& cell& types)& transduction& with& a& viral& vector&
provides&an&alternative&way&(Mansouri&et&al.,&2016).&Major&problems&for&delivery&
of& CRISPR/Cas9& components& by& virus& are& either& capacity& of& viral& vector& for&
packaging& of& transgenes& or& integration& of& virus& & into& the& host& genome& (Smith,&
1995).&AAV&and&adenovirus&are&a&nonAintegrating&virus&and&generally&consider&as&
safe&and&effective&delivery&viral&vehicles&(Seto&et&al.,&2012).&These&viruses&have&a&
small&packaging&size&which&is&almost&4.7&kb.&Using&smaller&variant&of&Cas9&(e.g.,&
staphylococcus& aureus& cas9& or& SaCas9& encoded& by& a& 3.2& kb& DNA)& or& driving&
gRNA& expression& with& smaller& promoter,& utility& of& AAV& and& adenoviruses& for&
genome& editing& is& increasable& (Nelson& and& Gersbach,& 2016).& Integrating& viral&
vectors& like& retrovirus& and& lentiviruses& are& the& other& options& for& CRISPR/Cas9&
components&delivery.&Although&retrovirus&is&limited&to&dividing&cells&but&lentivirus&
is& able& to& transduce& both& dividing& and& nonAdividing& cells& (Smith,& 1995).&
Transgene&packaging&capacity&of&these&two&viruses&is&almost&10&Kb&(Nelson&and&
Gersbach,& 2016).& This& capacity& is& practically& good& for& knocking& out& of& one& or&
multiple& genes.& For& example,& Kabadi& et& al& (Kabadi& et& al.,& 2014)& have& used&
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multiplex&knock&out&using&single&lentiviral&virus.&Anyway,&knock&in&based&genome&
editing&usually&need&to&at&least&one&more&construct&including&gene&of&interest&and&
homology& arms& (Platt& et& al.,& 2014a).& It& seems& that& loading& of& lentiA& and&
retroviruses& with& CRISPR/Cas9& is& more& than& their& capability& for& packaging.&
Additionally,& major& problem& of& lentiA& and& retroviruses& is& their& random&
intergradation&to&the&host&genome&which&may&lead&to&insertional&mutagenesis&and&
cause& cancer& (Nelson& and& Gersbach,& 2016f& Shao& and& Wu,& 2010).& A& nonA
integrating&virus& that&has&a& large& transgene&capacity& is&baculovirus& (Kost&et&al.,&
2010).&Baculovirus&normally&infect&insect&cells&but&by&using&promoters&which&are&
active&in&mammalian&cells&(e.g.,&CMV,&CAG&and&etc.)&they&can&be&harnessed&to&
deliver& large& constructs& to& mammalian& cells& (Mansouri& et& al.,& 2016).& Recently&
using&baculovirus,&we& fused&GFP&exactly&before&stop&codon& in& the& last&exon&of&
HMGA1&(a&histone&protein&in&human&cells)&gene&(Mansouri&et&al.,&2016).&We&have&
reported& successful& knock& in& GFP& both& in& established& cell& line& (HEK293)& and&
primary&cell&(HUVEC).&&One&possibility&to&overcome&to&inability&of&virus&for& large&
cargo&delivery&is&coAinfection&of&cell&in&a&sequential&manner.&A&good&example&for&
this& case& is& lossAofAfunction& screening& for& certain& gene& knock& out& in& a& high&
throughput&assay.&Here,&cells&are&first&transduced&with&a&lentivirus&expressing&the&
Cas9&nuclease&and&then&select&to&be&ensure&that&they&are&expressing&a&high&level&
of& Cas9.& Cells& are& then& coAtransduced& with& a& lentivirus& expressing& a& pooled&
gRNA&library,&at&a&multiplicity&of&infection&(MOI)&such&that&each&cell&expresses&no&
more& than&one&gRNA.&Such& libraries&will& aid& in& the& study&of& gene& functions& via&
functional&genomics&in&human&cells&(Gilbert&et&al.,&2013,&2014).&One&drawback&of&
this& system& is& isolation&of& stable& cell& that& & express&Cas9,& expansion&and&again&
transduction&is&time&consuming&and&tedious.&&
In&the&first,&CRISPR/Cas9&system&has&developed&for& insertion&(KI),&deletion&and&
mutation& (KO)& in& the& targeted& place& in& the& genome.& KO& and& KI& have& many&
applications& in& molecular& cell& biology.& KO& can& be& used& for& study& of& gene&
functionality&even&in&large&scale&for&genome&wide&screening&(Gilbert&et&al.,&2014).&
Also,&KI&can&be&used&for&correction&of&a&mutation&that&led&to&disease&(Schwank&et&
al.,&2013),&make&reporter&cell&lines&(Wu&et&al.,&2016),&creation&of&modeling&animal&
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in&cancer&biology&harboring&mutation(s)&in&&different&genes&(SánchezARivera&and&
Jacks,&2015),&and&etc.&&
CRISPR/Cas9& system& is& not& only& a& tool& for& gene& editing,& but& also& it& can& be&
recapitulated& for& gene& regulation& (Sander& and& Joung,& 2014).& dCas9& protein,&
which&is&inactivated&form&of&Cas9,&retains&the&ability&to&target&specific&sequences&
through& the& gRNA.& dCas9& can& be& used& for& down& regulation& of& genes& in&
mammalian&cells&through&interfere&with&transcription&elongation&by&blocking&RNA&
polymerase&II&(Pol&II)&or&the&binding&of&important&transcription&factors&(Dominguez&
et&al.,&2015).&&This&genetic&perturbation&though&CRISPR&system&refer&as&CRSPRi&
(interference).& To& increase& repression& by& CRISPRi,& the& KRAB& (KrüppelA
associated&box)&or& four& concatenated&SID4X& (mSin3& interaction&domains)&were&
fused& to& dCas9& (dCas9& chimera).& Together& with& a& targetAspecific& gRNA,& the&
dCas9–KRAB& or& dCas9–SID4X& fusion& proteins& can& efficiently& repress&
endogenous& genes& in& mammalian& cells& (Gilbert& et& al.,& 2013,& 2014).& In& this&
approach,&K562& cells&were& stably& expressed& dCas9& chimera& and& then& infected&
with& lentivirus&bearing&gRNAs.&Conversely,& coAexpression&of& dCas9&with& recruit&
transcription& activators& that& mediate& gene& activation& is& called& CRISPRa&
(activation).& CoAexpression& of& dCas9& along& with& VP64& or& of& the& p65& activation&
domain& (p65AD)& in& mammalian& cells& lead& to& activation& of& endogenous& genes,&
with&a&single&gRNA&(Farzadfard&et&al.,&2013f&PerezAPinera&et&al.,&2013).&A&good&
example&for&CRISPRa&is&SunTag&system&which&is&a&coAexpressed&array&of&scFVA
GFPAVP64& fused& to& dCas9.&Sun&Tag& improved& genomic& imaging& by& amplifying&
the&fluorescent&signal&(Tanenbaum&et&al.,&2014).&Sun&Tag&transfected&to&HEK&and&
U2OS& cells& by& PEIAbased& transfection& procedure.& Also,& Sun& Tag& is& based& on&
constrictively& activation& of& gene& expression& whereas& using& inducible& promoter&
enable&temporal&gene&regulation&which&is&more&interested.&&
Also,&dCas9&can&be&used&for&regulation&of&epigenetic&events&in&mammalian&cells&
(Dominguez& et& al.,& 2015).& For& example,& coAexpression& of& histone& demethylase&
LSD1with&Neisseria&meningitidis&Cas9&(Nm&dCas9)&and&specific&gRNA&removes&
the&histone&3&Lys4&dimethylation&(H3K4me2)&mark&from&targeted&distal&enhancers&
and& leading& to& transcription& repression& (Kearns& et& al.,& 2015).& They& used& Nm&
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dCas9& which& is& an& orthogonal& and& substantially& smaller& Cas9& variant& allowing&
lentivirus& packaging.& Also,& Nm& dCas9& can& works& on& alternative& PAM&
(Protospacer&Adjacent&Motif)&sequences.&
dCasp&can&be&also&fused&to&a&domain&to&activate&gene&expression.&For&example,&
CoAexpression&of&dCas9&with&histone&acetyltransferase&p300&and&specific&gRNA&&
can&activate&transcription&through&acetylation&of&H3K27&(H3K27ac)&(Hilton&et&al.,&
2015).&
Thanks& to&multigene& expression& systems,&CRISPR/dCas9& can& be& also& used& to&
simultaneous& repression& and& activation& of&multiple& genes& in& single&mammalian&
cells&using&scaffold&RNAs&(Dominguez&et&al.,&2015).&Scaffold&RNAs&(scRNA)&are&
extended& form& of& gRNA& with& protein& binding& RNA& aptamers.& Zalatan& et& al&
(Zalatan& et& al.,& 2015)& shown& that& coAexpression& of& a& scRNA& against& βA1,4ANA
acetylAgalactosaminyl& transferase& 1& (B4GALNT1)& gene& and& dCas9& can& recruit&
expressed&aptamer&binding&protein&that&called&Com.&Com,&itself&is&fused&to&KRAB&
domain& and& can& repress& B4GALNT1& gene.& Simultaneously,& coAexpression& of&
scRNA,& dCas9,& and& aptamer& binding& protein& MSC& fused& to& VP64& activated&
CXCR4&gene&in&mammalian&cells.&&
 
Application)of)multigene)delivery)systems)in)cellular)reprogramming)
The&field&of&stem&cell&biology&has&undergone&rapid&development&in&recent&years.&
Some&features&make&stem&cells&very&attractive&in&medicine&and&industry.&First& is&
selfArenewal& property& of& stem& cells& that& enables& them& to& proliferate& unlimited&
times& while& maintain& their& undifferentiated& state.& Second,& their& remarkable&
potential&to&develop&into&many&different&cell&types&in&the&body&during&development&
(Martello& and& Smith,& 2014).& Three& methods& and& their& delivery& systems& that&
enable&to&change&the&cell& fate&are&discussed&here.&These&methods&are&included&
reprogramming& of& somatic& cells& to& stem& cells& (iPSC),& and& direct& conversion& of&
somatic&cells&to&somatic&cells&(trans&differentiation).&&
InducedA&Pluripotent&Stem&Cell&(iPSCs)&are&useful&technique&in&disease&modeling&
and&drug&discovery,& and& it& promises& to&provide&a&new&generation&of& cellAbased&
therapeutics& (Schlaeger& et& al.,& 2014).& Although& generation& of& iPS& cells& from&
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somatic&cells&by&protein& transduction&or& in&combination&with&small&molecules&as&
virusAfree&procedure&and& safe& is& possible,& but& reprogramming&efficiency& is& very&
low& (Nelson& and&Terzic,& 2009).& The&most& of& the& techniques& for& reprogramming&
and&transAdifferentiation&utilize&plasmids&or&related&viral&vehicles&that&carrying&one&
or& multiple& genes.& These& multigene& delivery& systems& overexpress& or& repress&
certain&transcription&factors&or&pathways&(Shao&and&Wu,&2010).& In&2006,&Shinya&
Yamanaka&made&a&groundbreaking&discovery&that&enable&to&‘reprogramme’&adult,&
specialized& somatic& cells& to& turn& them& into& stem& cells& state& (Takahashi& and&
Yamanaka,& 2006).& Yamanaka& induced& pluripotency&of& differentiated& cells& in&
vitro&to& generate& induced& pluripotent& stem& cells& (iPSCs)& through& retroviral& coA
transduction& of& four& transcription& factors& (TFs)& include& OCT3/4,& SOX2,& KLF4,&
MYC& (Known& as& OSKM& or& Yamanaka’s& factors)& (Takahashi& and& Yamanaka,&
2006).&However,&cMyc&may&be&reactivated& in& the& iPS&cells&during&differentiation&
and& then& induce& tumor& formation& (32&and&33& lijing).&Exclude&cAMyc& from&OSKM&
lead&to&generation&of&fully&functional&iPS&from&mouse&fibroblast&but&with&more&less&
efficiency& (Nakagawa& et& al.,& 2007).& Another& problem& of& this& reprogramming&
system& is& that& retroviruses&are& not& able& to& transduce&non&dividing& cells& (Smith,&
1995).& Also,& they& integrate& to& the& genome& and& increase& risk& of& tumorigenesis&
afterwards.&Lentivirus&encoding&Oct4,&Sox2,&Nanog&and&LinA28&has&been&used&to&
reprogram&human&fibroblast&into&iPS&cells&(Yu&et&al.,&2007).&To&increase&efficiency&
of& delivery,& lentivirus&was& generated& that& four& transcription& factors&were& on& the&
single&open&reading&frame&(ORF)&and&they&were&linked&together&by&selfAcleavage&
2A& (Sommer&et& al.,& 2009).&Conversely,&Carey&et& al,& reported& significantly& lower&
efficiency& of& this& reprogramming& system& than& single& vector& coAtransduction&
(Carey& et& al.,& 2009).& One& interpretation& is& coAtransduction& of& several& individual&
vectors& allows& to& express& factors& with& different& (and& optimal)& stoichiometry&
whereas&2A&system&support&near&equimolar&protein&expression.&Lentiviral&system&
may& also& lead& to& rearrangement& and& instability& of& chromosome& specially& when&
iPS&cells&are&differentiated&into&various&lineage&leading&to&tumor&formation.&Some&
groups& tried& to& tackle& this& problem& with& developing& of& doxycyclineAcontrolled&
lentiviral&vectors&(Hockemeyer&et&al.,&2008f&Maherali&et&al.,&2008).&Another&way&to&
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delivery& of& reprogramming& factors& with& viral& vectors& is& using& adenovirus& as&
vehicle.& Adenovirus& enable& overexpression& of& TFs& while& integration& into& host&
genome& is& very& rare.& & Stadtfeld& et& al.& generated& iPS& cells& from& mouse&
hepatocytes& using& adenovirus& that& expressed& oct4,& cAMyc,& Klf4& and& Sox2&
(Stadtfeld&et&al.,&2008).&Anyway,&efficacy&of&this&method&to&generate&iPS&cells& is&
low& (Shao& and& Wu,& 2010).& One& of& the& safe& method& with& lower& chance& for&
integration& into& the& genome& is& transient& transfection& of& TFs& in& somatic& cells.&
Yamanaka& and& Gonzalez& generated& iPS& cells& from& MEF& though& transient& coA
transfection&(Okita&et&al.,&2008)&or&a&single&polycistronic& (Gonzalez&et&al.,&2009)&
vector&encoding& four&TFs,& respectively.&Problem&of& transient& transfection& is& that&
primary&cells&usually&are&hard& to& transfect&and&also&gene&expression&duration& is&
usually& short.& An& alternative& for& plasmid& transfection& is& episomal& vectors.& This&
type& of& vectors,& such& as& OriP/EpsteinABarr& nuclear& antigeneA1& (EBNA1),& can&
replicate&autonomously&without&integration&into&host&genome&(Yates&et&al.,&1985).&&
Yu& (Yu&et& al.,& 2009)& cloned& seven&TFs& into& three& different&EBNA1& vectors& and&
generated& iPS& cells& from& human& fibroblast& cells.& Another& way& to& generate&
relatively&clean&iPS&cells&is&to&deliver&TFs&to&somatic&cells&using&piggyBac&system.&
Piggyback& system& is& a& class& II& mobile& genetic& elements& that& can& excise&
themselves&from&their&original&place&inside&the&genome&and&insert&themselves&to&
the& new& locus& within& genome.& Problem& of& episomal& vectors& and& piggyback&
systems& is& that& they& are& systems& that& rely& on& plasmids& transfection& whereas&
transfection& is& hard& in& some& cells& (like& primary& cells)& and& sometimes& it& can& be&
toxic& for& living&cells.&Baculocirus&can&be&an&option& to& reprogramming&of&somatic&
cells&to&iPSC.&Takata&et&al&reprogrammed&MEF&to&iPSC&by&baculovirus&encoding&
OKSM&TFs&in&the&single&ORF&separated&by&2A&selfAcleavage&sequence&(Takata&
et&al.,&2011).&&Baculovirs&has&great&capacity&to&deliver& large&DNA&constructs&but&
preparation&of&virus&harboring&all&expected&constructs,&due& to& rearrangement&of&
virus&genome&during&production,&is&difficult&(Fitzgerald&et&al.,&2006).&&
In&some&cases,& it& is&even&possible& to&directly&convert& fully&differentiated&mature&
somatic& cells& into& a& variety& of& other& somatic& cell& types& while& bypassing& an&
intermediate& pluripotent& state& via& transAdifferentiation& (Jopling& et& al.,& 2011).&
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Marius&developed&an&inducible&lentiviral&based&system&for&trans&differentiation&of&
MEF&directly&to& induced&neuron&(iN)&through&co&expression&of&Ascl1,&Myt1L&and&
Brn2& (Lujan&and&Wernig,&2013f&Vierbuchen&et&al.,&2010f&Wapinski&et&al.,&2013).&&
Although& these& viruses& integrated& to& the& genome& of& host& cells& but& their&
expression&were& inducible.& Therefore,& it& reduces& chance& of& reactivation& of& TFs&
after& transAdifferentiation&but&problem&of&random&integration&to&host&genome&still&
exist.&We&made&a&single&baculovirus&harboring&Ascl1,&Myt1L&and&Brn2& that&can&
express& each& TF& independently.& Then& we& trans& differentiated& MEF& to& neuron&
(Mansouri& et& al.,& 2016).& Advantage& of& this& system& is& that&MEF& cells& transduce&
with& a& high& efficiency& and& also& virus& does& not& integrate& to& the& genome.& Trans&
differentiation& has& been& also& used& to& direct& conversion& of& fibroblast& to&
dopaminergic& neuron,& motor& neuron,& hepatocyte& through& force& expression& of&
different&transcription&factor&based&on&lentiA&or&retroviral&systems&(Caiazzo&et&al.,&
2015f&Jopling&et&al.,&2011).&
Although& many& systems& have& developed& so& far& but& a& perfect& system& for&
reprogramming,& trans& differentiation& and& differentiation& would& be& a& single& nonA
integrating&system&that& is&able&to&deliver&multiple&TFs&or&inhibitory&factors&with&a&
high&efficacy&into&dividing&or&nonAdividing&mammalian&cells.&&
&
Application)of)multigene)delivery)in)synthetic)biology)
Synthetic&biology&aims&to&engineer&cells&by&introduction&of&genetic&circuits&in&order&
to& rewiring& endogenous& gene& regulatory& systems,& rescue& cellular& metabolism,&
and& regulate& cellular& behaviors& (Wang& et& al.,& 2013).& Synthetic& biology& is& also&
leading&to&creation&of& innovative&tools&for&disease&modeling,&drug&discovery&and&
production,&and&development&of&novel&therapeutic&approaches&(Abil&et&al.,&2015).&
Building& blocks& in& synthetic& biology& is& assembly& of& multiple& gene& circuits& and&
successfully&delivery&of&them&to&mammalian&cells&(Heng&et&al.,&2014f&Wang&et&al.,&
2013).& First& step& in& synthetic& biology& is& to& establish& some&methods& to& facilitate&
assembly& and& subsequence& deliver& genetic& circuits& faster,& simpler& and& more&
efficiently& (Guye& et& al.,& 2013).& One& of& most& useful& applications& of& synthetic&
biology& in& molecular& biology& is& construction& of& transcription& regulators.&
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Transcription&regulator&tool&enable&scientist&to&repress&or&activate&one&or&a&cluster&
of& genes& at& the& certain& time& (Way& et& al.,& 2014).& As&motioned& earlier,& fusion& of&
KRAB&and&VP64&to&Cas9&endonuclease&protein&and&co&expression&with&specific&
gRNA(s)&can&act&as&repressor&or&activator,&respectively&(Dominguez&et&al.,&2015f&
Maeder&et&al.,&2013).&&A&circuit&of&transcription&factors&can&also&be&engineered&to&
interact&with&endogenous&signaling&network& (Lienert&et&al.,& 2014).&Xie&and&et&al&
(Xie& et& al.,& 2011)& described& a& sensor& platform& consist& of&
transcriptional/posttranscriptional& synthetic& regulatory& circuit&which&were&able& to&
detect& a& pattern& of& up& to& six& endogenous& miRNAs.& This& sensor& platform&
transduced&via& lentivirus&to&HEK293&(as&normal)&and&HeLa&cell&(as&cancer&cell).&
Sensor& platforms& have& used& to& classify& cancer& cells& from& normal& cells& in& a&
mixture&HEK293/Hela&culture&cells&using&unique&miRNA&signature.&Here,&miRNAs&
are& usually& small& constructs& and&multiple& of& them& can& be& convey& by& lentivirus.&
Also,&lentivirus&can&transduce&a&broad&range&of&cells&enabling&broad&application&of&
this&sensor&platform.&Furthermore,&production&of&virus&is&relatively&fast&and&do&not&
need& to& special& equipment.& One& of& the& growing& subject& in& synthetic& biology& is&
genetic&switch& tools.& &For&example,& these& tools&can&be&used& for&control&of&gene&
expression& in&mammalian& cells.&Deans&et& al& have&developed&a& tunable&genetic&
switch& to& regulate& gene& expression& (Deans& et& al.,& 2007).& They& showed& that&
coupling& repressor proteins an nd an RNAi repressor could effectively turn off 
expression of GFP, Cre recombinase and diphtheria toxin genestoxin in different 
tested mammalian cells. They have used Lipofectamin 2000 for delivery of 
repressor and RNAi array to cells which is often toxic for cells. Also, primary 
cells are usually resistant to this type of transfection.& One& of& the& attractive&
applications& of& synthetic& biology& which& rely& on& multigene& delivery& systems& is&
generation&of&new&signaling&pathway&and&networks through&pathway&engineering&
in&mammalian&cells&(Lienert&et&al.,&2014f&Wang&et&al.,&2013).&Recently,&Morsut&et&
al&have&developed&a&synthetic&Notch&(synNotch)&pathways&(Morsut&et&al.,&2016).&
synNotch& is& a& chimeric& forms&of&Notch,& in&which& both& the& extracellular& and& the&
intracellular& of&Notch& receptor& are& replaced&with& heterologous& protein& domains.&
This&system&can&drive&userAdefined& functional& responses& in&diverse&mammalian&
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cell& types.& For& inastance,& they& engineered& a& double& synNotch& receiver& cells&
expressing& both& an& antiACD19& receptor& and& an& antiAGFP& receptor.& These& two&
receptors& were& each& linked& to& a& different& intracellular& transcription& activation&
domain& (Gal4AVP64&and& tTA& respectively)& that& in& turn& drives& a& distinct& reporter&
fluorescent& protein& (mCherry& and& tagBFP,& respectively).&Stimulation& of& receiver&
cells&by&a&sender&cells&(K562)&expressing&CD19&and&GFP&on&the&surface,&lead&to&
expression& of& both& mCherry& and& BFP& in& the& receiver& cells.& In& this& approach,&
chimeric&Notch& receptors& built& by& fusion& of& different& domain& though& 2A& system&
and& delivered& to& mammalian& cells& by& coAlentiviral& transduction.& In& this& case,&
Lentivirus&is&a&good&vehicle&because&it&can&transduce&nonAdividing&(e.g.,&neuron)&
and&dividing&cells&with&a&high&efficiency.&Another&application&of&synthetic&biology&
that& require& efficient& delivery& of& a& complex& gene& circuits& is& cell& engineering&
(Lienert& et& al.,& 2014f&Way&et& al.,& 2014).&One& important& example& in& this& case& is&
recapitulating& of& TAcell& receptor& (TCR)& signaling& pathway& in& nonAimmune& cells&
using& heterologousely& expression& of& more& than& 10& proteins& (James& and& Vale,&
2012).&they&have&used&a&combination&of&both&lentiviral&transduction&and&transient&
transfection&of&cells&for&this&TAcell&engineering.&Briefly,&they&made&a&cell&line&that&
constitutively&expressed&TCR&and&then&coAtransduced&or&coAtransfect&cells&using&
lentivirus&or&GeneJuiceAtransfection&reagent,&respectively.&Although&they&believed&
that& for& instance& co& transfection& with& four& individual& plasmids& leading& to&
expression&of&four&genes&simultaneously& in&the&single&cells,&but& in&our&hand&it& is&
very& difficult.& Usually& transfection& with& multiple& plasmid& generate& a&
heterogeneous& cell& population& which& make& it& difficult& to& analysis.& Design& all&
interested&genes&in&one&vector&(e.g.,&MultiLabel&system)&can&facilitate&generation&
of&homogenous&cell&population&that&all&cells&express&all&the&expected&genes&in&a&
favorite& level.& One& attractive& example& of& synthetic& biology& usage& in& clinical&
therapy&is&chimeric&antigen&receptor&(CAR)&therapy&(Lienert&et&al.,&2014).&In&this&
approach,&TAcell&of&patient&are&engineered&to&express&CAR,&which&is&specialized&
against&a&certain&antigen,&and&then&transfer&back&to&the&patients&(Brentjens&et&al.,&
2011f&Gross&et&al.,&1989).&CAR&based&TAcell&therapy&highly&depended&on&efficient&
and&safe&multigene&delivery&systems.&For&example,&a&synthetic&signaling&cascade&
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mediated&by&CARAbased&TAcells&has& reported& for& treatment&chronic& lymphocytic&
leukemia&(Porter&et&al.,&2011f&Ye&and&Fussenegger,&2014).&In&this&example,&CAR&
was& formed& from& fusion&of& four&different&domains:&an&antiACD19&single&chain,&a&
CD8αAderived& transmembrane& domain,& a& human&CD137Aderived& coAstimulatory&
domain,&and&a&CD3ζ&signaling&domain.&PatientAderived&T&cells&were& transduced&
with&CARAencoding& lentiviral& particles&and& then&were& injected& to&patient.&CD19A
positive&cancer&cells&were&recognized&by&CARAtransgenic&T&cells&which&resulted&
in& expansion& of& the& engineered&TAcell& population& and& killing& of& the& tumor& cells.&
Although&delivery&of&CAR&constructs&to&the&TACells&by&lentivirus&is&an&efficient&way&
but&due&to&some&concerns&about&lentivirus,&its&application&for&ex&vivo&experiments&
is& restricted.& Lentivirus& can& randomly& integrate& to& the& genome& of& TAcells.& This&
integration&may&lead&to&genetic&rearrangements&and&instability&of&chromosome&or&
even& it& can& induce& mutation& and& cancer& formation& (Smith,& 1995).& A& good&
application& of& multigene& expression& in& applied& synthetic& biology& has& shown& in&
cellular& studies& using& optogenetic& toolkits& (Tischer& and& Weiner,& 2014).&
Optogenetics& is& a& method& that& uses& light& to& modulate& molecular& events& in& a&
targeted&manner& in& living&cells&or&organisms&(Müller&and&Weber,&2013).& It& relies&
on& the& use& of& geneticallyAencoded& lightAsensitive& proteins& that& change&
conformation& in& the& presence& of& light& to& alter& cell& behavior,& for& example,& by&
activating& signaling& pathways& or& changing& the& membrane& voltage& potential& of&
excitable& cells& (Tischer& and& Weiner,& 2014).&The& most& frequently& used& light&
sensors& in& the& design& of& optogenetic& tools& for& eukaryotic& systems& are& PHYB&
(Phytochrom&B),&CRY2&(Cryptochrom&2),&LOV&(Light–oxygen–voltage)&domains,&
and&Dronpa& (Müller& and&Weber,& 2013f& Tischer& and&Weiner,& 2014).&One& of& the&
optogenetic&systems&that&highly&required&to&simultaneous&expression&of&different&
constructs&is&recently&described&by&Bergeijk&et&al&(van&Bergeijk&et&al.,&2015).&They&
have& established& an& optogenetic& tool& to& recruit& specific& cytoskeletal& motor&
proteins&(kinesin,&dynein&or&myosin)&to&selected&cargoes&within&cells.&This&system&
enabled& them& to& control& intracellular& transport& through& rapid& organelle&
repositioning&by&light.&For&example,&two&plasmids&harboring&individual&expression&
cassettes& (PEX3AREFALOV)& and& (ePDZAGFPAKinsin)& were& co& transfected& into&
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COSA7&cells& to&demonstrate& that& the&motility&of&peroxisomes&can&be& locally&and&
repeatedly& induced& or& stopped& by& light.& They& have& transfected& COSA7& and&
neuron& cells& by& Fugene6& transfection& reagent& and& Lipofectamin& 2000,&
respectively.& These& chemical& reagents& are& easy& to& work& but& viability& and&
homogeneity& of& transfected& cells& are& usually& lower& than& transduction& with& viral&
vecthors.&
&
Application)of)multigene)delivery)in)developmental)biology))
Developmental& biology& aims& to& understand& principles,& mechanisms& and&
dynamics&of&fundamental&biological&events&during&both&normal&development&and&
its&deviations&in&disease&([CSL&STYLE&ERROR:&reference&with&no&printed&form.]).&
In& many& cases,& it& is& required& to& analysis& expression& of& some& markers&
simultaneously.& Although& coAimmunostaining& of& different& markers& using&
antibodies&from&different&species&is&possible&but&it&cannot&extend&to&living&cells&or&
in&vivo&studies.&For&example,&analysis&of&novel&cell&reporter&lines&using&realAtime&
imaging&techniques&allows&visualization&of&the&activity&and&dynamics&of&signaling&
pathways& within& cells.& As& a& sample,& Dietrich& et& al& (Dietrich& et& al.,& 2015)&&
established&a&fluorescence&gene&trap&system&for&quantitative&description&of&gene&
expression& dynamics& at& a& singleAcell& resolution& in& living& mouse& embryos.& The&
gene&trap&cassette&was&consisting&of&a&splice&acceptor&(SA)&followed&by&IRES&site&
and&Venus& as& fluorescent&marker& and& transduced& into& a&Denuded& 2& cell& stage&
embryos& by& a& selfAinactivating& lentivirus.&This& system& allowed& them& to& build& a&
comprehensive&lineage&map&of&mouse&preAimplantation&development.&&
Multigene& delivery& system& also& can& help& to& study& role& and& mechanism& of& cell&
differentiation& during& development& by& over& expressions& or& down& regulations& of&
certain& multiple& genes& for& specific& duration& time.& For& example,& to& understand&
mechanism&of&regulation&in&neuronal&differentiation,&Packard&et&al&(Packard&et&al.)&
used& retroviralAvector& transduction& to& overAexpress& Pax6& and& Sox2& individually&
and&together&during&postAlesion&recovery.&They&found&out& that&Pax6&accelerates&
neuronal& production,& while& Sox2& retards& it& and& expands& the& pool& of& neuronal&
progenitors.& Lineage& tracing& is& another& method& that& highly& depending& to&
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multigene& expression& and& delivery& systems.& Although& established& techniques&
(like& brainbow)& are& based& on& transgenic& animals& but& usually& first& step& of& this&
techniques& need& to& delivery& of& multigene& constructs& to& embryonic& stem& cells&
though&viral&vectors&or&physical&methods&(Weissman&and&Pan,&2015).&&&
&&
Application)of)multigene)delivery)for)production)of)complex)proteins)
Expression& of& heterologous& proteins& in& E.& coli& host& system& often& remains& a&
convenient&choice& for&some& reasonsf& low&cost,& fast&growth&and&high&production&
yield& (Assenberg&et&al.,&2013b).&However,&production&of&heterologous&protein& in&
E.&coli&can&lead&to&insoluble&or&nonAfunctional&target&proteins&due&to&lack&of&postA
translational& modifications& like& mammalian& cells& (Tolia& and& JoshuaATor,& 2006).&
Therefore,& co& expression& of& multiple& genes& in& E.& coli,& like& nuclear& receptor&
partners&(Li&et&al.,&1997)&or&a&GroESL&chaperonin&(MartínezAAlonso&et&al.,&2010f&
Yan&et&al.,&2012),&along&with&desired&protein&can&partially&overcome&this&shortage.&
Ability&to&production&of&larger&and&glycosylated&recombinant&protein&with&a&higher&
yield& in& comparison& with& E.& coli& for& structural& biology& purposes& promoted&
multigene& expression& systems& in& insect& cells& (Assenberg& et& al.,& 2013bf& Berger&
and&Mayr,&2013).&One&of&the&most&relevant&systems&for&multiprotein&expression&in&
insect& cells& is& MultiBac& (Barford& et& al.,& 2013f& Bieniossek& et& al.,& 2012).& The&
MultiBac&allows&for&simultaneous&expression&of&multiple&proteins&in&a&single&cell,&
which&can&be&used& to&produce&protein&complexes&and& to& recapitulate&metabolic&
pathways&in&insect&cells.&Although&glycosylation&pattern&in&insect&cells&is&similar&to&
mammalian&cells&but&still&it&is&not&completely&the&same&(Assenberg&et&al.,&2013b).&
Many&attempts&have&been&performing&to&improve&&&glycosylation&pattern&in&insect&
cells.&Glycoengineering&of&either& the&baculovirus&or& its&host& insect&cells& through&
co& expression& of&mammalian& glycosyltransferases& is& one& of& the& strategies& that&
improve& this& drawback& (Aumiller& et& al.,& 2012f& Harrison& and& Jarvis,& 2006f&
Palmberger& et& al.,& 2012).& In& spite& of& all& the& achieved& progress,& production& of&
highly&glycosylated&mammalian&proteins&(such&as&secreted&proteins&or&membrane&
proteins)& in& insect& cells& should& be& consider& carefully.& Conversely,& mammalian&
expression& systems&are& the& systems&of& choice& for& production&of& therapeutically&
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important&human&proteins& in&a& functional& form& (Jenkins&et&al.,&2008f&Walsh&and&
Jefferis,& 2006).& The&mammalian& environment,& chaperone& systems& and& specific&
modifiers& (i.e.,& kinases,& phosphatases,& glycosylases,& and& others)& allowing& for&
native&postAtranslational&modifications&of&the&target&protein&are&the&most&privilege&
of&production&of&complex&proteins& in&mammalian&cells& (Trowitzsch&et&al.,&2011).&
Depending&on&the&experiments,&transient&gene&expression&(easier&and&faster)&or&
generation& of& stable& cell& line& (more& tedious& but& cheaper& and&more& relevant& for&
largeAscale& production)& can& be& applied& to& deliver& multipleAgene& constructs& to&
mammalian& cells.&Backliwal& et& al.& developed&an&optimized&protocol& that& though&
polyethyleneimine& (PEI),& transiently& coAtransfected& light& and& heavy& chains& of&
antibody& in& HEK293E.& They& achieved& an& antibody& expression& yield& of& 1& g/L&
(Backliwal&et&al.,&2008).&This&yield&is&in&the&rate&of&those&that&achieved&from&stable&
cell& lines.&Anyway,& transient& transfection& is& easier& and&process& can&be&done& in&
shorter&time&&than&stable&cell&line&generation.&It&seems&that&heavy&and&light&chains&
that&are&produced&in&the&same&cells&are&more&functional.&Luke&et&al&reviewed&that&
expressing&the&heavy&chain& in&one&cell&and&the& light&chain& in&another&cell&would&
not&produce&a&functional&product&(Luke&and&Ryan,&2013).&Some&strategies&help&to&
force&cells& to&express& light&and&heavy&chains& together.&For&example,&Fang&et&al&
(Fang&et&al.,&2005)&described&a&monoclonal&antibody&production&system&based&on&
2A&selfAprocessing&peptide.&This&system,&allowed&continuous&production&of&a&fullA
length& antibody& and& transiently& transfected& to& HEK& cells.& They& showed& that&
expression& of& the& same& antibody& using& internal& ribosomal& entry& sites& (IRES)&
leads&to&substantially&lower&expression&of&IRESA&based&antibody&in&HEK&293&cell&
(0.1& &µg/ml)& in&comparison&with&2AAbased&Ab& (1.6&µg/ml).& In&agree&with& results,&
Ho& et& al& (Ho& et& al.,& 2013)& compared& quality& and& expression& level& of& antibody&
produced&by&IRESA&or&furin&2AA&based&systems.&They&have&shown&that&although&
level& of& expressed& heavy& chain& and& light& chains& by& 2A& system& is& higher& than&
IRESA&mediated&expression&but&almost&40%&of&products&generated&by&F2A&were&
aggregated&showing&a&poor&post&translational&process&after&production&with&furin&
2A&system.&Also,&they&showed&that&ordering&of&heavy&and&light&chains&can&effect&
on& expression& level.& They& have& obtained& higher& rate& of& expression& when& light&
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chain& (and& not& heavy& chain)&were& in& the& first& cistron.& Therefore,& a& system& that&
ensure& co& expression& of& both& light& and& heavy& chain& in& the& same& ratio& and&
independent& from&ordering&of& genes& is&more&desirable.& In& agreement,&we&used&
baculovirus& to&deliver& individual&heavy&and& light& chains,&harboring&on& the&same&
vector,& in& mammalian& cells& and& insect& cells.& We& produced& recombinant& fully&
functional&IgG&from&scFV&in&HEK293&and&primary&HUVEC&cells.&In&the&same&way,&
Goehring&have&used&BacMam&(baculovirusAmediated&transduction&of&mammalian)&
technology& for& production& and& screening& of& recombinant&membrane& proteins& in&
mammalian& cells& (Goehring& et& al.,& 2014).& It& seems& that& BacMam& system& is& a&
good&choice&when&transient&transfection&of&large&protein&with&high&rate&of&delivery&
is&needed.&Recently&Coleman&et&al&(Coleman&et&al.,&2016)&has&produced&human&
serotonin& transporter& (SERT)&into&HEK293S&GnTI−&cells&using&BacMam&system&
for&structural&biology&research.&Additionally,& they&reported&XAray&crystallographic&
structures& of& human& SERT,& which& was& co& expressed& with& GFP,& at& 3.15xÅ&
resolution.& Mammalian& cells& can& also& be& used& for& largeAscale& production& of&
AdenoAassociated& virus& (AAV)& requiring& for& gene& therapy& (Ayuso,& 2016).&
Production&of&AAV&viruses&for&gene&therapy&usually&can&be&performed&either&by&
co&transfection&of&three&plasmids&(pAAVAtransgene,&pAAVrep2/cap8&and&pHelper)&
in&HEK&cells&(Grimm&et&al.,&1998)&or&two&plasmids&(BacAAAV&transgene&and&BacA
rep2/cap8)&in&baculovirus&(Kotin,&2011).&
In&the&all&mentioned&applications,&a&robust&multi&gene&expression&strategy&as&well&
as& a& reliable& delivery& system& for& production& of& desired& complex&
protein/component&is&needed.&&
&
Application)of)multigene)delivery)in)cell)signaling)and)trafficking)
Monitoring&and&analysis&of&different&parameters&within&living&cells&may&need&to&coA
expression& of& multiple& fluorescently& tagged& biosensors& (BallmerAHofer& et& al.,&
2011),&coAoverexpression&of& impaired&proteins&(Berger&et&al.,&2011),&or&up/down&
regulation& of& multiple& genes& (Greber& and& Fussenegger,& 2007).& We& have&
developed& a& series& of& different& intracellular& biosensor& systems,& such& as& Rab&
GTPases&regulating&vesicular&membrane&traffic&in&cells,&phosphoinositide&binding&
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signaling&proteins&or&fluorescentlyAlabelled&cytoskeletal&markers&(Kriz&et&al.,&2010f&
Mansouri& et& al.,& 2016).& These& biosensors& were& simultaneously& delivered& and&
expressed&in&mammalian&cells&allowing&to&quantitatively&monitor&a&large&variety&of&
intracellular&parameters.&For&example,&using&Rab&biosensors,&we&studied&cellular&
trafficking&of&EGFA&receptor&after&activation&with&EGF&(Mansouri&et&al.,&2016).& In&
this&case,&we&transduced&COSA7&cells&with&a&baculovirus&harboring&three&different&
labeled& Rab& GTPases& biosensors& which& were& able& to& localize& in& different& cell&
compartments& .& CoAlocalization& of& receptorAligand& complex& with& Rabs& markers&
evaluated&by&Squassh&(Rizk&et&al.,&2014)&or&SquasshAnalyst& (Rizk&et&al.,&2015)&
softwares& over& the& time.& This&method& is& a& fair& way& to& complete& delivery& of& all&
interested& biosensors& simultaneously& in& many& cells& (including& primary& cells).&
Anyway,& generation& of& baculovirus& in& comparison& with& the& other& viruses& (like&
Lentivirus,&adenoviruses)&is&more&time&consuming.&&
Other&important&techniques&for&in&proteinAprotein&interaction&studies&which&require&
multiAgene& delivery& systems& are& BiFC& (Bimolecular& fluorescence&
complementation),& BRET& (bioluminescence& resonance& energy& transfer),& FRET&
(fluorescence&resonance& energy& transfer)& and& split& luciferase& complementation&
assays&(Kaláb&and&Soderholm,&2010f&Trowitzsch&et&al.,&2011).&The&BiFC&assay&is&
based&on&reconstitution&of&an&intact&fluorescent&protein&when&two&complementary&
nonAfluorescent& fragments&are&brought& together&by&a&pair&of& interacting&proteins&
(Miller& et& al.,& 2015).& FRET& relies& on& the& distanceAdependent& transfer& of& energy&
from&a&donor&molecule& to&an&acceptor&molecule.&FRET& is& the&method&of&choice&
for& analyzing& shortAterm& interactions& of& proteins& in& living& cells& (Kaláb& and&
Soderholm,& 2010).& Parsons& et& al.& (Parsons& et& al.,& 2016)& have& used& BiFC& to&
measure& initiator& caspases& (caspaseA2,& A8,& andA9)& activation.& They& have& fused&
nonAfluorescent& fragments& of& the& fluorescent& protein&Venus& to& initiator& caspase&
monomers.& After& transient& coAtransfection,& the& initiator& caspaseABiFC& fusion&
proteins& remain& as& monomers& in& unstimulated& cells.& Following& a& caspase&
activating&stimulus,& the&caspase&fusion&protein&monomers& interact& to&each&other&
so& that& they& refold& and& reconstitute& the& full& length& Venus& protein,& leading& to&
fluorescence.&Also,&Lucker&et&al&(Luker&and&Luker,&2016)&described&a&dualAcolor&
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click&beetle&luciferase&complementation&assay&for&cellAbased&analysis&interactions&
of& two&different&chemokine&receptors,&CXCR4&and&ACKR3,&with& the& intracellular&
scaffolding&protein&βAarrestin&2.&This&assay&provided&a&realAtime&quantification&of&
receptor&activation&and&signaling&in&response&to&chemokine&CXCL12.&They&used&
either&IRES&or&2A&system&for&co&expression&of&different&either&fluorescent&proteins&
or& selectable& markers& along& with& proteins& of& interest& to& distinguish& cells& that&
received&both&receptors&and&βAarrestin&2.&Hida&et&al&(Hida&et&al.,&2009)&dissected&
luciferases&from&firefly&(FLuc),&click&beetle&in&green&(ELuc),&and&click&beetle&in&red&
(CBR)& to& the& NA& and& CAterminal& parts.& Then,& the& NAterminal& and& CAterminal&
fragments& were& fused& to& FK506Abinding& protein& (FKBP)& and& FKBPAbinding&
domain& (FRB)& and& coAexpressed& in& mammalian& cells& and& the& luminescence&
intensities& were& examined& using& a& luminometer.& This& system& is& an& imaging&
method& for& realAtime& analysis& of& proteinAprotein& interactions& using& multicolor&
luciferases&with&different&spectral&characteristics.&
In&all& the&mentioned&examples,&using&a&reliable&multigene&delivery&system&allow&
coAexpression&of&full&or&halves&of&fluorescent&proteins&and/or&luciferase&fragments&
which& are& fused& to& interested& proteins.& Although& coAexpression& of& induvial&
plasmids&is&easy&but&find&the&cells&expressing&both&constructs&are&difficult.&Also,&
cleaved& proteins& of& interest& can& be& expressed& along& with& different& fluorescent&
proteins& or& selectable& markers& using& IRESA& or& 2AA& based& systems.& These&
procedures&allow&to&select&cells&that&express&all&expected&fragments&by&FACS&or&
combination& of& antibiotics& selection.& Some& systems& like& MultiLabel& and&
MultiPrime& can& provide& split& fragments& as& well& as& fluorescent& protein& or&
selectable&marker&in&a&single&vector.&&&&
&
Application)of)multigene)delivery)in)immunology)and)gene)therapy)
Gene& therapy& is& the& introduction& of& new& genetic& material& into& the& cells& of& an&
individual&for&therapeutic&purposes.&Therapeutic&proteins&are&usually&expensive&to&
produce,&have&a&short&halfAlives&of&stability,&and&need&to&administration&frequently&
(Chernajovsky& et& al.,& 2004).& Therefore,& gene& therapy& can& be& an& alternative&
method& to& overcome& to& these& drawbacks.& In& the& other& hand,& some& therapeutic&
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proteins& are& either& relatively& large& and& complex& or& need& to& be& express& in&
combination& with& other& proteins& for& a& better& effect.& Here,& a& multigene& delivery&
system& can& fairly& facilitate& delivery& of& all& desired& therapeutic& proteins.& For&
example,& Fang&et& al& generated& a& rAAV& encoding& single& ORF& VEGFR2A
neutralizing& mAb& DC101& (rAAV8ADC101)& using& a& 2A& selfAprocessing& system.&
rAAV& is&a&preferred&vector& system&when& longAterm&gene&expression& is&desired.&
rAAV& vectors& can& stably& transduce& host& cells& and& are& capable& of& expressing&
therapeutic& proteins& at& high& constant& levels&in& vivo&following& a& single& vector&
administration& (Fang&et&al.,&2005).& &Recently,&GianniABarrera&et&al&have&made&a&
retrovirus& encoding& single& bicistronic& construct& coAexpressing& VEGFAA& and&
PDGFABB&spaced&apart&by&IRES&sequence&(VEGFAIRESAPDGFB).&CoAdelivery&of&
VEGFAA& and& PDGFABB& promoted& longAlasting& and& safe& angiogenesis& in& a&
schemia& mouse& model.& In& this& case,& expression& of& VEGF& and& PDGFB& were&
imbalanced&due& to&using& IRES&sequence& (GianniABarrera&et&al.,&2016).&Using&a&
single& 2A& peptide–linked& retroviral& vector,& Szymczak& et& al& could& restore& TAcell&
development& and& function& in&CD3Adeficient&mice& (Szymczak& et& al.,& 2004).& This&
retroviral&vector&was&containing&of&all&four&CD3&proteins&(CD3&ε,&γ,&δ,&ζ)&of&TAcell&
receptor:CD3& complex.& Although& 2A& systems& ensure& equivalent& level& of& all& the&
domain& but& postAtranslational&modifications& (NA& and& CAterminal& alternation)& can&
effect&on&the&functionality&of&the&complex&proteins.&&&
Multiprotein& expression& system& can& be& harnessed& for& vaccine& development.&
Hoffmann& et& al& developed& an& eightAplasmid&DNA&transfection&system&for& the&
rescue&of&infectious&influenza&A&virus&(H6N1)&from&cloned&cDNA&(Hoffmann&et&al.,&
2000).& In& this& plasmidAbased& coAexpression&system,& eight& plasmids& harboring&
single& cDNA& transfected& into& coAcultured& MDCK& and& 293T& cells.& This& strategy&
profits&from&the&fact&that&a&replication&competent&virus&is&produced.&It&is&therefore&
sufficient& that& only& a& small& portion& of& the& cells& take& up& all& eight& plasmids.&
Production&of&virus&like&particles&(VLPs)&is&another&example&than&can&show&role&of&
multigene&delivery&systems&in&vaccine&development&research.&VLPs&consisting&of&
components&of&a&virus&without& its&genetic&material&can&be&used&to&produce&safe&
vaccines&(Roy&and&Noad).&VLPs&were&shown&to&stimulate&the&immune&response&
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and& could& replace& attenuated& viruses& that& are& currently& used& for& vaccination.&
Many&of&the&VLPs&synthesized&for&vaccine&development&have&already&entered&the&
preclinical&stage,&or&phase&I,&or&were&licensed&as&vaccines&(Noad&and&Roy,&2003).&
Tang&et&al&produced&VLP&though&transduction&of&mammalian&cells&by&baculovirus&
(Tang& et& al.,& 2011).& In& this& BacMam& system,& three& CMVApromoters& drive& the&
hemagglutinin,& neuraminidase,& and& matrix& of&influenza&virus&was& constructed.&
After&transduction&of&HEK&293&cells&with&BacMam&virus,& influenza&VLP&secreted&
to&the&medium.&&
Targeted& immunotherapy& is& another& attractive& subject& that& clearly& depicting&
importance&of&multigene&delivery& in&a&potent& therapy& (Maude&et&al.,&2015).& In&a&
chimeric&antigen&receptor&engineering&approach,&T&cell&of&patient&are&isolated&and&
retarget& toward& cells& with& the& targeted& surface& antigens& (Gross& et& al.,& 1989).&
Three&generation&of&CAR&are&available&which&in&addition&to&extracellular&domain&
coAexpress&different&intercellular&domains:&CD3ζ&intracellular&signaling&domain&of&
the&TAcell&receptor&either&alone&(first&generation)&or&in&combination&with&1&(second&
generation)&or&2&(third&generation)&costimulatory&domains&(Maude&et&al.,&2015).&&
For& gene& therapy,& safety& of& multigene& delivery& vehicle& has& first& priority.& Some&
physical&approach& like& in&eutro&gene&delivery& can&be&used& to& transfer&genes& to&
some& specific& tissues& (e.g.,& brain)& but& it& is& limited& to& animal.& ChemicalA& based&
multigene& delivery& usually& suffer& from& toxicity& although& some& progress& using&
nanoparticles& has& reported.& Using& viral& vectors& due& to& possibility& of& virus&
integration& to& the& host& genome& and& beyond& problem& like& induction& of&mutation&
causing&cancer,&is&restricted.&NonAintegrating&viral&vectors&that&are&able&to&deliver&
multigene&constructs&can&be&an&option&but&more&research&in&this&area&is&needed.&&
&
&
Conclusion)
Multigene&delivery&and&subsequent&cellular&expression&is&a&key&technology&for&a&
wide&range&of&applications&in&current&biology.&Depending&on&the&mammalian&cell&
type& (established& cell& lines,& primary& cells& or& stem& cells)& many& strategies& and&
methods& are& available& for& delivery& of&multigene& constructs& albeit& each& of& them&
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with& their& own& merits.& Depending& to& the& interested& experiments,& generation& of&
stable& cell& line& or& transient& gene& expression& (TGE)& system& can& be& chosen.&
Although& for& production& of& recombinant& proteins& in& large& scale& generation& of&
stable&cell& line&can&be&a&good&choice&but& it& is&anyway&a& tedious& task&and& takes&
long& time& (weeks).& TGE& systems& are& easy& to& work& and& desired& result& can& be&
prepared&very&fast.&Anyway,&some&cells&(like&primary&cell&and&stem&cells)&are&hard&
to& transfect.& A& variety& of& chemical& and& physical& methods& for& transferring&
multigene&cassettes& to&mammalian&cells&are&available.&Although& these&methods&
are& easy& to& use& but& they& have& often& toxic& effect& on& the& cells& or& have& some&
limitations& for& in& vivo& applications.& ViralA& based&methods,& conversely,& are&more&
natural& but& production& of& virus& usually& is& time& consuming& and& raise& some&
biosafety&issues.&Viral&systems&usually&lead&to&high&infection&rates&(up&to&100%),&
but& their& capacity& as& carriers& of& foreign& DNA& is& limited& and& the& expression& is&
usually&transient.&&&
To& choose& a& suitable& strategy& for& multigene& assembly& some& parameters& like,&
duration& time& for& gene& expression,& availability& of& numerous& antibiotics,&
modification& of& NA& and& CAterminal& of& proteins,& stoichiometry& ratio& of& genes& of&
interest,&homogeneity&or&heterogeneity&of&cell&population&and&biosafety&should&be&
carefully& considered.& We& have& developed& two& multigene& expression& toolkits,&
MultiLabel& and&MultiPrime,& to& facilitate&multigene&expression& for& easy&and&hard&
cells& to& transfection.& Both& systems& leading& to& homogenous& cell& population,& no&
modification& in& NA& and& CAterminal& of& interested& proteins,& expression& in& desired&
levels&and&individually.&&&
We& have& outlined& in& this& review& a& broad& range& of& applications& that& could&
potentially& improve& both& research& and& production.& Multigene& delivery& and&
subsequent& expression& could& be& instrumental& for& the& production& of& important&
multiprotein& assemblies& such& as& antibodies& or& VLPs.&Genome& editing& specially&
for& in&vivo&application&demand&to&a&reliable&system&that&enable&delivery&of&Cas9&
and&other&necessary&components& in&a&safe&and&amenable&manner& to& the& target&
cells.& Synthetic& biology& would& need& to& easier,& or& automated& able& multigene&
assembly& techniques& to& accelerate& creation& of& new& devices& for& manipulation,&
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construction&and& reAorganization&of&cell&behaviors.&Moreover,&we&anticipate& that&
many& researches& in& contemporary& research& and& drug& discovery& applications,&
benefit&from&multigene&delivery&and&expression&in&mammalian&cells.&&
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Table#1.#comparison#between#viral#gene#delivery#systems#
!
# Baculovirus# lentivirus# Adenovirus# Adeno<associated#virus#(AAV)# Retrovirus#
Infection#of#
dividing#cells# Yes# Yes# Yes# Yes# Yes#
Infection#of#non<
dividing#cells# Yes# Yes# Yes# Yes# No#
Genome#
integration# No# Yes# No# No# Yes#
Size#of#the#wild#
type#genome# 134#kb# 9.7#kb# 37.7# 4.7#kb# 8.3#kb#
Biosafety#level# BSL1# BSL2# BSL2# BSL1# BSL2#
Cargo#capacity# Up#to#50#kb# 2.5<5.0#Kb# 3.0<8.0#Kb# 2.5#kb# 2.5<5.0#Kb#
Packaging#cells# Insect#cells/27#oC# HEK293T/37oC# HEK293T/37oC# HEK293T/37oC# HEK293T/37oC#
!
!
!
Table#2.#Advantages#and#disadvantages#of#different#strategies#for#multigene#delivery#to#
mammalian#cells#
strategy# technique# advantages# disadvantages#
Co<transfection/#
co<infection#
*Several#plasmids#or#
virus#bearing#individual#
gene#
*#Fast#and#straightforward#
#
*#Generation#of#heterogonous#cell#population##
*#Different#level#of#gene#expression#
*#Difficult#to#analysis#the#results#
IRES# *Single#transcript#with#
multiple#sites#for#
translation#initiation#
*#Co#expression#of#all#genes#
*#Ideal#for#co#expression#of#
markers#or#antibiotic#
resistance#genes#
*#Imbalanced#level#of#expression#
*#Different#activity#in#different#cells#
polyprotein# *#Protease/proteolytic#
processing#
*#Reinitiation#
*#2A#and#ribosomal#
skipping#
#
*Ensured#co<expression#
*Ideal#for#multigene#
expression#
*A#variety#of#sequences#is#
available#
*#N<#or#C<terminal#modification#of#proteins#of#
interest#
#
Direct#assembly# *#Multiple#transcription#
units#with#their#own#
promoters##
*#Flexible# *#Consider#many#items#for#cloning#design#
*#Restricted#to#certain#enzymes#
*#Decrease#efficiency#by#increasing#number#of#
genes#
MultiLabel# *#Multiple#expression#
cassettes#in#one#single#
plasmid#
*Every#gene#has#its#own#
promoter#
*ideal#for#multigene#
expression#
*#Large#size#
*#Restricted#to#transfection#approach#
*#Low#efficiency#in#primary#and#stem#cells#
MultiPrime# *#Multiple#expression#
cassettes#in#one#single#
baculovirus#
*Every#gene#has#its#own#
promoter#
*Ideal#for#multigene#
expression#
*High#efficiency#in#primary#
and#stem#cells#
*#Rearrangement#of#virus#during#over#amplification#
*#Need#to#insect#cell#culture#facilities##
#
!
!
!
!
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or   certain   cell   types   including   widely   used   HEK293   and   HeLa   cells,   multigene  
delivery  can  be  achieved  by  plasmid-­based  transfection.  However,  a   large  number  
of   cell   lines   and   particularly   primary   cells   are   recalcitrant   to   plasmid   transfection,  
thus   requiring   a   different   approach.   Infection   by   viral   vectors   as   an   efficient   way   can   be   an  
alternative.     However,  most  of   the  common  viral  vectors  (Lentivirus,  Retroviruses,  Adenovirus,  
AAV)   suffer   from   one   or   more   of   the   following   disadvantages:   inability   to   infect   non-­dividing  
cells,   small   transgene   packaging   capacity,   and   risks   associated  with   insertional  mutagenesis.  
Baculovirus,  which   normally   infects   insect   cells,   can   be   used   to   overcome   these   bottlenecks.  
Therefore,   I   developed   the   MultiPrime   system,   which   is   a   baculovirus-­mediated   multigene  
delivery  system  for  mammalian  cells  (Mansouri  et  al.,  2016).  
This   chapter   contains  my   original   paper  which  was   recently   published.   In   the   introduction  
part,   I   explain   the   importance,   concept   and   workflow   of   the   MultiPrime   system.   In   the   result  
section,  I  demonstrate  possibilities  of  MultiPrime  for  simultaneous  delivery  of  multiple  genes  to  a  
variety   of   cells   including   cell   lines,   primary   cells   and   stem   cells.   Also,   I   show   different  
applications  of   the  MultiPrime  system  for  example   for   reprogramming   fibroblasts   into  neurons,  
for  producing  functional  antibodies  and  for  CRISPR/Cas9-­mediated  genome  engineering.    
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MULTIPRIME  UNLOCKS  MULTIGENE  DELIVERY  TO  PRIMARY  MAMMALIAN  CELLS  
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Multigene delivery into cultured cells or tissues isemerging as an indispensable tool for manyapplications in biological research and development.
Examples include simultaneous labelling of living cells with various
fluorescently-tagged sensors for monitoring changes in cellular
architecture or metabolism, lineage tracing during morphogenesis
to follow regenerative tissue processes, visualization of multi-
component molecular pathways for high-content screening in
pharmacological applications or the construction of recombinant
adeno-associated viruses for gene therapy1–5. Multigene delivery
systems also allow reprogramming of somatic cells to stem cells6 or
to specifically differentiated cell lines7. The construction of
complex multigene circuits in mammalian cells is a core concept
in synthetic biology requiring the flexible generation of modular
multigene expression systems8,9. Moreover, structural and
biophysical characterization of multiprotein complexes relies on
co-expression of an ensemble of genes that may include ancillary
factors, such as chaperones or protein modifying enzymes10. All
applications share in common that they require versatile tool-kits
to flexibly engineer and to simultaneously, efficiently and
reproducibly deliver multiple genes into target host cells.
Several strategies for multigene expression in mammalian cells
exist, each with its own merits11. All of these applications require
specific boundary conditions. For instance, it is essential that
all transfected cells in a population express all heterologous genes
at the same defined level, on an equal time frame. Other
applications require that the proteins of interest retain native
N- or C termini. Furthermore, long-term stable expression versus
transient expression is a crucial parameter to be considered.
Ideally, an efficient multigene-delivery system would provide the
means to afford many or all of these requirements.
We have developed systems for the delivery of multigene
constructs in prokaryotic and eukaryotic hosts12–14. A central
feature of these technologies is the assembly of multiple gene
expression cassettes by recombineering15, from custom designed
plasmids encoding specific genes, into a single multicomponent
DNA construct for gene delivery. This approach was shown to
overcome the limitations hampering classical co-transfection or
co-infection techniques, which for statistical reasons, are
inherently unbalanced16,17. More recently, we introduced
MultiLabel14 and demonstrated that homogenous mammalian
cell populations could be achieved by transient introduction of
single recombineering-based multigene expression plasmids by
classical transfection methods. This method performs well with
cell lines that are readily transfected, such as HEK293 or HeLa
cells. However, a large number of cell lines and particularly
primary cells are markedly recalcitrant to plasmid transfection,
thus requiring a different approach. Primary cells are a central
focus of contemporary biological research efforts, and efficient
multigene delivery in primary cells is thus highly desirable.
Infection by viral vectors emerged as the dominant method of
choice to deliver genes into primary cells18. An ideal viral vector
for multigene delivery should have virtually unlimited foreign
DNA cargo capacity allowing for integration of a multitude of
independent expression cassettes, functionalities and regulatory
elements. Moreover, such an optimal viral vector should exhibit
low cytotoxicity in mammalian cells and should enable
transduction of dividing and non-dividing mammalian cells
alike. Currently used lenti- and other retroviruses, as well as
adeno- and adeno-associated viruses have a limitation on DNA
cargo size due to spatial constraints imposed by the tight
geometry of their capsids.
Baculoviral vectors, in contrast, can accommodate very large
DNA cargo insertions19. The Autographa californica multiple
nuclear polyhedrovirus (AcMNPV), is a baculovirus with a large
(134 kb) double-stranded circular DNA genome that normally
infects specific moth larvae19. Transgene capacity of AcMNPV is
very large, extending probably beyond 100 kbp. Replication of
AcMNPV is highly insect-cell specific; however, AcMNPV is
capable of efficiently transducing not only insect but also
mammalian cells. Transduction is usually transient without
DNA integration into the target cell genome and such viruses
are replication deficient20,21. In baculoviruses used for
mammalian cell transduction (BacMam)22,23 heterologous genes
are placed under the control of mammalian promoters and
inserted into the baculoviral genome, and viral stocks are
produced in insect cells. Once the baculovirus enters
mammalian cells, these genes are actively transcribed within 9 h
and the cells produce the heterologous gene product. In the last
decade, baculovirus has emerged as a useful and safe technology
to deliver heterologous genetic material to mammalian cell types
both in vitro and in vivo24.
Here we introduce MultiPrime, a novel tool-kit specifically
designed for efficient delivery of large multigene constructs into
primary and established mammalian cells. MultiPrime enables
simultaneous expression of multiple, independent cassettes in
mammalian cells. This system combines the ease and flexibility
of our recombination-mediated multigene DNA assembly
technology with the superior performance of baculovirus as a
viral vector for transducing mammalian cells. We transduced
with MultiPrime a large variety of cell types including difficult to
transfect stem cells and primary neurons. Moreover, we
utilized MultiPrime for reprogramming mouse embryo
fibroblasts (MEFs) into neurons. Further, we show that our
system is not limited to mammalian transduction but can also be
used to transduce zebrafish embryos. We applied our system to
create synthetic multicomponent intracellular biosensor
systems, such as Rab GTPases regulating vesicular membrane
traffic in cells, phosphoinositide binding signalling proteins or
fluorescently-labelled cytoskeletal markers. These biosensors were
simultaneously delivered and expressed in mammalian cells
allowing to quantitatively monitor a large variety of intracellular
parameters. A wide range of promoters are available in
MultiPrime, to regulate and fine-tune individual heterologous
target gene expression.
With the objective to provide a means to concomitantly exploit
with one single expression system the advantages of high-level
protein production in baculovirus-infected insect cells and
protein expression in a ‘native’ mammalian environment, we
incorporated dual-host-specific promoters in MultiPrime that are
functional in both insect and mammalian cells.
Our MultiPrime system is not limited to the assembly of RNA
polymerase II-based expression cassettes. It can likewise harbour
U6-driven expression cassettes and homology constructs that are
required for CRISPR/Cas9-mediated genome engineering. We
demonstrate the aptitude of our system by applying MultiPrime-
CRISPR/Cas9 to express a HMGA1-EGFP fusion protein in
primary cells from the native genomic HMGA locus.
Results
MultiPrime system design. We developed MultiPrime specifi-
cally to overcome the limitations of transfecting mammalian cells
for multigene transfer applications. We redesigned our previous
pFL plasmid25, which contains the Tn7R and Tn7L DNA
elements required for Tn7-transposase-mediated integration
into a baculovirus genome containing a Tn7-attachment site26.
Expression cassettes with promoters active in mammalian cells,
or, alternatively, with activity in both mammalian and insect cells,
were inserted into this MultiPrime acceptor plasmid. This
acceptor plasmid is poised to receive further multigene express-
ion cassettes by incorporating donor plasmids (Supplementary
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Figs 1–3). All donors from our previous plasmid-based
MultiLabel system can be used for incorporation into this new
acceptor to generate acceptor-donor fusions by recombineering.
Moreover, expression cassettes can be freely exchanged between
donors and acceptors due to the modular design14.
Acceptors or acceptor–donor fusions containing multigene
expression cassettes are integrated into baculoviral genomes by
means of Tn7 transposition25. We utilized two different
baculoviral genomes in our experiments. In addition to our
EMBacY baculoviral genome25 we generated in this study a new
baculoviral genome, MultiBacMam, which expresses a vesicular
stomatitis virus glycoprotein (VSV-G) and the fluorescent protein
mCherry in insect cells during virus production. Both genomes
were generated from the original MultiBac virus by integrating
genes encoding EYFP (EMBacY) or mCherry and VSV-G
(MultiBacMam) by Cre recombination into the LoxP site
present on the MultiBac virus12,25. The expression of mCherry
results in a characteristic purple colour of MultiBacMam
infected cell cultures (Supplementary Fig. 1), thereby
simplifying the tracking of virus amplification by eye.
Moreover, the MultiBacMam virus gives rise to baculovirions
displaying VSV-G on their surface. The presence of VSV-G in the
baculoviral envelope has been shown to increase the efficacy of
mammalian cell transduction27. All composite baculoviruses
prepared in this study were produced in Sf21 cells. Virus was
obtained with comparable efficiency and resulting in similar viral
titers to what we had observed in previous multigene expressions
in insect cells with recombinant MultiBac or EMBacY viruses25.
Our multigene viruses are characterized by multiple use of
regulatory elements such as the CMV promoter, which in theory
could introduce genomic instability during repeated rounds
of viral amplicfication14,25. We had developed previously
efficient protocols to amplify baculoviral constructs containing
multiple copies of late viral promoters (polh and p10) by
stringently applying a low multiplicity of infection (MOI)
regimen and few, ideally not more than two amplification
rounds thus preventing accumulation of non-productive viruses
containing genomic deletions28. Strictly adhering to this
strategy for amplifying baculoviruses containing multiple copies
of CMV promoter-driven expression cassettes again resulted in
stable virus producing all proteins of choice in each transduced
mammalian cell in homogenous cultures, while failure to adhere
to the protocol resulted in heterogeneous cell populations where
expression of individual heterologous genes had been lost,
presumably due to accumulation of deletion virus species
(Supplementary Fig. 4). Occasionally, we observed cell fusion in
tissue culture plates of insect cells infected with MultiBacMam
viruses, which, however, was found not to be detrimental to
transduction experiments with the viral supernatant. In the
following, we use the EMBacY baculoviral genome to prepare
composite MultiPrime baculoviruses, unless indicated otherwise.
Transduction and viability. As proof-of-concept, we generated a
composite MultiPrime baculovirus expressing five fluorescently-
tagged proteins (EBFP2-nucleus, mTFP1-FYVE (PI-3-P-binding,
early endosomes), EYFP-tubulin, Mito-dsRED (mitochondria)
and Plum-PLCd-PH (PI-4,5-P2-binding, plasma membrane)
localizing to different subcellular compartments. We used this
baculovirus to test a variety of different cell types for their
propensity to be transduced efficiently. We initially transduced
well-established cell lines including HEK293, PAE, COS7, HeLa,
SK-MEL-28, CCL39 and Swiss 3T3. All cell lines that were tested
proved to be highly transduceable by MultiPrime and efficiently
expressed all heterologous proteins (Supplementary Fig. 5 and
data not shown). Typically, transduction efficiencies ranged
between 20 and 100%. Transduction frequencies up to 100% were
observed even in cell lines, such as PAE that are traditionally
considered to be difficult to transfect.
We then asked whether we can use MultiPrime to transfect
primary cells. Primary cells are an intense focus of contemporary
research efforts for many reasons, and it is well documented
that they are typically extremely difficult to transfect. For this
experiment, we utilized human umbilical vein endothelial cells
(HUVEC), rat embryo fibroblasts (REF), rat cortical neurons and
human-induced pluripotent stem cells (iPS). With our
MultiPrime virus, all of these primary cell types could be
transduced efficiently and again expressed all heterologous genes
of interest, compellingly underscoring the utility of our approach
(Fig. 1 and Supplementary Fig. 5).
To analyze viability and functionality, we proceeded to express
multiple intracellular sensors simultaneously from a MultiPrime
baculovirus. COS7 cells expressing epidermal growth factor
receptor (EGFR) endogenously were used to monitor trafficking
of EGFR. Genes encoding fluorescently-tagged markers for early
(RAB5A), recycling (RAB11A) and late (RAB7A) endosomes
were expressed from a single MultiPrime virus and the cells were
stimulated 40 h post-transduction with Cy5-labelled epidermal
growth factor (EGF). As expected, EGF was found in early
(RAB5Aþ ) and late (RAB7Aþ ) endosomes, but not in recycling
(RAB11Aþ ) endosomes after 30min (Fig. 2a). A time-resolved
quantitative analysis confirmed that EGF was transferred to late
endosomes but not to RAB11-positive, recycling vesicles
(Supplementary Movie 1). Next, we used PAE cells stably
expressing VEGFR2 and neuropilin-1 (NRP1). A composite
MultiPrime baculovirus was used to express fluorescently-tagged
Rab4, Rab5 and Rab7 in these cells. Cells were then stimulated
with Nt647-labelled VEGF-A165a for 3 h. VEGF was found in
Rab5 and Rab7 vesicles clearly indicating that it was properly
internalized, in accordance with previous reports3. Using the
same cell line transduced with the RAB5A-RAB11A-RAB7A virus
in a time-resolved study, we could show that VEGFR2 behaves
differently from EGFR. VEGFR2 is, in contrast to EGFR, partly
recycled through the RAB11 compartment (Supplementary
Movie 2).
Next, we tested the functionality of baculovirus-transduced
HUVEC in migration and angiogenesis assays. HUVEC trans-
duced with a MultiPrime baculovirus encoding mTFP1-actin,
EYFP-tubulin and Mito-DsRed were plated on matrigel and
incubated for 14 h. HUVEC are known to establish a character-
istic vascular network within this time frame. Transduced cells
efficiently integrated in this network, clearly demonstrating that
MultiPrime-transduced HUVEC show identical behaviour com-
pared to untransduced cells (Fig. 2c). Moreover, in a migration
assay, we could show that transduced cells migrate with similar
efficiency as untransduced cells (Fig. 2d).
We quantitatively compared baculovirus-mediated trans-
duction with the classical plasmid transfection approach. In
addition to EMBacY, we used our MultiBacMam baculovirus
displaying VSV-G on its surface in this experiment. As expected,
we observed increased transduction rates with MultiBacMam
compared to EMBacY, albeit the gain in efficacy in our hands
turned out to be modest in many cases. Clearly, transduction with
both EMBacY and MultiBacMam outperformed the classical
transfection approach (Fig. 3a). We routinely obtained transduc-
tion efficiencies higher than 50% when using the MultiPrime
baculovirus compared to transfection efficiencies well below 20%
with the corresponding plasmid (13,305 bp) that had been used to
generate the composite baculovirus.
Baculovirus displaying VSV-G on its surface was superior to
virus lacking VSV-G at all tested MOI. Saturation was usually
obtained at a MOI of 500 (Fig. 3b). The relative expression levels
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11529 ARTICLE
NATURE COMMUNICATIONS | 7:11529 | DOI: 10.1038/ncomms11529 | www.nature.com/naturecommunications 3
between cells appear to be similar (Fig. 3c). This is in contrast to
transfected cells that typically show a wide variety of expression
levels (data not shown). Since we use relatively high MOI, the
toxicity of the virus could conceivably be an issue. We tested
baculovirus toxicity at MOI 500 compared to plasmid transfec-
tion with Fugene HD, which is considered to be a mild
transfection reagent. Both EMBacY- and MultiBacMam-derived
viruses exhibit negligible toxicity similar to plasmid-based
transfection (Fig. 3d).
Baculovirus transduction of mammalian cells is transient in
nature as the foreign DNA does not integrate into the host
genome. We therefore tested the persistence of recombinant
expression following transduction with a MultiPrime baculovirus
by immunofluorescence and western blotting. In our experi-
ments, the percentage of positive cells decreased to B20% after
20 days and 5% after 30 days (Fig. 3e).
Modulation of expression levels in mammalian cells. The
hCMV-IE1 promoter we used in our experiments is considered to
be the strongest promoter available for heterologous expression in
most mammalian cells. It may be desirable to have alternative
promoters that are characterized by lower levels of expression. We
expanded our tool-box by incorporating the SV40, PGK and UBC
promoters in alternative expression cassettes in our MultiPrime
system (Supplementary Fig. 6). We determined expression levels
from these alternative promoters by expressing EYFP-tubulin, and
simultaneously expressing citrine from a CMV promoter as a
bench-mark to normalize expression levels. All three alternative
promoters show distinctly lower expression levels in HEK293 and
PAE cells as well as in primary REF compared to CMV promoter-
driven expression (Fig. 4a,b). Furthermore, we included a tetra-
cycline-inducible promoter in our system (Supplementary Fig. 6).
Tetracycline-inducible promoters are dependent on a transacti-
vator, for example tTA, to initiate expression29. We observed
approximately four times higher expression levels in the absence of
doxycycline in HeLa cells stably producing tTA, which were
transduced with a MultiPrime baculovirus containing a
tetracycline-inducible expression cassette, in good agreement with
reports involving tetracycline-inducible promoters on plasmids
(Fig. 4c,d).
Bifunctional dual-host promoters. Expression plasmids that
could be used for heterologous protein production in insect as
well as in mammalian cells have not found wide-spread
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application so far, possibly because comprehensive comparative
data which would have encouraged their use is currently lacking.
We addressed this issue by creating, validating and incorporating
dual-host promoters as a choice in our MultiPrime system. Our
objective was to provide a single expression reagent, which is the
composite MultiPrime baculovirus containing the genes of choice
controlled by this validated dual-host promoter, for example to
produce a protein or protein complex of choice efficiently in
insect cells for structural studies and in mammalian cell lines for
functional validation. We used two promoters, the first one
(denoted CMVP10) is a fusion of the CMV promoter and the
baculoviral very late promoter p10, the second (denoted
CMVintP10) contains the p10 promoter in an intron of the CMV
transcription unit (Fig. 5a and Supplementary Fig. 7). These two
dual-host promoters were validated in mammalian cells by
expressing EYFP-tubulin from a MultiPrime baculovirus,
which also expressed citrine driven by a CMV promoter
for normalization purposes. In HEK293 and PAE cells, the
dual function promoters expressed at comparable levels to the
original mammalian-only CMV promoter. In REF cells, the
intron-less CMVP10 promoter resulted in lower expression
(Fig. 5b,c). We quantified expression from these MultiPrime
baculoviruses in insect cells and found them entirely satisfactory
(Fig. 5d,e). Furthermore, we tested MultiPrime constructs
expressing human transcription factors, which we had produced
before for structural studies in insect cells with our MultiBac
insect-cell expression system (Supplementary Fig. 8)30,31.
We observed virtually indistinguishable levels of expression
for complexes formed by these human TATA-box associated
factors (TAFs) from dual function promoters as compared
to the MultiBac expressed complexes. Transduction of HeLa cells
with the TAF producing MultiPrime baculoviruses resulted
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in close to complete transduction rates (Supplementary
Fig. 8).
Genome engineering by CRISPR/Cas9. CRISPR/Cas9-mediated
genome engineering requires the expression of Cas9, the
concomitant expression of a U6-driven guide RNA (gRNA) and
the provision of a DNA construct for homologous recombination.
Currently used viral systems can harbour Cas9 and the gRNA but
are unable to include a homology construct due to limited
cargo capacity32. We assembled DNAs for the expression of a
HMGA1-EGFP fusion protein from its endogenous locus
in a MultiPrime virus33 (see Supplementary Fig. 9 for details).
Transduction of HEK293 and HUVEC led to expression of
HMGA1-EGFP in the nucleus in B1% of the cells. Successful
homologous integration of the DNA construct was verified by
PCR (Fig. 6a and Supplementary Fig. 9).
Reprogramming by MultiPrime. We next investigated whether
MultiPrime viruses are suitable for reprogramming of cells.
Currently, this is mainly carried out with lentivirus, which is a
retrovirus that stably integrates into the genome of cells. We
assembled a MultiPrime virus expressing the transcription factors
Asc1, Brn2 and Myt1L, which were shown to convert MEFs into
neurons7. Transduction of MEFs with this MultiPrime
virus resulted in cells with neuron-like morphology, which
expressed the neuronal markers MAP2 and b-tubulin III 20 days
after transduction, indistinguishable from co-infection with
three lentiviruses each expressing one of the transcription
factors (Fig. 6b). Our results provide compelling evidence that
reprogramming can be successfully achieved with a transient
expression system such as MultiPrime.
Functional antibody production. Our MultiPrime approach
can not only induce morphological changes in cells but also
potentially interfere with it. We addressed this by using
MultiPrime to express functional antibodies in primary cells.
Our previously described single-chain antibodies targeting
VEGF (SZH9) and VEGFR2 (ADH9), and a control single-chain
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antibody (A1) were converted into a full length IgG consisting
of light and heavy chains34,35. The dual-host promoter CMV-
CMVintP10 was utilized to drive recombinant IgG expression.
The resulting MultiPrime baculovirus was successfully tested for
expression in HEK293 and insect cells (Fig. 6c). All IgG
antibodies tested were expressed at comparable levels. The same
virus was then used to transduce HUVEC that were then placed
into a tube formation assay. Only the function-blocking
anti-VEGF antibody SZH9 was able to interfere with tube
formation. All other antibodies, including the VEGFR2-binding
but not function-blocking antibody ADH9, did not interfere with
tube formation (Fig. 6c).
Zebrafish transduction. It was previously shown that mammalian
promoters can be used for heterologous expression in zebrafish
embryos36. We set out to establish whether MultiPrime viruses are
restricted to mammalian and insect cells, or whether they can also
be used to transduce zebrafish. A MultiPrime virus encoding
mTFP1-actin, EYFP-tubulin and Mito-dsRed under control of
mammalian CMV promoters was injected into intercellular spaces
in the brain region of zebrafish embryos at 24 h post fertilization.
Injection of this virus showed heterologous expression of all genes
in zebrafish embryos. Expression was restricted to the site of
injection and could be detected for at least 5 days (Fig. 6d).
Discussion
In the three decades since their inception, baculovirus-based
expression systems have become well-established and widely used
for recombinant protein production in insect cells. Later, it was
discovered that baculoviruses not only infect insect cells but can
also drive heterologous protein expression in mammalian cells if
appropriate mammalian regulatory elements are provided in the
recombinant baculovirus genome22,23,37. This so-called ‘BacMam’
method has been applied to produce heterologous proteins in
academic and industrial research and development, notably for
pharmacological screening37. Today, it is becoming increasingly
evident that most physiological activities are mediated by multiple
proteins forming complex assemblies. Therefore, a powerful tool
that exploits recombinant baculovirus to deliver multiple genes
simultaneously and reproducibly into a range of mammalian cell
types and notably primary cells is highly desirable to study health
and disease states, and to analyze molecular mechanisms of cell
fate. Notwithstanding, such a tool has been lacking so far.
Therefore, we developed MultiPrime, a versatile, flexible and fully
modular system for efficient multigene delivery and expression in
any mammalian cell type, primary and established. MultiPrime
relies on a set of customized DNA plasmid modules, called
acceptors and donors that provide the means to combine a
theoretically unlimited number of genes of interest with different
promoters, terminators and other control elements in multiple
expression cassettes to generate multigene-delivery constructs,
which are then inserted into engineered baculoviral genomes.
Moreover, they can comprise all the elements necessary for
genome engineering including editing functions and the
sequences required for homologous recombination. We provide
and validate a range of mammalian promoters that can be
introduced into our MultiPrime system in this way. In addition,
b
CM
V TR
E
-
Do
xTR
E
+ 
Do
x
Co
ntr
ol
EYFP-
tubulin
Tubulin
Citrine
HeLa-tTA
c
d
100
50
0
CMV
TRE -Dox
TRE +Dox
EY
FP
-tu
bu
lin
 
/ c
itr
in
e
HeLa tTA
100
50
0
CMV
UBC
PGK
SV40
EY
FP
-tu
bu
lin
 / 
cit
rin
e
HEK293 PAE REF
**** ****
****
********
****
***
***
**
CM
V
UB
C
PG
K
SV
40
Co
ntr
ol
EYFP-
tubulin
Tubulin
Citrine
HEK293
a
EYFP-
tubulin
Tubulin
Citrine
PAE cells
EYFP-
tubulin
Tubulin
Citrine
REF cells
70 kDa
25 kDa
55 kDa
70 kDa
25 kDa
55 kDa
70 kDa
25 kDa
55 kDa
70 kDa
25 kDa
55 kDa
Figure 4 | Modulation of expression levels with alternative promoters. (a) Transduction of HEK, PAE and REF cells with baculoviruses expressing EYFP-
tubulin under the control of the indicated promoters and citrine under the control of the CMV promoter is shown. (b) Quantification of the blots. EYFP-
tubulin/citrine ratio was used as a measure for promoter strength. Endogenous tubulin was used as loading control. Data shows mean value±s.d.; n¼ 3;
****Po0.0001, ***Po0.001 determined by comparing CMV promoter with alternative promoters using one-way analysis of variance followed by the
Dunnet’s post hoc test. The CMV promoter is the strongest promoter in all tested cell lines. (c) HeLa-tTA cells were infected with a baculovirus expressing
EYFP-tubulin under the control of a tetracyclin inducible element and citrine under the control of the CMV promoter. (d) Quantification of the blots shown
above. Data shows mean value±s.d.; n¼ 3; **Po0.01 determined by comparing induced versus non-induced tet promoter using one-way analysis of
variance followed by the Tukey post hoc test. No significant difference between CMV promoter and induced tet promoter.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11529 ARTICLE
NATURE COMMUNICATIONS | 7:11529 | DOI: 10.1038/ncomms11529 | www.nature.com/naturecommunications 7
we provide dual-host promoters to drive heterologous
multiprotein production in both insect and mammalian cells.
This highly versatile and flexible tool-box allows users to
conveniently introduce many different proteins simultaneously
into mammalian and insect cells. Corroborating previous
observations, we found negligible toxicity and sustained
viability when infecting a range of mammalian cells with
recombinant MultiPrime reagents. Importantly, we demonstrate
here that MultiPrime infected cells are competent to divide and
migrate normally and are capable of adequately responding to
external stimuli as, for example, growth factors.
In this study, we utilized two baculovirus types, EMBacY and
MultiBacMam. These engineered baculoviral genomes are
characterized by reduced proteolysis and delayed cell lysis
during virus amplification in insect cells, resulting in high
quality, high titre virus25. The EMBacY and MultiBacMam
viruses express either EYFP or mCherry fluorescent marker
genes, to signal late replication cycle entry. Expression of
fluorescent marker proteins during virus production is a
convenient tool to simplify and standardize monitoring the
production of baculovirus, in particular for non-specialist users.
MultiBacMam virus generated in this study expresses also VSV-G
during virus production in insect cells. Decorating baculovirus
with VSV-G has been shown to improve mammalian
transduction efficiencies. Consequently, we observed superior
transduction efficiencies with our MultiBacMam-derived viruses
that display VSV-G on their capsids. We note here that, at least in
Switzerland where these experiments were performed,
MultiBacMam-derived reagents expressing VSV-G have to be
handled at biosafety level 2, which requires specific laboratory
infrastructure. To circumvent this complication the EMBacY
virus variant can be utilized, which is devoid of VSV-G but still
resulted in satisfactory transduction rates in our experiments.
Nonetheless, for experiments which may rely on maximum
transduction efficiencies, the VSV-G containing MultiBacMam
virus is recommended.
All viral genomes we utilized contain a site-specific integration
site in the backbone distal from the Tn7-attachment site.
This LoxP site allows introduction of additional genes by
Cre-LoxP mediated fusion in vivo12. This enables a range of
options to modify and tailor the baculovirus genomes for specific
applications. For example, a baculovirus called SweetBac was
developed to achieve mammalian-type glycosylation of
recombinant secreted proteins such as antibodies38,39.
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Currently, these functionalizations are limited to applications
in insect cells. We anticipate that a wide range of functions
to modify, enhance and regulate multiprotein production in
mammalian cells will be exploited by modifying the
baculoviral genome accordingly, providing appropriate
expression cassettes active in mammalian cells in the LoxP
locus of these vectors.
Multigene expression systems are rapidly gaining prominence
for producing protein complexes for structural and functional
studies. Often, several expression systems must be tested to
obtain functional complexes in sufficient quantity and quality.
This typically requires recloning of genes into different sets of
expression plasmids given that the regulatory elements in each
system, here mammalian and insect cells, are optimized for a
particular host, and are typically not compatible between the
different species. The incorporation of dual-host promoters into
MultiPrime allows simultaneous testing of expression constructs
in insect and mammalian cells by using the same reagent. This
feature can be conveniently exploited if high-level production of a
complex protein of interest is carried out in insect cells, while
functional analysis of the same complex is performed in
mammalian cells, which is increasingly the case in current
structural biology. The possibility to use the same reagent for
both host systems will also benefit analysis of structure–function
correlations requiring multiple mutational analysis. MultiPrime
affords the means to carry out such elaborate studies, notably also
of complexes controlling cell fate, which can be mechanistically
dissected by infecting primary cells.
Baculovirus constitutes an attractive tool for gene therapy for a
number of reasons. Due to its flexible envelope structure,
very large heterologous DNA cargo can be incorporated into the
baculoviral genome. Moreover, baculovirus is replication incom-
petent in mammalian cells, and virtually no viral protein
expression occurs on transfection in a mammalian host. Initial
in vivo experiments had limited success since injected
baculoviruses are rapidly inactivated and cleared by the immune
complement system. Strategies were developed to overcome this
impediment and many successful in vivo applications were
published since then (reviewed in ref. 24). For example,
expression of VEGF-D-induced vascularization in rabbit skeletal
muscle suggesting that baculovirus-driven VEGF-D expression
might be an option to cure lymphatic disorders40. Nevertheless as a
non-integrative virus it is a priori limited to transient expression,
which can be an advantage or a disadvantage depending on the
application. Transient expression may be desirable, for example,
for vaccination or to promote changes in cell fate. Of note, altering
cell fate is a particularly interesting application for multigene
expression systems, as it relies on the simultaneous
and temporally restricted expression of several transcription
factors. Induced-pluripotent stem cells have been generated
before with a BacMam virus in vitro using a fusion protein
construct41. Four transcription factors were expressed as a fusion
protein from a single open reading frame (ORF) via self-cleaving
2A peptides. Here, we converted MEFs into neurons using
independent expression cassettes, which offer advantages
especially when different protein combinations need to be tested
in a combinatorial fashion.
MultiPrime is not restricted to the delivery of expression
constructs. We anticipate that genome engineering will be an
important future application, owed to the very large cargo
capacity of baculoviruses. Other viruses such as lentiviruses or
adeno-associated viruses cannot accommodate all DNA elements
needed to produce Cas9, a gRNA and a construct for homologous
recombination. With MultiPrime, we were able to modify the
HMGA1 locus of HUVEC, which are human primary cells that
show restricted replication potential.
Our results compellingly validate MultiPrime as a powerful
vehicle for multigene delivery, protein expression and genome
engineering, relevant for a large number of applications, in vitro
and in vivo, and underscore the enormous potential of our
baculoviral system to deliver large multigene DNA constructs into
a wide range of mammalian cells, notably including primary cells.
A multitude of genes and regulatory elements can be delivered due
to the very large heterologous DNA cargo capacity of the system,
offering novel exciting possibilities for biological research. Entire
signalling cascades, gene regulatory systems or metabolic pathways
and multiple mutants thereof, can be efficiently engineered with
MultiPrime. We anticipate that many applications will benefit
from MultiPrime, notably when efficient transfer of multiple genes
or efficient engineering of genomes is required.
Methods
Molecular biology. DNA construction in MultiPrime follows the high-throughput
compatible logic of our ACEMBL concept to prepare multicomponent DNA
constructs from acceptor and donor plasmid DNA modules that are conjoined by
the Cre-LoxP fusion reaction13,14. Plasmid pSI-AGR10 is the common acceptor in
MultiPrime, and has been developed from our previous pFL plasmid25. The
ampicillin resistance gene and an internal SapI site were removed and the
expression cassettes for insect-cell expression replaced by the CMV-based
expression cassette from plasmid pSI-AKR1 by standard cloning methods
(Supplementary Fig. 2a)14. In addition, pSI-AGR10 contains a gentamycin
resistance marker, a LoxP site, and the DNA elements (Tn7R, Tn7L) required for
transposition into the baculovirus genome by Tn7 transposase.
All donor plasmids of the original MultiLabel system are compatible with this
acceptor14. Donors are fused to pSI-AGR10 by Cre-LoxP recombination
concomitantly or in a sequential manner. Acceptor–donor assembly was performed
as described and electrocompetent DH10b or CaCl2 competent XL1-blue cells were
used for transformation42. Sequences were assembled in silico using the ‘Multi-Cre
Recombination Tool’ in the plasmid editor software Ape (http://
biologylabs.utah.edu/jorgensen/wayned/ape/) or, alternatively, with software
Cre-ACEMBLER43. Integrity of all fusion plasmids was confirmed by restriction
mapping. Alternative mammalian promoters and dual-host promoters active in
both mammalian and insect cells were synthesized by Genewiz (South Plainfield,
USA) on the basis of sequences provided in the Supplementary Materials and
inserted as AscI–HindIII fragments into parent Acceptor plasmid pSI-AGR10.
Recombinant baculoviral genomes. Two baculoviral genomes were used in this
study, our previously described EMBacY genome and the novel MultiBacMam
genome, which we constructed in this study. Both baculoviral genomes are present
as bacterial artificial chromosomes (BAC) in E. coli cells (DH10EMBacY and
DH10MultiBacMam, respectively). EMBacY produces yellow fluorescent protein
(YFP) as a marker in infected insect cells as a means to track virus amplification
and performance by monitoring the fluorescence signal25.
Display of a VSV-G on the baculovirion was reported to enhance mammalian
transduction efficiency by baculovirus27. We therefore constructed a novel
MultiBacMam baculovirus by modifying our original MultiBac baculoviral genome,
retaining its advantageous features including reduced proteolysis and delayed cell
lysis12. A synthetic gene (Genscript, Psicataway, NJ) encoding for VSV-G was
inserted into a modified pUCDM donor plasmid25 by using BamHI and XbaI
restriction sites to yield plasmid pLox-VSV-G. Subsequently, a second cassette
containing a synthetic gene for mCherry (Genscript) was inserted by using the
multiplication module as described13. The resulting pLox-VSV-G-mCherry
Donor plasmid was incorporated into the MultiBac virus by transforming
DH10MultiBacCre cells harbouring the MultiBac baculoviral genome as a BAC and
Cre recombinase expressed from a pBADZHisCre helper plasmid on arabinose
induction12. Positive integrands were selected by antibiotic screening. Successful
Cre-mediated integration was further verified by PCR analysis as described44.
Competent DH10MultiBacMam cells were prepared following standard protocols
and contain in addition to the MultiBacMam baculovirus also a helper plasmid
expressing Tn7 transposase on induction with isopropyl b-D-1-
thiogalactopyranoside. Expression of mCherry from this baculovirus in infected
insect cells during virion production results in the cell culture adopting a
characteristic purple color, allowing tracking of successful viral infection and
production easily by eye.
Generation of composite MultiPrime baculovirus. MultiPrime acceptors or
acceptor–donor fusions were transformed into electrocompetent DH10EMBacY or
DH10MultiBacMam cells, respectively. Composite baculovirus generation occurred
by Tn7 tranposition mediated by Tn7 transposase expressed from a helper plasmid.
Transformants were selected and composite baculoviral genomes prepared as
described44 Sf21 insect cells were transfected with Cellfectin II (Life Technologies)
at a density of 0.5# 106 cellsml$ 1 according to manufacturer’s recommendations.
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We took particular care during virus amplification to prevent accumulation of
defective virus, which would not express all heterologous genes. We applied a
protocol we had developed previously for successful amplification of composite
baculovirus containing multiple copies of viral late promoters (polh, p10),
preserving the integrity of the viral genome28. Briefly, primary baculovirus stock
(V0, 2ml) was harvested 50–60 h after transfection and 0.5ml was used to infect
4ml new Sf21 cells for 75 h yielding V1 stock. Overall 3ml of this V1 baculovirus
stock was then used for a further round of virus amplification for 60 h (V2, 100ml).
The amplification of the virus was followed in this phase by monitoring EYFP
(EMBacY) or mCherry (MultibacMam) expression from the viral backbone
(Supplementary Fig. 1). Less than 1% of cells were positive when harvesting V0.
When harvesting V1, 20–30% of cells were positive and after V2, 80–90% of cells
were positive. Incubation times must not be extended during amplification,
otherwise over-amplification of the virus can occur, resulting in loss of
heterologous insert (Supplementary Fig. 4). The V2 virus stocks were stored either
at 4 !C or after addition of 5% FBS at $ 80 !C. For sensitive cells (for example, iPS)
or zebrafish, virus was concentrated by ultracentrifugation. For this purpose, virus
supernatant was placed on a sucrose cushion (25% sucrose/ 5mM NaCl/ 10mM
EDTA) and then centrifuged for 90min at 80,000g. The pellet containing the virus
was resuspended in PBS pH 6.2 (ref. 45). The titre of baculovirus stocks was
determined using end-point dilution assay46. Viruses displaying VSV-G were
handled as biosafety level 2 agents in Switzerland.
Cell culture. Insect cells (Sf21, Sf9; Life Technologies) were cultured in SF-4
BaculoExpress ICM medium (Amimed) containing 1% FBS at 27 !C. Mammalian
cells were incubated at 37 !C in a humidified atmosphere containing 5% CO2.
HEK293, COS7, REF, Swiss 3T3 and HeLa cells were cultured in DMEM
(Amimed) containing 10% FBS (Life Technologies) and 100 unitsml–1 penicillin
and 100mgml$ 1 Streptomycin (Life Technologies). PAE and HUVEC (Life
Technologies) cells were maintained in Ham-F12 media supplemented with 10%
FBS and penicillin/ streptomycin and M-200 medium (Life Technologies),
respectively. Primary rat cortex neurons (Life Technologies) were cultured in
Neurobasal medium supplemented with 1% B27 and 1% Glutamax (Life
Technologies). Human iPS cells (NAS2) were obtained from Tilo Kunth (Uni-
versity of Edinburgh) and cultured in feeder-free maintenance medium for human
ES/ iPS cells (mTESR1 medium; Stem Cell Technology)47. iPS cells were
immunostained with an Oct4 antibody (Santa Cruz Biotechnology, sc-5279, 1:500
in 10% NDS/ 0.2% Triton X100/ 1% BST/ PBS), transfections were performed with
FusionHD (Promega) according to manufacturer’s recommendations and cells
were analyzed 42 h after transfection. For endothelial tube formation assays,
MultiPrime-transduced HUVEC cells were seeded on a ibiTreat m-slide
angiogenesis plate (ibidi GmbH, Germany) at a density of 5,000 cells/slide in
EGM-2 medium (Life Technologies) and analyzed 16 h later. Migration assays were
performed by seeding 21000 MultiPrime-transduced HUVEC cells in ibidi
Culture-Insert plate (ibidi GmbH, Germany). The culture-insert was removed after
14 h and migration into the gap was monitored every 2 h for 24 h.
Transduction of mammalian cells. Mammalian cells were plated at a density of
2.5# 105 cells per well in six-well plates 1 day before transduction. Baculovirus was
added at a MOI between 100 and 500 in 80% insect medium/ 20% DMEM without
any FBS or antibiotics. Transduced cells were incubated at 37 !C for 8 h, and the
medium was then replaced with fresh mammalian cell culture medium. Plates were
cultured for one or two additional days. Cytotoxicity of baculovirus transduction was
monitored by MTT assay in various mammalian cells lines. Overall 104 cells were
plated in a 96-well plate and transduced with baculovirus at a MOI 500. After 24 h,
the medium was replaced with culture medium containing 20mM resazurin and the
cells were incubated for 2–4 h. The number of viable cells was obtained by mon-
itoring resazurin fluorescence with a microplate spectrofluorometer (Tecan Ltd).
For CRISPR/Cas9-mediated genome engineering, HEK293 cells and HUVEC
were transduced with a Multiprime virus that expresses CMV-driven Cas9,
U6-driven gRNAs and a homology construct as described in Supplementary Fig. 9.
Immunostaining for Cas9 after 40 h revealed 80% transduction. Cells were fixed
after 4 or 6 days and analyzed for nuclear EGFP expression by microscopy or DNA
was extracted with QIAamp DNA mini kit (Qiagen). Correct integration was
verified by PCR using primers described in Supplementary Fig. 9.
MEF cells used for reprogramming to neurons were obtained from Amsbio, and
were used at passage 3. Cells were transduced with concentrated bacuolovirus
expressing Ascl1, Brn2 and Myt1L in MEF medium for 8 h. In parallel, MEFs were
infected with lentiviruses containing expression constructs Tet-o-FUW-Ascl1, Tet-o-
FUW-Brn2 and Tet-o-FUW-Myt1L (all from Addgene) in presence of polybrene
(8mgml$ 1). Cells were cultured in N3 medium (DMEM/F12, B27, N2 (all (Life
Technologies), 25mgml$ 1 Insulin (Sigma-Aldrich)). Doxycycline (2mgml$ 1) was
added to lentivirus-transduced cells7,48. Cells were fixed after 6, 12 and 20days.
Immunostaining was performed with chicken anti MAP2 (Neuromics, CH22103,
1:5,000 in 10% NDS/ 0.2% Triton X100/ 1% BST/ PBS) and mouse anti b-tubulin III
(Sigma, T8578, 1:600 in 10% NDS/ 0.2% Triton X100/ 1% BST/ PBS) antibodies.
Microscopy. Cells for microscopic analysis were plated on glass coverslips.
Untreated coverslips were used for COS7, REF, Swiss 3T3 and PAE cells.
Poly-L-lysine (Sigma P4707) treated coverslips were used for HEK293 cells and
0.1% gelatin (Sigma G1393) treated coverslips for HUVEC. Poly-D-lysine
hydrobromide coated coverslips (Sigma P7280) were used for primary rat cortex
neurons and iPS were plated on hESC qualified Matrigel (BD Bioscence). Analysis
of cells was performed 27, 42 and 48 h after transduction. Cells were fixed with 4%
formaldehyde in PBS and mounted with Gelvatol. Imaging was performed on a
Leica SP5 laser scanning confocal microscope or on an Olympus IX81 equipped
with an Andor iXonEM camera. On Leica SP5, EBFP2 was excited with the 405 nm
laser line and the emission was collected from 430 to 450 nm (405/ 430-450).
The other fluorescent proteins were analyzed as follows: mTFP1 (458/ 485-510),
mCitrine (514/ 525-545), mCherry (543/ 585-620) and mPLUM (633/ 640-800).
In addition, the spectral mode (xyl) of the microscope was used to verify the
presence of all fluorescent proteins (data not shown). Standard excitation and
emission filters were used on the Olympus IX81. Quantification was performed
with Squassh49.
Western blotting. Mammalian cells were lysed 42 h after transduction with lysis
buffer (0.5% Triton X100, 50mM Tris–HCl, 100mM NaCl, pH 7.5). The
supernatant was used for western blotting after sonification and centrifugation.
Rabbit anti-GFP (Abcam ab137827; diluted 1:2500 in 3% BSA/TBST) and mouse
anti-tubulin (Sigma T5168; diluted 1:2,500 in 3% BSA/TBST) were used as primary
antibodies. As secondary antibodies, alkaline phosphatase-coupled goat anti-rabbit
and anti-mouse as well as donkey anti-human IgGs (Southern Biotech, diluted
1:10,000 in TBST) were used, followed by chemiluminescence detection.
Quantification was performed with ImageJ. Original western blots are shown in
Supplementary Fig. 10.
Transduction of zebrafish embryos. All experiments were performed in
accordance with the animal welfare guidelines of the Federal Veterinary Office of
Switzerland. Zebrafish (Danio rerio) were maintained as described50. Embryos
of the wild-type strain WIK were raised at 28!C in E3 medium (5mM NaCl,
0.17mM KCl, 0.33mM CaCl2 and 0.33mM MgSO4), and pigment development
was inhibited by phenylthiourea (1-phenyl-2-thiourea; Sigma-Aldrich) as described
in Westerfield50. For injections, individual dechorionated embryos at 24 h post
fertilization were anesthetized in 200mgml$ 1 3-aminobenzoic acid methyl
ester (MESAB, Sigma-Aldrich) and 4.6mM NaHCO3 and embedded in 1% low
melting agarose (Lonza). Concentrated viruses were injected in intercellular spaces
using borosilicate glass microcapillary injection needles (1mm outside
diameter# 0.78mm inside diameter, Science Products GmbH, Hofheim,
Germany) and a PV820 Pneumatic PicoPump (World Precision Instruments,
Sarasota, Florida, USA). After injection, the infected embryos were returned to E3
medium. For in vivo imaging, the larvae were anesthetized and embedded in 1%
low melting agarose in a 35mm imaging dish with a glass bottom (Ibidi) and
imaged using a CLSM SP5 Mid UV–vis Leica inverted microscope.
Bifunctional CMV/ P10 dual-host promoters. Subcomplexes of human general
transcription factor TFIID were produced in insect cells from the CMV-
CMVintP10 promoter (Supplementary Fig. 7). A complex formed by human TBP
associated factor (TAF) 8 and TAF10, and a complex formed by TAF5, TAF6 and
TAF9, were expressed. Production levels of these complexes on the basis of the
dual-host promoter was compared to previously established production levels on
the basis of the baculoviral polyhedrin (polh) promoter. A polyprotein strategy was
utilized51, which we had developed for high-level expression of complexes30,31.
Briefly, the genes encoding for the TAFs were placed in a single ORF flanked by
genes encoding for tobacco etch virus NIa (TEV) protease at 50 and a cyan
fluorescent protein at the 30-end51. The ORFs give rise to self-processing
polyproteins, which are cleaved by TEV protease at high specific TEV protease
cleavage sites in between the constituent proteins. The polyproteins are shown
schematically in Supplementary Fig. 8.
Polyproteins were expressed from the CMVintP10 and the polh promoter,
respectively, by using EMBacY, and purified as described30,31. Production levels of
the polyproteins in insect cells were indistinguishable notwithstanding the promoter
used (Supplementary Fig. 8). Next, the MultiBacMam virus (see above) was used in
conjunction with the CMVintP10 promoter, again leading to indistinguishable
expression levels (Supplementary Fig. 8). HeLa cell cultures were transfected with
MultiBacMam-derived baculoviruses that had been used to express the proteins in
insect cells. Complete DMEM containing 10% foetal calf serum and 8mM
L-glutamine was utilized. Best results were achieved by supplementing the media
with 3mM sodium butyrate for cell recovery after aspirating the virus. Nearly all
HeLa cells were transduced as revealed by measuring the specific fluorescence of the
cyan fluorescent protein marker encoded by the polyprotein (Supplementary Fig. 8).
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mCherry
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Supplementary Figure 1: Schematic presentation of the MultiPrime workflow. 
One Acceptor is fused to one or several Donors (each with a different resistance marker). Acceptor 
and Donors can each contain one or several genes of interest (one gene shown for clarity). Acceptors 
contain the Tn7L and Tn7R sequences for transposition mediated by Tn7 transposase. Acceptor-
Donor fusions are selected on plates with appropriate antibiotics, and verified by restriction mapping. 
Cre mediated fusion of further Donors, each with one or several genes of interest, can be performed 
iteratively. Verified Acceptor-Donor fusions containing all genes and DNA elements (regulatory 
elements,  enhancers, etc) of interest are then integrated into a baculoviral genome (e.g. EMBacY or 
MultiBacMam) in vivo by Tn7 transposition in bacterial cells. Integrands are selected by blue-white 
screening, and baculovirus produced in insect cell cultures displaying a red or yellow color depending 
on the used bacmid. MultiBacMam derived baculovirions display a VSV-G protein (yellow spheres) 
resulting in enhanced infectivity. Recombinant baculovirus is then harvested and can be used to infect 
a wide range of mammalian cells with high efficiency.
Abbreviations: Gent: Gentamycin; Amp: Ampicillin; Chlr: Chloramphenicol; Kan: Kanamycin; Spec: 
Spectinomycin; CMV: Cytomegalovirus promoter; Tn7R, Tn7L: Tn7 tranposition elements; loxP: Cre 
recognition site; ori: origin of replication. 
Selection
Verfication
In vitro
Cre-loxP
recombination
Sequential insertion of additional Donor(s)
5000 bp
2000 bp
1000 bp
600 bp
+
Supplementary Figure 1
Workflow of MultiPrime
Acceptor
Gent
CMV Gene 1
Donor
CMV Gene 2
Tn7L
Tn7R OriColE1 Amp, Chlr, Kan or SpecOriR6kγ
CMV Gene 1
CMV
Gene 2
Infect mammalian
cells with
multigene
baculovirus
Integrate by Tn7 into
baculoviral genome
LoxP LoxP
Produce
baculovirus
  
in insect
cells
pFLloxP
EC1EC2 Tn7L
Tn7RGent ColE1 Amp
M SapI
Supplementary Figure 2: MultiPrime compatible Acceptor vectors.
(A) Development of the initial MultiPrime Acceptor vector. This Acceptor plasmid is based on the previously 
described pFL vector (Fitzgerald et al., 2006). The following changes were made: (i) the ampicillin resistance gene 
was removed, (ii) an internal SapI site was deleted, and (iii) a mammalian expression cassette was inserted. The 
mammalian expression cassette derived from the previously described pSI-AKR1 plasmid (Kriz et al., 2010). The 
cloning sites (red) are compatible within the MultiLabel plasmid family. (B) Additional Acceptors with CMV 
promoter. (C) Acceptors with dual-host promoters for expression in insect and mammalian cells.
Abbreviations: Gent: Gentamycin; Amp: Ampicillin; M: Multiplication module;  EC1,EC2: original pFL expres-
sion cassettes; CMV: Cytomegalovirus promoter;  polyA: polyadenylation site;  lacZ: Marker gene for 
blue/white screening; Tn7R, Tn7L: Tn7 tranposition elements; loxP: Cre recognition site 
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Supplementary Figure 2
A) Development of the initial Acceptor vector
B) Additional CMV-based Acceptors
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C) Acceptor with dual-host promoters
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Supplementary Figure 3: MultiPrime compatible Donor vectors.
(A) Donor vectors with alternative promoters for expression in mammalian cells. TRE: tetracycline-inducible 
promoter; SV40: early promoter from simian virus 40; PGK: phosphoglycerate kinase promoter; UBC: ubiquitin 
promoter. Please note that all previously described CMV-based promoters are also compatible with MultiPrime 
(Kriz et al., 2010). (B) Donors with dual-host promoters suitable for insect and mammalian cell expression.
Abbreviations: Amp: Ampicillin; Spect: Spectinomycin; b-Gal: spacer with expression of b-galactosidase; 
R6Kγconditional origin of replication; CMV: Cytomegalovirus promoter;  polyA: polyadenylation site;  loxP: 
Cre recognition site. 
Supplementary Figure 3
A) Donors with alternative promoters
B) Donors with dual-host promoters
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Supplementary Figure 4: Importance of virus amplification protocol
(Top) Virus amplification according to the protocol in Materials and Methods leads to a homogenous HEK293 cell 
population. (Bottom) Virus amplification with prolonged incubation times leads to rearrangement of the baculovirus 
genome and inhomogenous HEK293 cell population after transduction. Scale bar: 20 Pm.
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Additional cell types and constructs
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Supplementary Figure 6
Sequences of alternative promoters
Tet responsive promoter (TRE)
GGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCGAGCTCGACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACT
CGACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTCGACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTC
GACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTCGACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTCG
ACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTCGACTTTCACTTTTCTCTATCACTGATAGGGAGTGGTAAACTCGA
CCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCG
GGACCGATCCAGCCTCCGCGGCCCCGAATTGAAGCTT
Mouse phosphoglycerate kinase (PGK)
GGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCTTCTACCGGGTAGGGGAGGCGCTTTTCCCAAGGCAGTCTGGAGCATG
CGCTTTAGCAGCCCCGCTGGGCACTTGGCGCTACACAAGTGGCCTCTGGCCTCGCACACATTCCACATCCACCGGTAGGCGCCAA
CCGGCTCCGTTCTTTGGTGGCCCCTTCGCGCCACCTTCTACTCCTCCCCTAGTCAGGAAGTTCCCCCCCGCCCCGCAGCTCGCGT
CGTGCAGGACGTGACAAATGGAAGTAGCACGTCTCACTAGTCTCGTGCAGATGGACAGCACCGCTGAGCAATGGAAGCGGGTAGG
CCTTTGGGGCAGCGGCCAATAGCAGCTTTGCTCCTTCGCTTTCTGGGCTCAGAGGCTGGGAAGGGGTGGGTCCGGGGGCGGGCTC
AGGGGCGGGCTCAGGGGCGGGGCGGGCGCCCGAAGGTCCTCCGGAGGCCCGGCATTCTGCACGCTTCAAAAGCGCACGTCTGCCG
CGCTGTTCTCCTCTTCCTCATCTCCGGGCCTTTCGACCTAAGCTT
Human Ubiquitin C promoter
GGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCGGTGCAGCGGCCTCCGCGCCGGGTTTTGGCGCCTCCCGCGGGCGCCC
CCCTCCTCACGGCGAGCGCTGCCACGTCAGACGAAGGGCGCAGGAGCGTTCCTGATCCTTCCGCCCGGACGCTCAGGACAGCGGC
CCGCTGCTCATAAGACTCGGCCTTAGAACCCCAGTATCAGCAGAAGGACATTTTAGGACGGGACTTGGGTGACTCTAGGGCACTG
GTTTTCTTTCCAGAGAGCGGAACAGGCGAGGAAAAGTAGTCCCTTCTCGGCGATTCTGCGGAGGGATCTCCGTGGGGCGGTGAAC
GCCGATGATTATATAAGGACGCGCCGGGTGTGGCACAGCTAGTTCCGTCGCAGCCGGGATTTGGGTCGCGGTTCTTGTTTGTGGA
TCGCTGTGATCGTCACTTGGTGAGTTGCGGGCTGCTGGGCTGGCCGGGGCTTTCGTGGCCGCCGGGCCGCTCGGTGGGACGGAAG
CGTGTGGAGAGACCGCCAAGGGCTGTAGTCTGGGTCCGCGAGCAAGGTTGCCCTGAACTGGGGGTTGGGGGGAGCGCACAAAATG
GCGGCTGTTCCCGAGTCTTGAATGGAAGACGCTTGTAAGGCGGGCTGTGAGGTCGTTGAAACAAGGTGGGGGGCATGGTGGGCGG
CAAGAACCCAAGGTCTTGAGGCCTTCGCTAATGCGGGAAAGCTCTTATTCGGGTGAGATGGGCTGGGGCACCATCTGGGGACCCT
GACGTGAAGTTTGTCACTGACTGGAGAACTCGGGTTTGTCGTCTGGTTGCGGGGGCGGCAGTTATGCGGTGCCGTTGGGCAGTGC
ACCCGTACCTTTGGGAGCGCGCGCCTCGTCGTGTCGTGACGTCACCCGTTCTGTTGGCTTATAATGCAGGGTGGGGCCACCTGCC
GGTAGGTGTGCGGTAGGCTTTTCTCCGTCGCAGGACGCAGGGTTCGGGCCTAGGGTAGGCTCTCCTGAATCGACAGGCGCCGGAC
CTCTGGTGAGGGGAGGGATAAGTGAGGCGTCAGTTTCTTTGGTCGGTTTTATGTACCTATCTTCTTAAGTAGCTGAAGCTCCGGT
TTTGAACTATGCGCTCGGGGTTGGCGAGTGTGTTTTGTGAAGTTTTTTAGGCACCTTTTGAAATGTAATCATTTGGGTCAATATG
TAATTTTCAGTGTTAGACTAGTAAAGCTT
Simian virus 40 early promoter (SV40)
Derived from pcDNA 3.1 using PCR
GGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCC
AGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGT
ATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCG
CCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTA
GTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGAAGCTT
SV40-forward: GATCGGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCCTGTGGAATGTGTGTCAG
SV40-reverse: GATCAAGCTTCTTTTTGCAAAAGCCTAGG
Supplementary Figure 6: Alternative mammalian promoter sequences.
The DNA sequences of promoters used as an alternative to CMV in this study are listed, including the Tet 
responsive promoter (TRE), the mouse phosphoglycerate kinase promoter (PGK), the human ubiquitin C 
promoter and the simian virus 40 early promoter (SV40). Insertion of promoters into the MultiPrime 
plasmids was done usin AscI (red) and HindIII (green). 
Supplementary Figure 7
Sequences of dual-host promoters
CMVP10 (based on Philipps B. et al, Biotechnol. Prog., 2005)
GGCGCGCCTAGTtattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacgg
taaatggcccgcctggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagg
gactttccattgacgtcaatgggtggagtatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtccg
ccccctattgacgtcaatgacggtaaatggcccgcctggcattatgcccagtacatgaccttacgggactttcctacttggcagt
acatctacgtattagtcatcgctattaccatgctgatgcggttttggcagtacaccaatgggcgtggatagcggtttgactcacg
gggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaat
aaccccgccccgttgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagcagacgtcgtttagtgaaccgtcaga
tcaccatccagtatacggacctttaattcaacccaacacaatatattatagttaaataagaattattatcaaatcatttgtatat
taattaaaatactatactgtaaattacattttatttacaatcactcgacgaagacttgatcacccgggatctcgaAAGCTT
CMVintP10 (including an intron with the P10 promoter)
GGCGCGCCTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGG
TAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGG
GACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACG
CCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGT
ACATCTAGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGG
GGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACA
ACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGAT
CGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGCGGCCGGGAACGGTGCATT
GGAACGCGGATTCCCCGTGCCAAGAGTGACGTAAGTACCGCCTATAGACTCTATAGGCACACCCCTTTGGCTCTTggacctttaa
ttcaacccaacacaatatattatagttaaaTAAGaattattatcaaatcatttgtatattaattaaaatactatactgtaaatta
cattttatttacaatcAGACAGACTGTTCCTTTCCTGGGTCTTTTCTGCAGGCACCGTCGTCGACTTAACAGATCTGTTTAAGCT
T
CMV P10 EYFP-tubulin poly A
Black: CMV sequence
Blue: P10 sequence
Black: CMV sequence
Blue: P10 sequence
yellow: intron sequence
CMV P10 EYFP-tubulin poly A
Supplementary Figure 7: Dual-host promoter sequences for expression in insect and
mammalian cells.
The DNA sequences of dual-host promoters CMVP10 and CMVintP10 are shown, which support 
heterologous expression of target proteins of choice both in insect cells and in mammalian cells. 
Promoter structures are depicted in a schematic representation. Promoter DNAs were inserted into 
MultiPrime Acceptor and Donors by using restriction sites AscI (red letters) and HindIII (green letters). 
CMV stands for cytomegalovirus promoter, P10 for baculoviral very late promoter p10, polyA for the 
SV40 polyadenylation site. CMVintP10 contains in addition an intron sequence.
CMV P10 poly ATEV-tcs-TAF6-tcs-TAF5-tcs-TAF9-tcs-CFP DP-659
polh TEV-tcs-TAF6-tcs-TAF5-tcs-TAF9-tcs-CFP poly A polh-659
CMV P10 poly ATEV-tcs-TAF8-tcs-TAF10-tcs-CFP DP-810
polh TEV-tcs-TAF8-tcs-TAF10-tcs-CFP poly A polh-810
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Human transcription factor complex expression
A)
B)
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Supplementary Figure 8: Validation of bifunctional dual promoter expression 
cassettes. Human General Transcription (GTF) factor TFIID subcomplex expression 
from expression cassettes driven by the bifunctional dual promoter CMVintP10-b 
was compared to expression from baculoviral very late promoter polyhedrin (polh) 
driven cassettes which are only active in insect cells. (A) Expression cassettes 
tested are shown in a schematic representation. CMV stands for cytomegalovirus 
late promoter, P10 for baculoviral very late promoter p10.  TEV stands for tobacco 
etch virus NIa protease, tcs for TEV cleavage site, TAF stands for TBP associated 
factor, CFP for cyan fluorescent protein and poly A for the SV40 polyadenylation site. 
Small arrows indicate transcription start sites. An intron sequence enhancing 
transcription following the p10 promoter is represented as a box colored in gray. 
TFIID subcomplexes TAF8-TAF10 and TAF5-TAF6-TAF9 were expressed as self-
processing polyproteins tailored into the individual subunits by TEV.  (B) SDS-PAGE 
analysis of the expression of TAF8-TAF10 complex in baculovirus-infected insect cell 
cultures is shown (left). CC stands for uninfected cell control, SNP for whole cell 
extract, SN for cleared lysate. DP-810 denotes expression from the bifunctional dual 
promoter, polh-810 denotes expression from the baculoviral late promoter. EMBacY 
baculovirus was used. Virtually identical amounts of purified TAF8-TAF10 complex 
were obtained in the expression experiments. DP-810 VSVG denotes purified TAF8-
TAF10 complex expressed from the bifunctional promoter, using MultiBacMam virus 
which displays VSV-G protein on its surface to enhance mammalian cell infectivity 
(middle). This virus was used to efficiently infect HeLa cells as evidenced by CFP 
fluorescence (right). (C)  SDS-PAGE analysis of the expression of TAF5-TAF6-TAF9 
complex in baculovirus-infected insect cell cultures is shown (left). CC stands for 
uninfected cell control, SNP for whole cell extract, SN for cleared lysate. DP-659 
denotes expression from the bifunctional dual promoter, polh-659 denotes 
expression from the baculoviral late promoter. EMBacY baculovirus was used. 
Virtually identical amounts of purified TAF5-TAF6-TAF9 complex were obtained in 
the expression experiments. DP-659 VSVG denotes purified TAF5-TAF6-TAF9 
complex expressed from the bifunctional promoter, using MultiBacMam virus which 
displays VSV-G protein on its surface to enhance mammalian cell infectivity (middle). 
This virus was used to infect HeLa cells with high efficiency as evidenced by CFP 
fluorescence (right). 
HMGA1_out_F: GTCCCTCCCTCTCCTGCTCCTAGAATACTCAG
HMGA1_out_F3: TTGTCCTTCCTATGAGCCTCTGCAG
HMGA1_out_R: CAATGACGGATGTCGAAGAATGGAACATTGAAC
EGFP_R:  CACGCTGCCGTCCTCGATGTTG
EGFP-N-Rev-long: GTCAGCTTGCCGTAGGTGGCATC
Supplementary Figure 9
Modification of the HMGA1 locus with CRISPR
modified from Ratz et al., Scientific Reports, 2015
(EGFP instead of rsEGFP2 was used)
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Plasmids for modification of the human HMGA1 locus
Plasmids were obtained from Stefan Jakobs (Ratz et al., 2015). The homology arm was cloned into the AscI/ 
PacI sites of AG10. rsEGFP2 was replaced by EGFP (left). U6-driven HMGA1-gRNA2 and Cas9 expression
cassette from px330 were transfered to AscI/ PacI sites of plasmid DA2 (middle). U6-driven HMGA1-gRNA1
from px330 was transfered to AscI/ PacI sites of plasmid DS2cx (right).  
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MultiPrime-based genome engineering of HEK293 cells. (left) HEK293 cells were infected with the
indicated viruses to modify the HMGA1 locus. Cells were fixed after five days and the nuclei were
counterstained with NucRed Dead 647 (Molecular Probes, red). Cells with a modified genome have
a green nuclei. Scale bar: 20 Pm. (right) PCR analysis of the infected cultures. The fragment with
1139bp for the mutant allel was only obtained from cultures that express the Homology construct
together with gRNAs and Cas9.
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Supplementary Figure 10a
i) Original western blots of HEK293 cells (modulation of expression levels)
 
ii) Original western blots of HEK293 cells (dual-host promoters) 
anti-GFP anti-tubulin
RE
F_
Pr
om
ot
er
s_
ex
pe
rim
en
t 1
RE
F_
Pr
om
ot
er
s_
ex
pe
rim
en
t 2
RE
F_
Pr
om
ot
er
s_
ex
pe
rim
en
t 3
Promoters Dual promoters Promoters Dual promoters
Original western blots of REF cells (modulation of expression levels and dual-host promoters)
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Supplementary Figure 10c
 
Original western blots of PAE cells (modulation of expression levels and dual-host promoters)
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Supplementary Figure 10d
i) Original western blots of Hela tTA cells (modulation of expression levels)
 
ii) Original western blots of Sf21(insect) cells (dual-host promoters) 
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Supplementary Figure 10e
Original western blots related to conversion of single chains to full length human antibodies
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aculovirus   is   a   promising   vector   for   transducing   numerous   types   of   mammalian  
cells.  Anyway  production  of   functional  baculovirus,  harbouring  all  expected  genes  
is  challenging  due  to  rearrangement  of  genetic  materials  in  genome  of  virus  during  
amplification.      
In   this   chapter,   I   describe   a   step-­by-­step   protocol   for   the   cloning   and   assembly   of   genes   of  
interest   into  MultiPrime  system,  and  for  generation  of  MutiPrime  baculovirus.  Furthermore,   the  
protocol  for  efficient  transduction  of  mammalian  cells  is  included.  I  also  provide  some  key  steps  
which   are   critical   for   users   from   other   labs   to   implement   MultiPrime   system.   Finally,   a  
troubleshooting  table  consisting  of  possible  problems  and  their  solutions  is  introduced.    
Manuscript  related  to  this  chapter  is  planned  for  publication  (Mansouri  et  al.,  in  preparation).  
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1'Abstract'
'
Efficient,"simple"and"reliable"method"for"multigene"delivery"to"mammalian"
cells" is"a"crucial" topic" in"many"biological"research" laboratories."Baculovirus" is"a"
good"choice"for"highly"efficient"delivery"of"multitude"gene"to"mammalian"cells"due"
to" its" large"cargo"capacity."However," instability"of"genetic"material" during"over9
amplification"of"virus"can"restrict"utility"of"this"vehicle"for"gene"delivery."Here,"we"
introduce" a" step9by9step" protocol" for" assembly" and" generation" of" intact"
baculovirus"harboring"multigene"plasmid."Protocol"for"transduction"of"a"variety"of"
mammalian"cells"is"also"provided."
"
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'
'
2'Introduction'
Baculovirus"is"a"promising"vector"for"transducing"numerous"types"of"mammalian"
cells" (Sung" et" al.," 2014)." Bacoluvirus," which" normally" infects" insect" cells," is" a"
non9integrating"virus"that"has"a"large"cargo"capacity,"low"toxicity"and"broad"ability"
to"transduce"many"mammalian"cells"(Kost"et"al.,"2010)."Although"Baculovirus"has"
unique" advantages" in" comparison" with" other" viruses," generation" of" intact"
baculovirus,"harbouring"all"expected"gene"cassettes,"can"be"quite"challenging."In"
principle," the" transgene" in" the" genome"of" baculovirus" is" prone" to" spontaneous"
excision" owing" to" instability" and" rearrangement" of" genetic" material" during"
amplification"of"virus"within"host"cells"(Chen"et"al.,"2010]"Fitzgerald"et"al.,"2006]"
Sung"et"al.,"2014)."Mutation"and"rearrangement"of"genome"is"a"general"strategy"
in" viruses" and" allow" them" to" obtain" higher" variation" in" the" next" generation."
Therefore," uncontrolled" baculovirus" generation" can" lead" to" production" of"
defective"virus"resulting"in"incomplete"gene"delivery."This"drawback"can"be"even"
worse" when" baculovirus" is" carrying" multigene" constructs." In" fother" words,"
multigene" baculoviral" vectors" are" composed" of" numerous" repetitive" elements"
(promoters," terminators," recombination" sequences)" which" may" be" a" preferred"
site" for"eliminating"recombinant"cassettes"during"virus"generation" in" insect"cells"
(Fitzgerald"et"al.," 2006)."Therefore,"development"of"a"highly"optimized"protocol"
for" production" of" healthy" baculovirus," bearing" all" the" transgene" constructs" is"
highly" desirable." " We" have" recently" developed" an" efficient" baculovirus9based"
multigene"delivery"system,"called"MultiPrime," for"mammalian"cells" (Mansouri"et"
al.,"2016)."MultiPrime"is"established"to"tackle"the"difficultly"of"multigene"delivery"
to"mammalian"cells"particularly"primary"and"stem"cells,"which"are"recalcitrant"to"
plasmid" transfection." Here," we" introduced" a" simple" protocol" for" production" of"
multigene" baculoviral" vectors." We" optimized" our" protocol" for" minimum" gene"
deletion"with"maximum"virus"titration."This"feature"allows"baculovirus"supernatant"
to" be" directly" added" to" the" mammalian" cell" and" eliminate" the" requirement" to""
concentrate" virus" by" ultracentrifugation" or" special" kits" for" virus" purification."
Furthermore," this" protocol" is" faster" than" other" introduced" protocols." The" entire"
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MultiPrime"procedure,"from"assembly"of"constructs"to"baculovirus"generation"and"
transduction," can" be" completed" in" one" month." This" protocol" can" be" used" for"
generation"of"virus"for"multiple"protein"expression"purposes"in"structural"biology"
as"well.""
"
"
3'Reagents'
E." coli" competent" cells" for" normal" cloning:"TOP10," DH10β,"
Mach1,"BW23473"(pir+)"
E."coli"competent"cells"for"MultiPrime"baculovirus"generation:"DH10Bac"EMBacY"
and"DH10MultiBacMam"competent"cells"
Spodoptera)frugiperda (Sf21)"cells"(Life"Technologies)!
Mammalian"cells"to"be"transduced,"for"example]"
Established"cell"lines:"HEK293,"Hela,"COS97,"PAE,"Swiss"3T3,"etc."Primary"cells:"
HUVEC"(Life"Technologies),"REF"(isolated"from"rat"embryos),"Rat"cortex"Neuron"
(Life" Technologies)." Stem" cell:" induced9" pluripotent" stem" (iPS)" cells" (we" have"
used"the"human"iPS"cells,"supplied"by"the"Taylor’s"lab"(University"of"Basel)."
SF9900" II" serum9free" (SFM)" medium" or" SF9900" II" 1%FBS" and" +1%"
Penicillin/Streptomycin"medium""
DMEM"(high"glucose"4.5g/L"with"L9Glutamine,"Amimed)"
Trypsin9EDTA"PBS" 1:250" (0.05%/0.02%)"without" Ca++/Mg++," with" Phenol" red"
(Amimed)"
Gentamycin,"Ampicillin,"Chloramphenicol,"Kanamycin,"Tetracycline""
X9gal,"IPTG""
Cell"fectin"II"reagent"(Invitrogen)"
Penicillin9streptomycin,"100×"(10,000"U/ml,"Amimed)"
MultiPrime"vectors:""
Acceptor" vectors" with" CMV" promoter:" pSI9AGZ10" (Accession" code" at" NCBI:"
KX001771),"pSI9AGR10"(KX001770),"pSI9AGL10"(KX001778)."
Donor"vectors"with"CMV"promoter]"can"be"obtained" from" reference" (Kriz"et"al.,"
2010)."
Acceptor"vectors"with"dual"promoters]"pSI9AGL109DM"(KX001779),"pSI9AGL109
DI"(KX001780)."
Donor"vectors"with"dual"promoters]"pSI9DSZ2cx9DI"(KX001773),"pSI9DSZ2cx9DM"
(KX001774),"pSI9DAZ9DI"(KX001782),"pSI9DAZ9DM"(KX001781)."
Acceptor"and"donor"vector"with"different/inducible"promoters]"pSI9DSZ2cx9TRE"
(KX001772,"with"a"tetracycline9"inducible"promoter),"pSI9DSZ2cx9PGK"
(KX001775,"with"a"mouse"phosphoglycerate"kinase"1"or"PGK"promoter),"pSI9
DSZ2cx9UBC"(KX001776,"with"a"human"Ubiquitin"C"or"UBC"promoter)"and"pSI9
DSZ2cx9SV40"(KX001777,"with"a"simian"virus"40"early"promoter"or"SV40)."
Cre"recombinase"and"10×"reaction"buffer"(NEB)"
Phusion"high9fidelity"DNA"polymerase"in"2×"HF"or"2×"GC"buffer"(NEB)"
PCR"primers""
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Paraffin"wax"beads"(e.g."Fluka"Chemika,"#411671)"
Restriction"enzymes"DpnI,"AscI"(SgsI),"SapI"(LguI),"and"PacI"(NEB,"Fermentas)"
QIAprep"Gel"Extraction"kit,"QIAprep"PCR"purification"kit"(Qiagen)"
Midiprep"plasmid"extraction"kit"(Genomid,"Jetstar"2.0"plasmid"Midiprep"kit)"
Miniprep"plasmid"extraction"kit"(Thermo"scientific)"
QIAprep"PCR"purification"kit"(QIAgene)"
T4"DNA"ligase,"10×"T4"DNA"ligase"buffer"(NEB)"
Fetal"calf"serum"(Amimed)"
FuGENE"HD"(Promega)"
Opti9MEM"I"Reduced"Serum"Medium"(Gibco)"
"
4'Equipment'
Ultra9centrifuge"(OptimaTM"XL9100K,"BECKMAN"COULTER)"
Confocal"microscope"(Leica"SP5)"
Fluorescent" microscope" (Olympus" IX81" equipped" with" an" Andor" iXonEM"
camera)"
Inverted"microscope"equipped"with"a"phase9contrast"ring"and"fluorescence"filters"
Thermocycler"
Equipment"for"agarose"gel"electrophoresis"
Electroporator"and"cuvettes"
Tissue"culture"Laboratory"
Incubator,"37"°C,"5%"CO2!"
Incubator,"27"°C,"no"CO2""
Refrigerator,"4"°C""
Freezer,"−20"°C""
Tissue"culture"plates"(10"cm"and"69,"129"and"969well)"
Tissue"culture"flasks"(T925,"T975"and"T9150)"
Micro"centrifuge""
Neuobar"counting"system"
Syringes"(BD"Biosciences)"
Syringe"filter"0.22μm"(Merck"Millipore"Ltd.)"
Filter"0.22"μm"and"0.45"μm"(SARSTEDT,"Germany)"
'
'
'
'
'
'
'
'
'
'
'
'
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5'Procedures'
A:'Cloning'genes'of'interest'into'MultiPrime'vectors'and'
mutigene'assembly'
1." Make" your" plan" for" cloning" of" interested" genes" into" MultiPrime" vectors."
First"gene"must"be"clone"into"an"acceptor"and"the"rest"into"donor"vectors."
Different"methods"of"cloning"(A,"B,"C,"D)"can"be"used"to"achieve"this"goal."
Use"option"A,"if"a"SapI"(LguI)"recognition"site"dose"not"present"inside"gene"
of" interest" sequence."Option"B," is" suitable"when"an"expression" cassette"
including"promoter,"gene"of"interest"and"a"terminator"signal"already"exists."
Use" option"C," for" a"Gibson" assembly" based" cloning" in" a" free" restriction"
enzyme"(RE)"reaction."Option"D"is"a"Sticky"end"based"PCR"cloning"and"is"
suitable"when"one" (or"more" than"one)" internal" recognition" site" for"RE" is"
present."
CRITICAL'STEP"Plasmid)prepared)with)option)C)can)directly)jump)to)step)
7.)Meaning)that)it)does)not)need)to)further)treatments."
2." Amplify" DNA" fragments" via" PCR" reaction." We" amplify" DNA" fragments"
using"this"PCR"reaction"and"program:""
Template"DNA"(100"ng/μl)"" " 1"μl"
5′"primer"(5"μM"stock)"" " 3"μl"
3′"primer"(5"μM"stock)"" " 3"μl"
ddH2O"" " " " 8"μl"
One"paraffin"wax"bead"" " 20"μl"
2×"Phusion"HF"Reaction"mix""" 15"μl"
"
1x" " 98"oc" 5"min"
25930x" 98"oc" 30s"(denaturation)"
52"oc"" 30s"(annealing)"
72"oc""" 1min/kb"(extension)"
1x"" " 72"oc""" 10"min"(final"extension)" "
CRITICAL' STEP" It) is) crucial) to) use) a) high) fidelity) proofreading)
polymerase)with)a)low)error)rate)to)amplify)your)DNA)fragments.)We)used)
Phusion)highAfidelity)DNA)polymerase)in)2x)HF)buffer.))
Troubleshooting'"
CRITICAL'STEP"Treatment)of)PCR)product)with)DpnI)(directly)add)1)ul)
DpnI)to)30)ul)PCR)product,)overnight)at)37oc))leading)to)elimination)of)
methylated)parental)DNA.)Therefore,)it)can)decrease)rate)of)background)
after)transformation.)"
3." Digest"PCR"product"with"suitable"restriction"enzymes"at"37oc"for"Overnight"
(O/N)."
4." Clean"up"your"PCR"products"by"QIAprep"PCR"purification"kit"and"run"2"ul"
of"final"products"on"1.2%"agarose"gel"to"evaluate"their"qualities.""
5." Prepare"your"acceptor"and/or"donor"MultiPrime"vectors"according"to"your"
ligation" strategies." For" option" A" and" B," MultiPrime" vectors" must" be" a"
cleaned" up" product" of" a" SapI" or" AscI" /PacI" digestion," respectively." For"
option"D,"it"should"be"prepared"according"to"restriction"enzymes"that"has"
been"used"for"amplification"of"PCR"fragments."
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6." Ligate"MultiPrime" vector" backbone"with" prepared"PCR"products" through"
T4"DNA"ligase"for"O/N"in"room"temperature"(RT)"or"Fast"T4"Ligase"for"20"
min"at"RT."
7." Transform"1"ul"of"ligation"or"Gibson"assembly"product"to"100"ul"of"E."coli"
competent"cells"(TOP10,"DH10β,"Mach1"or"BW23474)."A"mixture"of"DNA"
and"competent"cells"should"be"keeping"on"ice"for"20"min"and"then"use"it"
for" electroporation" (1.7" kV" pulse," 25" µF," 200Ω)." Transformed" cells" are"
recovered"in"400"ul"of"SOC"medium"and"2h"at"37oc."Plate"250"ul"of"them"
into" LB" agar" containing" appropriate" antibiotic" (List" and" concentration" of"
antibiotics"are"available"in"table"2a)."Incubate"the"plates"at"37oc"for"O/N.""
CRITICAL' STEP"Donor) plasmids) are) containing) a) conditional) origin) of)
replication) derived) from) R6Kγ) and) then) have) to) be) propagating) in) cell)
strains)expressing)the)pir)gene)(pir+)strains)) like)BW23474.)But)acceptor)
plasmids) and) recombined) plasmids) can) be) propagated) in) common)
bacterial)strains)such)as)TOP10,)Mach1,)DH10)β.""
Troubleshooting'"
8." Pick"2910"colonies"and" inoculate" to"5"ml"LB"broth"containing"appropriate"
antibiotic." Incubate" the" tubes" in"37oc"with"an"orbital"shaker" (150" rpm)" for"
O/N.""
9." Isolate"recombinant"plasmids"via"miniprep"plasmid"extraction"kit" from"4.5"
ml"of"culture"and"keep"the"rest"(500"ul)"in"4oc.""
10."Validate"correct"clones"through"restriction"enzyme"digestions"and/or"PCR."
It"is"also"recommended"to"verify"the"cloned"gene"by"sequencing,"as"well."
11.""Inoculate"50"ul"of"positive"clones" into"100"ml"LB"broth"culture"comprise"
correct"antibiotic."Incubate"them"at"37oc"for"O/N."
12.""Apply" a" midiperep" kit" to" isolate" recombinant" plasmid." Measure" DNA"
concentration"through"a"nanodrop.""
CRITICAL' STEP" Usually) concentration) of) DNA) in) this) step) should) be)
around)1A2)ug/ul)with)a)ratio)of)absorbance)(A260/280))1.8A2."
13."Combine"MultiPrime"acceptor"and"donor"plasmids"through"in"vitro"cre/loxP"
recombination"reaction:""
Acceptor"(1ug)" 1ul"
Donor"(1"ug)" " 1ul"
10x"Buffer""""""""""""""""1ul""
Cre"recombinase"""""1ul"
ddH2O"""""""""""""""""""""6ul"
Total' ' ' 10'ul'
Incubate"reaction"for"30"min"at"37oc"and"then"5"min"on"ice.""
CRITICAL'STEP"One)acceptor)plasmid)can)be)assembled)with)one)donor)
plasmid) in)an) in) vitro) cre/loxP) recombination) reaction.)The)second,) third)
and)fourth)donor)plasmids)should)be)inserted)in)a)sequential)manner)with)
doubleA,)tripleA,)fourAassembled)MultiPrime)plasmids,)respectively."
14.""Repeat"step"7."Add"appropriate"combination"of"antibiotics"to"the"LB"agar"
plates"(Tabel"2a)."
15.""Pick"5" colonies"and" inoculate" to" small9scale" cultures"of" LB"broth"media"
containing"all"combined"antibiotics"in"32oc"and"110"rpm"orbital"shaker."
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CRITICAL' STEP" Grow) bacterial) in) 32oc) (instead) of) 37oc)) to) avoid)
unwanted)recombination)that)can)happen)over)fast)bacterial)amplification.)
This)type)of)recombination)can)lead)to)deletion)of)expression)cassette(s))
completely)or)partially.""
16.""Repeat"step"9.""
17."Validate" correct" clones" through" restriction" enzyme" digestions" (restriction"
mapping).""
CRITICAL' STEP" Although) assembly) of) acceptor) and) donor) (and) a)
combined) acceptorAdonor) with) the) next) donor) vector)) plasmids) can) be)
done)with)any)DNA)sequence)analyzer)software)but)we)recommend)Ape)
plasmid)editor)software.)This)software)is)an)open)source)software)and)can)
be) acquired) from) http://biologylabs.utah.edu/jorgensen/wayned/ape/.) The)
most)convenient)way) to)assemble) two)vectors) is) to)open) their)sequence)
with) Ape.) Then) select) MultiAcre) recombination) from) Tools) menu.) Next,)
determine) acceptor) and) donor) vector) sequence) files) and) press) OK.)
Finally,)save)your)fused)acceptorAdonor)sequence)in)your)desired)place."
18."Repeat"11"and"12.""
19."(Optional)" Functional" analysis" of" recombinant"MultiPrime" plasmid" can"
be" done" in" this" step." This" step" can" validate" expression" of" all" interested"
genes" in" mammalian" cells" via" tranfection." Many" procedures" for"
transfection" are" available." In" the" simplest" one," plate" 60" x" 104" HEK293"
cells/69well"plate"about"698"h"before" transfection." If"genes"of" interest"are"
fused"to"fluorescent"proteins,"poly9L9lysine"treated"coverslips"can"be"put"in"
the"69well"plates,"as"well."Mix"2"ug"of"assembled"MultiPrime"plasmid"with"
6"ul"of"Fugene"HD"in"100"ul"Optimum"medium"and"keep"the"mixture"for"15"
min"at"RT."Add"the"cocktail"of"DNA"and"transfection"reagent"to"the"6"well"
plate"as"drop"wise"and"analyze"cells"through"WB,"RT"PCR"or"fluorescent"
microscopy"after"24948h.""
"
B:'Generation'of'MultiPrime'baculovirus'
" 20."Transform"100"ngr/ul"of"recombinant"multigene"plasmid"into"100"ul"of"E."
coli"DH10"BacEMBacY"and/or"E."coli"DH10"MultiBacMam"competent"
cells."We"apply"2"kV"pulse"(instead"of"1.7"which"were"mentioned"in"step"
6),"25"µF,"and"200"Ω"for"transposition"of"MultiPrime"plasmid"into"E."coli"
harboring"bacmids."Add"400"ul"of"SOC"medium"and"incubate"them"for"O/N"
at"37oc.!
CRITICAL'STEP"E.)coli)DH10)MultiBacMam)is)a)pseudotyped)baculovirus)
with) VSVg) (Vesicular) Stomatitis) Virus) glycoprotein).) VSVg) has) been)
shown) to) improve)mammalian) cell) transduction) efficiency.) E.) coli) DH10)
EMBacY)does)not)express)this)glycoprotein)on)its)surface.)Also,)EMBacY)
and) MultiBacMam) baculoviruses) express) EYFP) and) mCherry,)
respectively.) These) fluorescent) markers) simplify) and) standardize)
monitoring) the) generation) of) baculovirus) during) infection) in) insect) cells)
(Fig.3)"
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21."Plate" 250" and" 50" ul" of" transformed" bacteria" on" LB" agar" contain" all"
appropriate" antibiotics," X9gal" and" IPTG." Incubate" the" plates" in" 32oc" for"
O/N."
CRITICAL' STEP' LB) agar) should) containing) Gentamycine,) Ampicilin,)
Kanamycin,) tetracycline,) chloramphenicol,) IPTG) and) XAGal) (Table) 2b).)
Prepare) at) least) three) plates) for) each) MultiPrime) constructs.) After)
preparation,) plate) should) be) keeping) at) 4oc) and) away) from) light.) Before)
spreading)of)bacteria,)preAwarm)the)plates)at)37oc)for)30)min."
22."Pick"5"white"colonies"as"well"as"one"blue"colony"(as"control"negative)"and"
re9streak" them"down"on" new"LB"agar" (with" all" the" antibiotics" as"well" as"
IPTG"and"X9gal)."
23.""Pick" at" least" two" white" re9streaked" colonies" and" inoculate" them"
individually"into"100"ml"LB"broth"consist"of"all"antibiotics"but"not"X9gal"and"
IPTG."Incubate"them"at"32oc"and"110"rpm"orbital"shaker"for"O/N."
CRITICAL' STEP' Make) 2A3) bacterial) stocks) from) each) white) colony)
through)mixing)with)100%)glycerol)(1:1))and)keep)them)at)A80oc.""
24."Apply" a" midiperep" kit" to" isolate" recombinant" bacmid" plasmid." Use" a"
nanodrop" to" measure" concentration" of" extracted" Plasmid." Usually"
concentration"of"DNA"in"this"step"is"about"0.591"ug/ul.""
CRITICAL' STEP'We) recommend) to) dry)DNA) pellet) (in) the) last) step) of)
plasmid)isolation))under)a)bacterial)hood.)Also,)use)a)sterile)ddH2O)or)TE)
for)reAsuspension)of)DNA)pellet).""
CRITICAL' STEP' Use) at) least) two) different) bacterial) white) colonies) to)
generate)MultiPrime)baculovirus.""
25.""For"each"MultiPrime"bacmid"DNA,"take"two"tubes]"A"and"B."Add"100"ul"of"
SF9900"II"SFM"medium"plus"8"ul"of"Cell"fectin"II"to"the"tube"A."Add"100"ul"
of"SF9900" II"SFM"medium"plus"2"ugr" recombinant"bacmid" in" the" tube"B."
Keep"them"for"5"minutes"away"and"then"mix" them"together"gently."Keep"
the"mixed"tubes"(A+B)"for"30940"min"at"R/T."
CRITICAL'STEP'From)step)25,) the)entire)steps)must)be)performed) in)a)
sterile)cell)culture)hood.""
Troubleshooting'"
26."For" every" MultiPrime" bacmid" DNA," seed" 2" ml" of" 0.5" x" 106" insect"
Sf21cells/ml" in"a"69well"plate" for"V0"virus"generation."Seal" the"plate"with"
parafilm"and"incubate"it"in"a"27oc"incubator"for"30940"min."
CRITICAL' STEP' Use) newly) thawed) insect) cells) (Sf21) or) Sf9).) Cells)
should)proliferate)properly)every)18h.)Their)shape)and)numbers)are)very)
important.)Keep)the)stock)of)cells)between)1A1.5)x)106)cells/ml.))
CRITICAL' STEP' Keep) the) cells) in) SFA900) II) SFM) medium) during)
transfection.))
27."Transfect"Sf21"cells"with"a"mixture"of"DNA"from"step"25"in"69well"plate"as"
drop"wise." Seal" the" 69well" plate"with" parafilm" and" incubate" it" for" 5" h" at"
27oc.""
28."After"5"hours,"discard" the"supernatant" (contain" transfection" reagent)"and"
replace"it"with"2"ml"either"SF9900"II"SFM"or"fresh"SF9900"II"1%FBS91%PS"
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medium." Return" the" 69well" plate" to" 27oc" incubator" and" continue" it" with"
more"47"hours"incubation"(52"hours"after"beginning"of"transfection)."
Troubleshooting'"
29."Collect" supernatant" and" centrifuge" it" in" 1200" rpm" for" 10" min." Pass" the"
supernatant"through"a"0.45"uM"and"collect"them"in"29ml"eppendorf"tubes."
This"is"the"initial"virus"V0."
CRITICAL'STEP'Baculovirus)generated)in)steps)V0,)V1)and)V2)are)stable)
in)4)oc)and)dark)place) for)4A6)months.)Also,)baculovirus)stocked)with)5%)
FBS)and)2.5%)Glycerol)can)be)keep)in)A80oc)for)long)time)(months).""""
30."Seed"4"ml"of"0.5"x"106"insect"Sf21cells/ml"in"a"25"cm"T9flask."Add"600"ul"of"
V0"stock"into"T9flask"and"put"the"flask"in"27oc"incubator"with"80"rpm"orbital"
shaking."Keep"the"flask"to"culture"for"72"h."This"is"generation"1"virus"(V1)."
Monitor"MultiPrime"baculovirus"generation" inside" the" insect"cells" through"
fluorescent"protein"signals"with"a" fluorescent"microscope." In" this"step,"at"
least"50"%"of"cells"are"fluorescent.""
Troubleshooting'"
CRITICAL' STEP' If) 20A30) of) cells) is) shiny,) add) 1.5) ml) SFA900) II) SFM)
medium)to)the)TAflask)and)let)them)growth)for)more)18A22h.)Cells)must)be)
harvest)in)this)step)even)if)they)are)not)60)%)infected)(Fig.)3).)
31."Harvest" V1" MultiPrime" virus" with" centrifugation" of" whole" medium"
suspension" in" 1200" rpm," 10"min" and" 4oc." Supernatant" should" be" filtrate"
with"a"0.45"ul"filter"and"keep"in"4"oc.""
32.""Seed"100"ml"of"0.5"x"106"insect"sf21cells/ml"in"a"75"cm"T9flask."Add"4"ml"
of"V1"stock"into"the"T9flask"and"put"the"flask"in"27oc"incubator"with"80"rpm"
orbital"shaking."Keep"the"flask"to"culture"for"48972.""
CRITICAL' STEP'Monitor) baculovirus) generation) by) fluorescent) signals.)
After) 48) h) should) almost) 50%) of) insect) cells) get) infected) and) be)
fluorescent.) After) 72) h)more) that) 90%) of) cells) are) infected.) Insect) cells)
should)not)keep)longer)than)72h)in)this)step."
CRITICAL'STEP'Harvest)V2)MultiPrime)virus)with)centrifugation)of)entire)
medium)suspension)in)1200)rpm,)10)min)and)4oc.)Supernatant)should)be)
filtrate)with)a)0.45)uM)or)0.22)uM)filter)and)keep)in)4oc.""
CRITICAL'STEP'With)this)protocol)usually)we)produce)1)x)108)to!3)x)108)
pfu/ml.) This) amount) of) bacuvirus) is) usually) enough) to) transduce)
mammalian)cells.)Therefore,)this)supernatant)can)be)added)directly)to)the)
mammalian)cell)plate.)But)anyway,)sometimes)a)higher) transduction)rate)
is)more)desirable.)We)recommend)concentrating)of)generated)baculovirus)
through)ultraAcentrifugation)(see)box)1).)""
CRITICAL' STEP'Determine) titer) of) generated)baculovirus) concentration)
using)either)plaque)assay)or)endApoint)dilution)assay.)It)would)be)help)you)
to)fineAtune)transduction)level)according)to)your) interest.)We)recommend)
endApoint)dilution)assay."
"
C:'Transduction'of'mammalian'cells'
'
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In" this"part,"we"explain"a"general"protocol" that"can"be"used"for"a"various"
mammalian" cells" including" established" cell" lines," primary" cells" and" stem"
cells.""
33."Seed"mammalian" cells" in" the" desired" density" in" the" 249," 129" or" 69" well"
plate"one"O/N"prior"transduction.""
CRITICAL' STEP"Density) of) mammalian) cells) depending) on) the) aim) of)
experiment,)size)of)cell)and)their)doubling)time.)HEK293)or)Hela)cells)for)
microscopy)purposes)usually)can)be)seed)2.5)x105A)3.6)x105)cells/ml)in)6)
well)plate.) )We)use)a)density)7.2)x105)and)8.4)x105)cells/ml) for)HEK293)
and) HeLa) cells) when) a) protein) expression) experiment) is) aimed.)COSA7)
and)PAE)cells)need) to)be)50)x)104)cells/6Awell)confluent)and)HUVEC)or)
REF)need)to)be)70)x)104)cells/6Awell.)We)used)2)x105)inducedAPluripotent)
Stem)cell)(iPS)."
CRITICAL'STEP' If)cells)are)plated)on)the)coverslips,)make)sure)that)they)
are) stably) mounted) to) the) glass.) Otherwise) treat) coverslips) before) cell)
seeding)for)30)min)at)RT)with)suitable)reagent)(like)PolyALALysine)for)HEK)
cells,)PolyADALysine)for)neurons,)Matrigel)for)iPS)and)etc).)
CRITICAL'STEP'Seed)mammalian)cells)in)their)usual)medium)along)with)
their)additives)(e.g.,)FBS,)growth)factors,)antibiotics)and)etc).)
34.""Check" the" cells" with" normal" phase" contrast" microscope" before" starting"
transduction."Cells"should"look"spread"and"completely"steak"to"the"plate."
35.""Next" day" after" seeding," aspirate" medium" and" add" desired" volume" of"
MultiPrime"baculovirus"to"mammalian"cell"culture"according"to"planed"MOI"
for"transduction."We"suggest"using"either"2"ml"un9concentrated"plus"500"ul"
normal"mammalian"medium"(without"FBS"and"PS)"or"250"ul"concentrated"
virus" along"with" 1"ml" normal"mammalian" cell"medium" (without" FBS"and"
PS)."Keep"the"cells"under"transduction"at"37oc"incubator"for"8h.""
CRITICAL' STEP' PreAwarm) baculovirus) stock) with) keeping) them) at) RT)
and)dark)place)half)an)hour)before)transduction.))
CRITICAL'STEP' If)viruses)are)going)to)be)thawed)from)A80,)it)is)better)to)
thaw)them)on)the)ice)at)4oc)for)O/N."
Troubleshooting'"
36.""Discard"supernatant"when"incubation"time"is"over.""Replace"transduction"
medium" with" fresh" and" complete" medium" containing" all" the" necessary"
antibiotics"or"FBS"(e.g."DEME"+"10%"FBS"+"1%"PS).'"
CRITICAL'STEP'We)recommend)keep)the)antibiotics)in)culture)as)could)
as)possible."
37.""Proceed" with" your" experiment]" fix" the" cells" after" 48" h" and" analyze" the"
expression" level" through" immunostaining" or" western" bloting." Also," lysed"
cells"can"be"used"for"mRNA"expression"level"analysis"and"etc."
Troubleshooting'"
"
"
"
"
"
!! 88"
6'conclusion'
'
We"described"a"rapid,"simple"and"efficient"for"production"of"baculovirus"harboring"
multitude" gene" cassettes." Using" this" protocol," generation" of" bacilovirus" take"
place"relatively"fast"(10"days"for"V0"to"V2)."Furthermore,"V2"virus"can"transduce"
mammalian"cells"directly"without"need"to"an"extra"ultra9centrifugation"step"when"
a" super" high" rate" of" transduction" is" not" aimed." In" contrast"with" other" protocols"
that" mainly" transduce" mammalian" cells" by" baculovirus" in" 25oc" for" a" higher"
efficiency"(Sung"et"al.,"2014),"we"transduced"all"the"mammalian"cells"in"37oc"and"
obtained"even"higher"that"95%"transduction"efficiency."Finally,"this"protocol"is"not"
only" restricted" for" generation" of" baculovirus," that" harboring" multigene" for"
mammalian"cells,"but"also"can"be"used"for"production"of"baculoviurs"with"either"
single"or"multigene"for"protein"production"in"insect"cells.""
"
"
7'troubleshooting'
Troubleshooting"advices"can"be"found"in"Tabel1.'
'
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Tabel1:(Troubleshooting(
#
# Problem# Reason# Solution#
2# Nonspecific#band# Mispriming#during#annealing#step# Increase#annealing#temperature,#use#wax#beads#
2# No#PCR#product# One#(or#more#than#one)#of#the#PCR#component(s)#
are#missed#
#
Concentration#of#template#is#too#low#or#too#high#
#
#
PCR#Product#has#GC#rich#templates#or#it#is#long#and#
has#complex#secondary#structures#
Make#sure#that#all#the#components#are#present#in#the#
PCR#reaction#
#
Adjust#template#concentration#between#50K200#ng/ul#
#
#
Use#Phusion#GC#Buffer##
7# No#colony#growth#on#the#
plate#
Transformed#bacteria#plated#on#inappropriate#
antibiotic#plate#
#
Donor#plasmid#is#transformed#into#incorrect#
competent#cells.##
Repeat#transformation#and#make#sure#that#the#
bacteria#are#plating#on#appropriate#antibiotic#plates#
#
Transform#donor#plasmid#into#BW23474#
25# One#day#after#transfection,#
insect#cells#got#contaminated#
#
#
MultiPrime#Plasmid#is#not#sterile## Filtrate#plasmid#through#0.22uM#filter,#or/and#adding#
1%#P/S#to#SFII#900#medium##
28# One#day#after#transfection,#a#
lots#of#dead#cells#are#
observed##
Present#P/S#in#the#SFK900#II#SFM#medium#
#
#
Use#more#than#8ul#of#Cell#fectin#II#
#
Repeat#transfection#with#SFK900#II#SFM#medium#
without#any#P/S#
#
Use#only#8ul#of#cell#fectin#for#transfection##
30# Insect#cells#are#not#infected#
at#all#
#
#
#
#
20K30%#(less#than#50%)#of#
insect#cells#are#infected##
Transfection#was#not#efficient#
#
#
#
#
#
Titer#of#V0#virus#was#not#high#
Throw#away#this#virus#and#come#back#to#step#25#and#
Transfect#new#insect#cells#again.#Just#before#adding#
A+B#mixture#to#the#6Kwell#plate,#remove#1000#ul#of#
the#6Kwell#medium#(now#total#volume#is#1000#ul)#and#
then#add#A+B#cocktail#to#medium#as#drop#wise##
#
Add#1.5#ml#SFK900#II#SFM#or#1%#FBS#+#1%#PS#
medium#to#the#TKflask#and#keep#them#for#18K22#h#
more.##
35# Mammalian#cells#are# Insect#cell#medium#is#not#good#for#mammalian#cells# 1#use#less#amount#of#unKconcentrated#(e.g,#500K1000#
!! 90#
rounded#and#starting#to#
detach#
#
#
#
#
#
Baculovirus#titration#is#very#high#
ul)#and#add#more#mammalian#cell#medium#(1K1.5#ml)#
2#use#concentrated#virus#(250#ul#virus+1750#ul#
medium)#3#decrease#incubation#time#from#8h#to#4h#or#
even#2h#at#37oc#
#
Use#a#lower#virus#concentration#for#mammalian#cell#
transduction#
38# Infection#rate#is#not#high# Virus#titer#is#not#high#
#
#
Titer#virus#and#use#a#higher#MOI#for#infection#
38# One#or#some#of#interested#
genes#do(se)not#express#
Over#amplification#of#virus#let#to#deletion#of#genes## Throw#away#virus#and#repeat#virus#production#again.#
Use#a#maximum#incubation#time#of#5h#for#V0,#72h#for#
V1#and#48#h#for#V2##
#
#
#
Table(2.a:(Concentration(of(antibiotics(and(essential(components(require(for(MultiPrime(vectors(
Vector#name# Acceptor#or#donor# Antibiotic#resistance#gene# Stock#of#antibiotic#
concentration#(mg/ml)#
Dilution#in#use#
pSIK#AGZ10,#pSIK#AGR10,#
pSIK#AGL10,#pSIK#AGL10K
DM,#pSIK#AGL10KDI#
Acceptor# Gentamycin## 10# 1:1000#
pSIK#DSZ2cxKDI,#pSIK#
DSZ2cxKDM,#pSIK#DSZ2cxK
PGK,#pSIK#DSZ2cxKSV40,#
pSIK#DSZ2cxKUBC,#
Donor# Spectinomycin# 50# 1:1000#
pSIK#DAZ2cxKDI,#pSIK#
DAZ2cxKDM#
Donor# Ampicillin# 100# 1:1000#
pSIK#DCPKDI,#pSIK#DCPK
DM#
Donor# Chloramphenicol# 34# 1:1000#
pSIK#DKLKDI,#pSIK#DKLKDM# Donor# Kanamycin# 50# 1:1000#
#
*#Add#a#combination#of#antibiotics#when#they#are#assembled.#For#example#when#pSIKAGR10#and#pSIKDAZ2cx#are#assembled,#you#should#add#
Gentamycin#plus#Ampicillin#to#LB#agar.#
**#Reduce#antibiotics#concentration#to#50%#when#more#than#3#MultiPrime#plasmids#are#assembled#
(
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Table(2.b:(Concentration(of(antibiotics(and(essential(components(require(for(MultiPrime(
baculovirus(generation(in(LB(agar(
Component# Concentration# Dilution#in#use# Note#
Antibiotics# Ampicillin#(100#mg/ml),#Kanamycin#(50#
mg/ml),#Gentamycin#(10#mg/ml),#
Chloramphenicol#(34#mg/ml),#tetracycline#
(15#mg/ml)#
1:1000# Reduce#antibiotics#concentration#
to#50%#when#more#than#3#
MultiPrime#plasmids#are#
assembled#
XKgal# 20#mg/ml# Add#100#ul#to#each#plate#(100ul#per#20#ml#LB#agar)# Add#in#last#step#and#should#be#
light#protected#
IPTG# 1000#mM# 0.5#mM# Add#in#last#step#and#should#be#
light#protected#
(
#
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uantitative   image   analysis  is   the   extraction   of   meaningful   information   from  
biological   images   or   movies   obtained   from   fixed   or   live-­cell   imaging.   In   this  
chapter,   I   introduced   two   original   papers   related   the   development   of   image  
analysis   software   including   Squassh,   Squassh3C   and   SquasshAnalyst.   These   tools   allow  
quantification  of  spatial  colocalization  between  fluorescently  tagged  species  with  known  labeled  
subcellular  markers  in  two  fluorescent  channels  (Squassh,  Rizk  et  al.,  2014)  or  three  fluorescent  
channels   (Squassh3C,   Rizk   et   al.,   2015).   Both   are   based   on   a   segmentation   technique  
combining   segmentation   and  deconvolution   in   a   single   step,  which  was   shown   to   yield   better  
results   than   computing  methods.   SquasshAnalyst   is   a   data   analysis   software   distributed  with  
user  friendly  interface  providing  data  browsing,  statistical  analysis  and  figure  generation.    
My  role  in  these  papers  included  construction  of  biosensors  (e.g.  fluorescently  labeled  Rab  
GTPases),   generation   of   related  MultiPrime   virus,   transfection   and/or   transduction   of   different  
mammalian   cells,   acquisition   of   fixed   and   live   cells   images   and  movies   and   interpretation   of  
results.      
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INTRODUCTION
An increasing amount of biological and medical research relies on 
single-cell imaging to obtain information about the phenotypic 
response of cells to a variety of chemical, mechanical and genetic 
perturbations. Although it is possible to distinguish obvious 
phenotypes by eye, computational analyses enable the following: 
the processing of large data sets; the generation of quantitative 
and less biased results; and the detection of subtler changes in 
phenotype by statistical analysis. In addition, the ability to observe 
and quantify multiple fluorescent markers in the same cell under 
various conditions and over time opens doors for spatiotemporal 
modeling of biological processes1.
Quantification of the shapes and spatial distributions of sub-
cellular objects is an important task, as the fluorescent probes 
are usually related to cellular markers. Colocalization of objects 
between different color channels can be quantified by various 
methods that are either pixel-based or object-based2. Pixel-based 
methods compute an overlap measure between the pixel intensi-
ties of the different color channels and include the following: 
Pearson’s correlation coefficient3; the overlap and Manders’ 
overlap coefficients4; intensity correlation5; cross-correlation6; 
and techniques correcting for unspecific (random) colocaliza-
tion7. Object-based methods first detect and delineate the objects 
represented in the image and then quantify their overlap3,8 or 
nearest-neighbor distances9. This approach also allows correc-
tion for the cellular context and for unspecific colocalization8. 
Methods based on intensity correlation are not suitable when 
fluorophores are not in ratiometric numbers10, whereas methods 
looking for co-occurrence are very sensitive to noise and back-
ground levels. A more robust method that indicates the fraction 
of colocalized molecules on the basis of cross-correlation and 
autocorrelation has been proposed, but it cannot be automatically 
applied to a set of images11.
Object-based analysis provides access to additional features of 
biological relevance, such as the spatial distribution of objects 
within the cell and the shapes and sizes of objects. This allows 
interactions between objects to be inferred and statistical hypo-
theses about their distribution (e.g., random versus nonrandom) 
to be tested9. However, object-based methods require that the 
objects in the image be first detected and delineated, which is a 
nontrivial task that involves image segmentation. Object detec-
tion and image segmentation are still frequently done by hand or 
by using ad hoc heuristics such as thresholding or hand-crafted 
pipelines of filters. However, recent progress in computer vision 
has provided well-founded theories that can give justification to 
the methodology12.
An overview of Squassh and its advantages 
Here we present a protocol for Squassh and the colocalization of 
subcellular shapes. Squassh makes use of a segmentation method 
that directly connects the image-segmentation task with biologi-
cal reality through prior knowledge about the imaged objects, 
the image-formation process and the noise present in the image. 
This allows the same method to be applied to a wide spectrum of 
images by adjusting the prior knowledge (i.e., changing parameter 
values). In addition, the segmentation method used here provides 
theoretical performance and robustness guarantees, is independent 
of manual initialization and directly corrects for microscope 
blur and detector noise, yielding optimally deconvolved 
segmentations13. This last feature is achieved by accounting for the 
microscope’s point-spread function (PSF), improving the capacity 
to segment objects with sizes close to the resolution limit. The 
algorithm makes no assumptions about the expected shapes of 
the segmented objects, hence minimally biasing the results. The 
algorithm is not limited to spot-like or spherical objects, and it can 
Segmentation and quantification of subcellular 
structures in fluorescence microscopy images  
using Squassh
Aurélien Rizk1,2, Grégory Paul2,5, Pietro Incardona2, Milica Bugarski1, Maysam Mansouri1, Axel Niemann3,  
Urs Ziegler4, Philipp Berger1 & Ivo F Sbalzarini2
1Paul Scherrer Institute, Biomolecular Research, Molecular Cell Biology, Villigen PSI, Switzerland. 2MOSAIC Group, Center of Systems Biology Dresden, Max Planck 
Institute of Molecular Cell Biology and Genetics, Dresden, Germany. 3ETH Zurich, Institute of Molecular Health Sciences, Zürich, Switzerland. 4Center for Microscopy 
and Image Analysis, University of Zurich, Zürich, Switzerland. 5Present address: ETH Zurich, Computer Vision Laboratory, Zürich, Switzerland. Correspondence should 
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Detection and quantification of fluorescently labeled molecules in subcellular compartments is a key step in the analysis of  
many cell biological processes. Pixel-wise colocalization analyses, however, are not always suitable, because they do not provide 
object-specific information, and they are vulnerable to noise and background fluorescence. Here we present a versatile protocol  
for a method named ‘Squassh’ (segmentation and quantification of subcellular shapes), which is used for detecting, delineating 
and quantifying subcellular structures in fluorescence microscopy images. The workflow is implemented in freely available,  
user-friendly software. It works on both 2D and 3D images, accounts for the microscope optics and for uneven image background, 
computes cell masks and provides subpixel accuracy. The Squassh software enables both colocalization and shape analyses.  
The protocol can be applied in batch, on desktop computers or computer clusters, and it usually requires <1 min and <5 min for 2D 
and 3D images, respectively. Basic computer-user skills and some experience with fluorescence microscopy are recommended to 
successfully use the protocol.
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be applied to the segmentation of more complex shapes, as shown 
in ref. 13 for an endoplasmic reticulum and epithelial tissue.
Squassh uses the segmentation algorithm from ref. 13 by imple-
menting it in a user-friendly multithreaded software plug-in for 
the free open-source bioimage processing frameworks ImageJ14,15 
and Fiji16, as part of the MosaicSuite. We extend the original algo-
rithm by accounting for the fact that different objects may have 
different fluorescence intensities17, and by allowing subpixel accu-
rate segmentations in both 2D and 3D. Subpixel segmentation has 
previously only been available in two dimensions18,19, and it has 
been shown to be useful, e.g., for studying the live morphology 
of endosomes20. We further extend the method with cell masks 
that allow the analysis to be restricted to a subpopulation of cells 
in an image, e.g., to transfected cells. The workflow is completed 
with a script, automatically generated by the plug-in as part of 
its output, for the free open-source statistical software program 
R (ref. 21), thereby providing statistical significance tests for the 
quantitative data generated.
Limitations of Squassh
The quality and reliability of Squassh analysis mainly depends 
on the success of image segmentation. We recommend visually 
checking the image-segmentation outcome in at least one case 
per condition in order to confirm its quality. The algorithm used 
in Squassh accounts for the linear characteristics of the micro-
scope, but imposes no further prior knowledge. Although this 
helps limit bias in the analysis, it also solely relies on the image 
data, and segmentation artifacts may occur. The most frequent 
problem is that objects in the same color channel that are sepa-
rated by less than the half-width of the PSF will be fused and 
detected as a single object. In addition, very dim objects may be 
missed altogether. Although this could potentially be avoided by 
imposing a shape prior (e.g., that all objects should be round-
ish), we choose not to do so, as such priors always bias the result 
toward objects of the sought-for shape. We prefer segmenting all 
shapes with equal probability, and defer any shape-based filter-
ing to the postprocessing step. There, objects below, e.g., certain 
sphericities can be filtered out by using the provided statistical 
analysis script.
The Squassh software also does not correct for chromatic 
aberration and other nonlinear optical effects. Positional shift 
between color channels must be corrected for either before (by 
image warping) or after (by object coordinate transformation) 
Squassh analysis.
Colocalization analysis is limited to detecting overlap between 
objects from two-color channels, and it cannot be used to infer 
patterns within a single channel or long-range order in the object 
distribution across channels. A separate method is available for 
that9 and implemented in software22.
The Squassh protocol is limited to fluorescence microscopy. 
Other imaging modalities are not currently supported.
Image segmentation
Image segmentation is a well-researched topic in computer vision, 
and many technological advances have successfully been applied 
to bioimage analysis12. Many user-friendly software tools are 
available for analyzing and quantifying fluorescence microscopy 
images23. They are either based on applying various filters to the 
pixels of the image (e.g., CellProfiler24), on using machine-learning 
techniques to classify pixels as belonging to an object or to 
the background (e.g., Ilastik25), or on including models of the 
imaged objects and the image-formation process (e.g., Region 
Competition19). Filter-based approaches require the user to 
construct an appropriate pipeline of filters and to select all fil-
ter parameters. Machine-learning approaches require the user to 
manually label or segment a part of the data for the algorithm to 
learn the task. Model-based approaches require the user to design 
or choose a model that appropriately describes the type of image 
to be segmented.
Model-based methods aim to find the segmentation that best 
explains the image. In other words, they compute the segmenta-
tion that has the highest probability of resulting in the actually 
observed image when imaged with the specific microscope used. 
We chose this framework because it is generic to a wide range of 
image types and segmentation tasks, and because it provides direct 
access to statistical quantitates that can be used in downstream 
analyses. We based our work on a recent extension of a family 
of image-segmentation models that include a variety of denois-
ing and deconvolution tasks13. The image-segmentation method 
used in Squassh is independent of initialization and robustly 
finds the optimal solution, because the underlying optimization 
problem is convex and hence has only globally optimal solutions; 
see ref. 13 for theoretical and algorithmic details.
We consider an image model where the intensity distribution 
within each object is homogeneous and where the image locally 
around each object consists of two regions: a brighter foreground 
and a darker background. The noise in the image can be either 
Gaussian or Poisson. Three quantities are estimated for each object 
in a given image: the segmentation, which is the estimated outline 
of the object; the fluorescence intensity in the local background 
around the object; and the fluorescence intensity in the interior 
of the object. The method used here provides optimal segmenta-
tions using prior knowledge about the microscope optics (see 
Supplementary Note for details). This strategy hence combines 
image denoising, deconvolution and segmentation13; it is not nec-
essary to separately denoise or deconvolve the images beforehand. 
The results provided by such a joint deconvolution-segmentation 
procedure are of higher quality and are more robust than those 
obtained by standard deconvolution, followed by segmentation13. 
This is because the two tasks naturally regularize each other when 
considered jointly. This helps cope with very noisy data and with 
small objects close to the diffraction limit.
We account for spatial variations in the background intensity 
and for different objects having different foreground intensities 
by iteratively applying the procedure to local windows in the 
image around each object. Hence, each object may have a differ-
ent estimated intensity, and the background around each object 
may locally be different (Fig. 1).
Overview of the procedure
Segmentation procedure. We illustrate the segmentation pro-
cedure implemented in Squassh by using an example image of 
Cherry-tagged RAB5 endosomes (Fig. 1a,b). First, object detec-
tion and separation is performed (segmentation stages (S)1–4), 
followed by estimation of the local background and object inten-
sities and computation of the optimal segmentation (S5–7). The 
individual stages are described in detail below and referred to in 
the PROCEDURE.
©
20
14
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
PROTOCOL
588 | VOL.9 NO.3 | 2014 | NATURE PROTOCOLS
(S1) Background subtraction (Fig. 1c) is performed first, as the 
segmentation model assumes locally homogeneous intensi-
ties. Background variations are nonspecific signals that are not 
accounted for by this model. We correct uneven background 
intensity by using the rolling-ball algorithm26. This algorithm 
computes intensity histograms in a window moving across the 
image (i.e., a ‘rolling ball’). The edge length of the window is set 
by the user (Step 4 of the PROCEDURE). In each window, the 
most frequently occurring intensity value is taken as the local 
background estimate. This is based on the assumption that the 
objects of interest are smaller than the window size and cover less 
than half of the total window area.
(S2) Object detection is performed over the entire image 
(Fig. 1d). This stage is not the final segmentation, but only serves 
to find regions in the image that contain objects of interest. This 
initial rough detection is done with the model-based algorithm 
from ref. 13 (see Supplementary Note for an intuitive descrip-
tion), but with fixed values for the mean background and object 
intensities (Steps 6 and 7 of the PROCEDURE). We find these 
fixed values by performing k-means clustering of all the pixels 
in the image.
(S3) Thresholding of the initial detection reveals the initial 
objects (Fig. 1e). The threshold value is set to the user-defined 
minimum intensity of objects to be included in the analysis (Step 
7 of the PROCEDURE). All objects with peak intensities lower 
than this threshold are discarded, and the others are retained. 
This parameter allows the user to control the sensitivity of the 
analysis, and it can be set to zero without compromising segmen-
tation accuracy. Connected regions are identified as individual 
objects19. Connected regions share a common object and com-
mon background intensity. They can, however, be separated into 
individual objects during the segmentation performed in stages 
S6 and S7 below.
(S4) Decomposition of the image into smaller parts is done in 
order to allow locally different background and foreground 
intensities for different objects (Fig. 1e). We decompose the 
image by (possibly overlapping) 2D or 3D boxes around 
each detected object from the previous stage (blue boxes in 
Fig. 1e). We ensure that objects in different boxes do not 
influence each other by computing the Voronoi diagram (on 
the basis of the actual shapes of the objects and not just their 
centroids) of the binary mask obtained in stage S3 (red lines 
in Fig. 1e). The image region considered for each object is 
then the intersection of the box around it with the Voronoi 
cell containing it (Fig. 1e).
•
•
•
•
(S5) Local background and object intensities are estimated in each 
image region (Fig. 1e). This determines what will be considered 
background and foreground in the subsequent segmentation 
stage, and it provides local analysis of the image (Step 9 of the 
PROCEDURE). Intensities are estimated by solving the optimi-
zation problem described in the Supplementary Note.
(S6) Individual object segmentation is obtained by running the 
algorithm from Paul et al.13 separately for each image region 
(Fig. 1f; Steps 5–7 of the PROCEDURE). This can be done with 
a spatial resolution that is higher than the pixel resolution of 
the image, thus providing subpixel accuracy20 (Step 8 of the 
PROCEDURE). As this oversampling is only done in local patches 
around the objects, rather than on the whole image, it has only 
moderate impact on the computational cost of the whole pro-
cedure (Table 1). As the segmentation algorithm accounts for 
the PSF of the microscope (Step 5 of the PROCEDURE), the 
influence of each pixel on its neighboring pixels is accounted for 
when segmenting apart individual objects. If the image is more 
likely to be the result of imaging two separate objects, they are 
split into two. If the image is better explained by assuming a 
single, connected object, the object is kept together. This always 
provides the segmentation that has the highest probability of 
explaining the observed image, given the knowledge of the PSF 
and the imaging noise model. Any further prior information, for 
example, about the expected shapes of objects, can be included 
in the postprocessing analysis.
(S7) The final segmentation (Fig. 1g) is obtained by optimiz-
ing stage S6 to minimize the segmentation error, automatically 
done according to a rigorous optimality theory as previously 
described13.
•
•
•
db
fe
ca
g
Figure 1 | Workflow of the Squassh protocol illustrated on endosome 
segmentation. (a) Original image of a Cherry-RAB5–transfected HEK293 cell; 
scale bar, 10 Mm. (b) Close-up of the region highlighted by the white square 
in a; scale bar, 1 Mm. (c) The same close-up after background subtraction. 
(d) Object model image found by Squassh. Intuitively, this is a denoised and 
deconvolved version of c taking into account the microscope’s PSF. (e) Objects 
(white) obtained by thresholding image d. The image is decomposed into 
regions (blue boxes), and objects are separated by Voronoi decomposition 
(red lines). (f) Refined subpixel object model images obtained by applying the 
Squassh segmentation method inside each region with individual estimates for 
the local object and background intensities. (g) Final segmentation with the 
estimated object intensities displayed in shades of green.
TABLE 1 | Computer time and memory requirements on a dual-core 
2.3-GHz Intel Core i5 with 8 GB of RAM.
x × y × z image size (pixels) and 
subpixel oversampling
Computer  
time (s)
Memory  
(MB)
512 × 512  17.2 275
512 × 512, 8× pixel oversampling 23.7 407
1024 × 1024 55.6 478
512 × 512 × 15 180.7 1,116
512 × 512 × 15, 4× pixel oversampling 201.3 1,536
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Colocalization analysis. Object-based colocalization is computed 
after segmenting the objects by using information about the 
shapes and intensities of all objects in both channels. This allows 
straightforward calculation of the degree of overlap between 
objects from the different channels. We consider three different 
colocalization measures (see Supplementary Note for details). 
The first one, Cnumber, counts the number of objects that overlap 
between the two channels. Objects are considered overlapping if 
at least 50% of their volumes coincide. The second measure, Csize, 
quantifies the fraction of the total volume occupied by objects 
that overlap with objects from the other channel. The third meas-
ure, Csignal, quantifies colocalization in an intensity-dependent 
manner. It computes the sum of all pixel intensities in one channel 
in all regions where objects overlap with objects from the other 
channel. This signal-based definition has been described and used 
before8, but here we use the estimated object intensities from 
the segmentation rather than the raw pixel values. This improves 
robustness against noise and optical blur from the microscope 
PSF, because the current segmentation method computes an opti-
mally denoised and deconvolved estimate.
Cell masks. Often, analysis should be restricted to a single cell or a 
subset of the cells present in an image. Examples include working 
with transfected cells or with mixed cell populations. The Squassh 
software provides the option to compute cell masks by threshold-
ing the original image and filling the holes of the resulting binary 
mask. Analysis is then restricted to the intersection of the image 
with the cell mask in order to ensure that only positive cells are 
considered in both channels.
Statistical analysis. Subcellular structures are often studied across 
a range of biological perturbations. A script for the R free open-
source statistical software21 is automatically generated by the plug-
in, and it can be used to perform one-way ANOVA27, followed by a 
Tukey-Kramer test28 for the statistical significance of differences 
observed between different sets of data (Supplementary Note).
MATERIALS
EQUIPMENT
Confocal or wide-field fluorescence microscope. When you are using the 
protocol for colocalization analysis, the microscope must be capable of  
two-channel acquisition
Image data files in any format supported by ImageJ (see http://rsbweb.nih.
gov/ij/features.html for supported formats)
A computer running Linux, MacOS X or Microsoft Windows with at least  
2 GB of RAM (4 GB of RAM for 3D images)
The free ImageJ (http://rsbweb.nih.gov/ij/) or Fiji (http://www.fiji.sc)  
software installed on the computer
The free MosaicSuite plug-in, available from http://mosaic.mpi-cbg.
de/?q=downloads/imageJ. In addition to Squassh, MosaicSuite also provides 
software for single-particle tracking29, image segmentation19, spatial pattern 
analysis9,22 and various utilities (for example, for estimating the microscope 
PSF from images)
(Optional for statistical analysis) The free statistical analysis software R 
(http://www.r-project.org/) to use the plug-in-generated script
(Optional for reading Leica .lif files) Leica .lif file extractor ImageJ/Fiji 
macro (provided in the Supplementary Data) to automatically extract 
individual images from .lif files. It uses BioFormats30 and the channel  
rearrangement tools of ImageJ
•
•
•
•
•
•
•
EQUIPMENT SETUP
Installing Squassh in ImageJ Download the MosaicSuite plug-in JAR file 
(http://mosaic.mpi-cbg.de/?q=downloads/imageJ) and Install the plug-in 
by moving the file into the plug-in subfolder of ImageJ, or by dragging and 
dropping the file into the ImageJ main window (Supplementary Video 1).
Installing Squassh in Fiji Register the update site http://mosaic.mpi-cbg.
de/Downloads/update/Fiji/MosaicToolsuite/ with your Fiji. In order to do so, 
open the Fiji Updater, then click on ‘Advanced’, and then on ‘Manage update 
sites’. Click ‘Add’ and paste the URL to add the new update site. After adding 
the update site, run a Fiji update or select ‘Mosaic ToolSuite.jar’ from the list 
of files of the newly added update site, then restart Fiji. The Mosaic submenu 
should now appear under the ‘Plug-ins’ menu. The advantage of using the 
update site is that the Fiji installation will automatically upgrade MosaicSuite 
every time a new version of it becomes available in the future. If automatic 
updates are not required, use the manual installation procedure described for 
ImageJ (Supplementary Video 1).
Installing the .lif file extractor macro Follow the ImageJ/Fiji menu path 
‘Plug-ins’ l ‘Macros’ l ‘Install’ to install the macro. Alternatively, paste  
the macro content into ‘Plug-ins’ l ‘Macros’ l ‘Startup Macros’ for a  
permanent installation.
PROCEDURE
Image data preparation
1| Export images from the microscope software. The plug-in works with any image format supported by ImageJ, but all 
stacks and channels of a single image have to be in the same .tif file. For Leica .lif files, use the .lif Extractor ImageJ macro 
to automatically extract dual-channel TIFF images. To do so, select ‘Plug-ins’ l ‘Macros’ l ‘Lif Extractor’ from the ImageJ/
Fiji menu-bar and choose a folder containing one or more .lif files. A new folder containing the extracted TIFF images is then 
created for each .lif file.
M CRITICAL STEP Channel order needs to remain the same across all files. The Squassh software refers to ‘Channel 1’ and 
‘Channel 2’ to indicate the location of segmented objects and for colocalization measures. It is possible to attribute other, 
clear-text names to the channels in the ‘Visualization and output’ settings (Step 15).
M CRITICAL STEP For colocalization analysis, care has to be taken to select spectrally separated fluorophores in order to avoid 
cross talk between the color channels, which would lead to spurious colocalization. Before computing colocalization between 
different color channels, it is important to correct for chromatic aberration as well as possible, as this biases the results9.
? TROUBLESHOOTING
©
20
14
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
PROTOCOL
590 | VOL.9 NO.3 | 2014 | NATURE PROTOCOLS
Plug-in launch and input selection
2| Start the segmentation by choosing the ImageJ menu 
item ‘Plug-ins’ l ‘Mosaic’ l ‘Segmentation’ l ‘Squassh’. 
This opens the main graphical user interface Squassh window 
shown in Figure 2. Protocol Steps 4–16 indicate how to 
navigate the four option windows that can be opened from 
this main window.
? TROUBLESHOOTING
3| Select the image file to be processed with the ‘Select 
File/Folder’ button (Fig. 2a). When selecting files containing 
two channels, both channels will be segmented and  
object-based colocalization analysis will be performed.  
For single-channel files, only segmentation is performed.  
For batch analysis, select a folder containing multiple  
images. It is recommended to first analyze a few individual 
images to determine suitable parameters that can then be 
applied across the whole set of images. Time-lapse images 
are not natively supported; they should be split into the  
different time points and analyzed separately. It is possible 
to batch-process a set of images by placing them in the 
same folder and selecting this folder as Squassh’s input.  
The software is also compatible with ImageJ macros,  
enabling batch automation of larger analyses.
Background subtraction
4| Reduce the background fluorescence by using the rolling 
ball algorithm. Click on ‘Background subtraction’ options,  
select ‘Remove background’ and enter the window edge 
length in units of pixels (Fig. 2b). This length should be 
large enough so that a square with that edge length cannot 
fit inside the objects to be detected, but smaller than the length scale of background variations. This step corresponds to 
segmentation stage S1 (Fig. 1b,c).
? TROUBLESHOOTING
Segmentation parameters 
5| Set the microscope PSF (Fig. 2c). To correct for diffraction blur, the software needs information about the PSF of the 
microscope. Either a theoretical PSF (option A) or a measured PSF (option B).
(A) Using a theoretical PSF
 (i)  Use a theoretical PSF model31 by specifying the imaging condition parameters in the ‘Segmentation parameters’  
options ‘Estimate PSF from objective properties’ subwindow (Fig. 2d). The software provides models for confocal and 
wide-field microscopes. Airy units only have to be entered for confocal microscopes.
 (ii) Click on ‘compute PSF’.
(B) Measuring the PSF
 (i)  Measure the microscope PSF from images of fluorescent subdiffraction beads. In this case, input the s.d. of the PSF 
separately for the lateral (x, y) and axial (z) directions (Fig. 2c). Use the menu item ‘Plug-ins’ l ‘Mosaic’ l ‘PSF Tool’ 
to measure these parameters from images of beads.
a
c d
e
g
f
b
Figure 2 | Screenshots of the graphical user interface of the Squassh 
software. (a) Main window with file selection, help and links to background 
subtraction, segmentation, cell masks and visualization options.  
(b) Background-subtraction options. (c) Segmentation parameter options. 
(d) Window for specifying the microscope’s point-spread function by  
using a Gaussian model. (e) Cell mask window. (f) Cell mask preview.  
(g) Visualization and output options.
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6| Set a regularization parameter for the segmentation (Fig. 2c). Use higher values to avoid segmenting noise-induced 
small intensity peaks (Supplementary Note and Fig. 3). Typical values are between 0.05 and 0.25. This parameter controls 
segmentation stages S2 and S6 (Fig. 1d,f).
M CRITICAL STEP Regularization is a key segmentation parameter. The effect of varying the regularization parameter is  
illustrated in Figure 3. Once determined, the same parameter must be used across all studied images in order to allow  
comparison of the results.
? TROUBLESHOOTING
7| Set the threshold for the minimum object intensity to be considered (Fig. 2c). Intensity values are normalized between 
0 for the smallest value occurring in the image and 1 for the largest value. This parameter controls segmentation stages S2 
and S6 (Fig. 1d,f). Use low values for increased sensitivity and high values to force object separation.
M CRITICAL STEP Minimum intensity is a key segmentation parameter. The effect of varying the minimum intensity  
parameter is illustrated in Figure 3. Once determined, the same parameter must be used across all studied images to allow 
comparison of the results.
? TROUBLESHOOTING
8| (Optional) Select ‘subpixel segmentation’ to compute segmentations with subpixel resolution in stage S6 (Fig. 2c).  
The resolution of the segmentation is increased by an oversampling factor of 8 for 2D images and a factor of 4 for 3D  
images. Note that subpixel segmentation requires more computer time and memory. See Table 1 for typical requirements.
9| (Optional) When images contain objects with inhomogeneous internal intensity distribution, the automatic local  
intensity estimation performed in segmentation stage S5 may not always be suitable. The ‘Local intensity estimation’  
parameter thus provides the ability to estimate local object intensities by clustering (Fig. 2c). Select ‘Low’, ‘Medium’ or 
‘High’ to set the local object intensity to the low-, medium- or high-intensity clusters obtained by k-means clustering of the 
pixels within the object. All results and benchmarks given in ANTICIPATED RESULTS section are obtained with the ‘Automatic’ 
setting, which is the recommended default setting.
10| Set the noise model corresponding to the microscope and detector used (Fig. 2c). We recommend using the Poisson 
model for confocal microscopes and the Gaussian model for wide-field microscopes. However, your equipment may differ. 
Detailed information should be found in the manufacturer’s data sheet.
Cell masks
11| A cell mask allows the analysis to be restricted to a certain region of an image, e.g., to a transfected cell. Select ‘cell 
mask channel 1’ and/or ‘cell mask channel 2’ to compute cell masks on the basis of the respective channel. Cell masks are 
computed by thresholding the respective channel and filling holes in the obtained binary mask. Open the ‘Cell masks’ option 
(Fig. 2e) and set a value between 0 and 1 for the threshold in ‘threshold channel 1’ and/or ‘threshold channel 2’. Adjust the 
threshold slider for a live preview (Fig. 2f) of the resulting mask. Adjust the z-slider to simultaneously adjust the z-position 
in the mask preview and the original image.
M CRITICAL STEP Once they have been determined, the same cell mask parameters must be used across all studied images in 
order to allow comparison of the results. When set of images is analyzed, cell masks are saved in files ending in ‘mask c1.zip’ 
and ‘mask c2.zip’ for the respective channel. Open them with ImageJ in order to check that the cell masks are correct for all 
images.
? TROUBLESHOOTING
Visualization and output 
12| Select one or several of the output visualization options ‘Colored objects’, ‘Labeled objects’, ‘Object intensities’ and  
‘Object outlines’ (Fig. 2g). With ‘Colored objects’, each object is visualized in a different, random color. ‘Labeled objects’  
a cb
1 µm
Figure 3 | Illustration of how the parameters affect segmentation results by 
using endosomes in a close-up view of a Cherry-RAB5-transfected HEK293 
cell as an example. (a) Segmentation with the minimum intensity threshold 
set to 0.100 and the regularization weight set to 0.250. (b) Segmentation 
with the minimum intensity threshold decreased to 0.050, resulting in a 
larger number of dimmer objects being detected. (c) Segmentation with 
a minimum intensity threshold of 0.050 and the regularization weight 
decreased to 0.075, resulting in a closer fit of the segmentation with the 
image data, but an increased sensitivity to noise (e.g., the small islands 
segmented, which may correspond to noise pixels).
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assigns to all pixels of an object a value that is identical to the label (index) of that object in the result file. ‘Object  
intensities’ displays objects in their estimated fluorescence intensities. ‘Object outlines’ shows an overlay of the original  
image with the segmented outlines in red (Supplementary Note). For two-channel images, an additional visualization is  
displayed, which attributes a distinct color to each channel in order to reveal colocalization.
13| (Optional) Select ‘Intermediate steps’ to visualize also the background subtraction result (step S1; Fig. 1c) and the 
initial segmentation approximation (step S2; Fig. 1d).
14| (Optional) Select ‘Save object and image characteristics’ to store the resulting object quantifications in .csv files, which 
can be opened with any spreadsheet software or with MATLAB. This option is always selected by default when applying the 
analysis in batch mode to a set of multiple images (Fig. 2g).
15| (Optional) In order to generate an R script for statistical analysis of the results, set the number of experimental  
conditions considered under ‘R script data analysis settings’. Click ‘Set condition names and number of images per condition’ 
to set the number of images per condition, the condition names (you can freely choose them) and the object names  
(can also be freely chosen). Names are used to generate graphical output and plots in human-readable form. The number of 
conditions and the number of images per condition are used to divide the set of images into the biological conditions  
studied. The set of images is divided according to the lexicographical ordering of the image file names.
Run the analysis
16| Click ‘OK’ in the main window (Fig. 2a) to start the analysis. Depending on the speed of the computer, the analysis may 
take up to several minutes, and on older computers it may take even longer. See Table 1 for typical runtimes on a typical 
modern computer.
? TROUBLESHOOTING
Quantitative results
17| Open the ImageJ log window for a preview of the analysis results. The log displays the number of objects found and the 
signal colocalization Csignal (Supplementary Note).
M CRITICAL STEP Csignal should only be used if the same microscope gain and offset settings were used to acquire all images.
18| Use any software that can read .csv files in order to open the file ending in ‘_ImagesData.csv’. This file contains the 
mean object features from each image. It stores the number of objects found in the image, the mean object size (in terms of 
area in 2D or volume in 3D), the mean object surface in 3D or perimeter in 2D, the mean length of objects (i.e., the maximum  
extension in the most extended direction) and the mean fluorescence intensity of the objects. For two-channel images,  
the file also stores the colocalization coefficients Csignal, Cnumber and Csize, as well as the Pearson correlation across the whole 
image and inside the cell mask. All .csv data files are contained in the folder in which the original images are located.
19| Open files ending in ‘_ObjectsData.csv’ in order to obtain individual, per-object features. Each object is indexed by its 
segmentation label. For two-channel images, the file also stores the amount of overlap for each object with objects from the 
other channel, and the sizes and intensities of all colocalizing objects from the other channel. These features are used by 
the R script to statistically evaluate colocalization.
Graphical output and statistical analysis (optional)
20| (Optional) Edit lines 23 to 27 of the automatically generated statistical analysis script ‘R_analysis.R’ to set thresholds 
for minimum and maximum object sizes, minimum object intensity and minimum number of objects in an image. Objects and 
images violating the thresholds will be excluded from the analysis.
? TROUBLESHOOTING
21| (Optional) Edit line 32 of ‘R_analysis.R’ to change the order in which the conditions are displayed in the resulting plots 
and graphs.
22| Start the R statistical software. Change to the working folder where ‘R_analysis.R’ is located and type ‘source(‘R_analysis.
R’)’ in the R console. This generates bar plots and performs statistical analysis of the data with one-way ANOVA27 followed  
by a Tukey-Kramer test28 for statistical significance of differences between different conditions. ‘Colocalization.pdf’  
(Supplementary Note) displays the colocalization measures defined in the Supplementary Note and the Pearson correlation 
coefficients in the whole image or inside cell masks. It also provides the P value from a one-way ANOVA. ‘ColocalizationCI.pdf’  
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(Supplementary Note) gives 95% confidence intervals for the difference of colocalization between pairs of conditions,  
together with their P values. The confidence interval and the P values are computed by a Tukey-Kramer test. The Tukey- 
Kramer test is suited for multiple comparisons (e.g., if there are more than two conditions), and it provides P values to 
estimate the statistical significance of differences between pairs of conditions. ANOVA P values test the hypothesis that all 
conditions have identical means. The two last pdf files generated contain the mean object properties across all conditions. 
See the Supplementary Note for examples of the output generated by this script.
M CRITICAL STEP If the number of objects detected for any condition is small (fewer than about ten), or the statistical  
distribution of features significantly differs from Gaussian, the results of the statistical test are unreliable and should not  
be trusted.
? TROUBLESHOOTING
Troubleshooting advice can be found in Table 2.
L TIMING
The only protocol steps requiring computational time in Squassh are image segmentation (Step 16) and statistical analysis 
(Step 22). All other steps only require setting parameter values and incur no computational cost. As a guideline, we provide 
here typical computation times measured on a dual-core 2.3 GHz Intel Core i5 with 8 GB of RAM. Statistical analysis (Step 22) 
required <1 min for a data set of 100 3D images of sizes between 512 × 512 × 10 and 512 × 512 × 25. Table 1 provides 
TABLE 2 | Troubleshooting table.
Step Problem Possible reason Solution
1 The ‘Lif Extractor’ menu item is not 
present
The .lif file extractor macro has 
not been installed
Install the macro as described in the  
Equipment section
2 The Squassh menu item is not 
present
The MosaicSuite has not been 
installed
Install the MosaicSuite as described in the  
Equipment section
4 Background removal removes objects 
of interest (check by selecting the 
visualization option ‘intermediate 
steps’)
Inappropriate parameter settings Reduce the edge-length parameter
6,7,16 Segmentation tends to fuse  
neighboring objects
Image is saturated
Inappropriate parameter settings
Avoid saturation by adjusting microscope gain and 
offset. There should be no more than a few, isolated 
saturated pixels
Decrease the regularization parameter
Segmentation is too sensitive. 
Background perturbations are  
interpreted as objects
Inappropriate parameter settings Increase the regularization parameter to remove small 
low-intensity objects. Increase the minimum intensity 
parameter to remove low-intensity objects
11 Masks from two positive cells  
fuse together and include parts  
of a negative cell
Cell spacing is too small Use images in which cells are farther apart or 
manually edit/curate the mask to exclude the space 
between two positive cells
16 The plug-in hangs during  
computation
There is not enough memory 
available or the image is too 
large
Computer is slow or data set is 
large
Analyze a down-sampled version of the image. Image 
size can be lowered from ImageJ by selecting  
‘Image’ l ‘Adjust’ l ‘Size’. If this solves the  
problem, it is a memory issue. Increase ImageJ 
maximum memory by selecting ‘Edit’ l ‘Options’ l 
‘Memory’. Memory requirements are given in Table 1
Wait longer. See Table 1 for typical runtimes on a 
modern computer. On older computers, the software 
can take markedly longer to complete the task
20 Some segmented objects are not 
biologically relevant and should be 
removed from the analysis
Fluorescence is not specific to 
the studied structures
Remove objects from the analysis by setting filters on 
object size or intensity in Step 20.
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 typical times for segmentation of 2D and 3D images with and without subpixel refinement. The computational cost only 
depends on image size for stages S1–S3 of the segmentation procedure. All other stages do not depend on image size, but 
rather on the sizes and numbers of objects detected in the images. The data in Table 1 was obtained for images containing 
~100 objects each. Image sizes are indicated in the table. For other numbers of objects, the times scale proportionally.  
The overhead incurred by subpixel oversampling mainly depends on the number and the sizes of the objects, and it ranged 
from 10 to 40% for the images used here. All pixel-intensity values are normalized between 0 and 1 and stored as 64-bit  
Java double variables. This renders the computational performance of the software independent of the bit depth of the  
original images.
ANTICIPATED RESULTS 
Figure 4 shows typical images and colocalization results for segmentation of a single dual-channel image. Squassh allows 
the user to visually confirm that the cell mask appropriately delineates the transfected cell, and that the objects are  
satisfactorily segmented (close-ups in Fig. 4e,f). The segmented objects (Fig. 4f) appear smaller and more compact than 
their images (Fig. 4e), because the segmentation algorithm corrects for the diffraction blur from the PSF of the microscope, 
which causes objects to appear more blurry and fused in the image. Dim objects (especially visible in the red channel) are 
cut off owing to the ‘minimum intensity’ parameter.
Figure 5 demonstrates a range of applications for Squassh. Figure 5a shows an analysis of subcellular localization of four  
RAB GTPases (RAB5, RAB4, RAB11 and RAB7) with known subcellular distribution and function, by using the following  
markers: early endosome antigen 1 (EEA1) as a marker for early endosomes; lysobisphosphatidic acid (LBPA) for late  
endosomes; lysosome-associated membrane protein 2 (LAMP-2) for lysosomes; and protein disulfide isomerase (PDI) for the 
endoplasmic reticulum. Two example images with close-ups of EEA1 (green) and RAB5 (red), and EEA1 (green) and RAB7 
(red) are shown in Figure 5b,c, respectively. Example images for all other conditions are shown in Supplementary Note. 
Squassh analysis confirmed previously described localization data of RAB GTPases32–35. In addition, it allowed the maturation 
of endosomes to be monitored quantitatively, either by loss of colocalization with EEA1 or gain of colocalization with LBPA.
Figure 5d demonstrates that Squassh can be used in infection assays; Squassh successfully found a linear correlation 
between virus titer and the percentage of virus-infected cells in Sf21 cells infected with different amounts of YFP-expressing 
baculovirus36.
Figure 5e demonstrates that Squassh can be used to study changes in cell morphology. In cells overexpressing GDAP1,  
a fission factor, which leads to fragmented mitochondria37, Squassh was able to detect reduced mitochondria lengths and  
increased numbers of mitochondria (Fig. 5e). The total volume of mitochondria remained constant within the statistical 
noise (Fig. 5e). This is in line with previous manual analyses37. Example images from both conditions are shown in  
Figure 5f, with the outlines as segmented by Squassh overlaid in green. We observe the same effect that the segmented  
outlines seem to be smaller than the apparent objects in the image, because they correct for the diffraction blur from the 
PSF, hence deconvolving and segmenting at once.
We quantitatively compared the segmentation method used in Squassh with eleven other methods on a test set of noisy 
synthetic images of cells with fluorescently labeled nuclei and vesicles. All images contained out-of-focus blur and uneven 
background illumination. The ground truth of all vesicle outlines was available and was used to compute the F-score quality 
measure. With an F-score of 0.62, the method used in Squassh performs as well as the previous winner on this benchmark38. 
This is remarkable, because the previous winner was a spot detector, tuned to detect round objects such as those present in 
these images, whereas Squassh makes no assumptions about the shapes of the objects (see ref. 13 for examples of  
complex-shaped structures, which would not be possible with a spot detector).
b
ed
a
f
c
RAB5 EEA1
Figure 4 | Segmentation and colocalization of EEA1 and RAB5. HEK293 
cells were transiently transfected with a Cherry-RAB5 expression 
construct. EEA1, a marker for early endosomes, was detected with a rabbit 
monoclonal antibody (Cell Signaling, cat. no. 3288). All images show 
maximum intensity projections along the optical axis. (a) Raw image of the 
Cherry-RAB5 channel. (b) Raw image in the EEA1 channel. (c) Mask of a 
transfected cell determined by using the RAB5 channel. (d) Segmentation 
results of the vesicles from both channels overlaid with the cell mask. 
EEA1-expressing vesicles are shown in green, and RAB5-expressing vesicles 
are shown in red. The colocalization coefficient computed for this image 
is Cnumber (EEA1RAB5+ / EEA1) = 0.36; it is Cnumber (EEA1RAB5+ / EEA1) = 0.02 
when not using a cell mask. (e) Close-up view of the raw image data in 
the area highlighted by the black square in d. (f) Object segmentation and 
overlaps in this area. Scale bars, 10 Mm (a–d) and 2 Mm (e,f).
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The Squassh object-based approach 
to colocalization analysis was compared 
with a pixel-based Pearson correlation 
analysis (Fig. 6a). The pixel-based method resulted in  
spurious colocalization of LAMP-2 with RAB4, RAB5 and 
RAB11. The object-based Squassh approach yields the best 
result. Two phenomena affect the pixel-based results: First, 
many objects in the LAMP-2 channel overlap with objects in 
the RAB7 channel, but not vice versa (compare the two Csize 
graphs in Fig. 6b). In such asymmetric situations, pixel-
based colocalization analysis is not appropriate, as it lumps 
both sides together. Second, pixel-based analysis is more 
sensitive to imaging noise than object-based analysis.  
This is shown in Figure 6b, where the Pearson correlation 
score tends to zero with increasing noise level3 (Fig. 6c).
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Figure 5 | Anticipated results of the Squassh 
protocol. HEK293 cells were transiently 
transfected with Cherry-tagged RAB5, RAB4, 
RAB11 and RAB7. Subcellular compartments were 
immunostained with the following antibodies: 
EEA1 for early endosomes, LBPA for late 
endosomes, LAMP-2 for lysosomes and PDI for 
the endoplasmic reticulum. (a) Colocalization 
results for subcellular markers with different RAB 
GTPases. Error bars show means and s.e.m. over  
20 images per condition of the fraction of 
subcellular marker colocalizing with the RAB 
channel, as determined by Squassh. ‘RABx’ 
represents a RAB in RAB5, RAB4, RAB11 or RAB7. 
(b) Example image with close-up of EEA1 (green) 
and RAB5 (red). (c) Example image with close-up 
of EEA1 (green) and RAB7 (red). Examples images 
for all conditions, as well as statistical analyses, 
are provided in the Supplementary Note.  
(d) Sf21 cells were infected with YFP-expressing 
baculovirus and stained with Hoechst 33258.  
A linear correlation between the amount of virus 
and the fraction of infected cells is observed.  
(e) Morphological analysis of mitochondria 
without and with overexpression of the fission 
factor ganglioside-induced differentiation-
associated protein 1 (GDAP1). Error bars show 
means and s.e.m. over eight images per condition. 
(f) Example images from both conditions with 
segmentation outlines in green; scale bars, 10 Mm.
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Figure 6 | Benchmarks of the Squassh protocol. HEK293 cells were 
transiently transfected with Cherry-tagged RAB7. Lysosomes were identified 
by LAMP-2 immunostaining. (a) Pixel-based Pearson correlation (range −1 
to +1) and object-based colocalization (range 0–100%) results for LAMP-2 
with RABx (where ‘x’ stands for any RAB). For object-based analyses, images 
were segmented with the Squassh software. LAMP-2 is known to colocalize 
mainly with RAB7. Error bars show means and s.e.m. over 20 images 
per condition. (b) Pearson correlation and object-based colocalization 
coefficients for the image shown in c corrupted with increasing amounts 
of Gaussian noise. (c) Example image with both channels shown; scale bar, 
10 Mm. (d) F-score of segmentation accuracy for fourfold subpixel–level 
and normal pixel-level segmentation. We show the mean values over five 
random images for each signal-to-noise ratio. (e) Example of a benchmark 
image with a signal-to-noise ratio of 12. The close-up views below show the 
ground truth outlines in green and those reconstructed by Squassh in red. 
The middle image uses normal pixel-level segmentation, whereas the right 
image uses fourfold subpixel oversampling; scale bars, 1 Mm for the top 
image and 0.5 Mm for the close-up images.
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The accuracy of subpixel segmentation is illustrated on a synthetic image obtained by blurring a previously determined 
segmentation of RAB5 endosomes with the PSF of the microscope and adding modulatory Poisson noise of various  
magnitudes. We computed the F-score of the obtained segmentations with respect to ground truth. Subpixel segmentation 
improved the segmentation accuracy for signal-to-noise ratios (defined for Poisson noise according to ref. 29) above four 
(Fig. 6d). Figure 6e shows example results in comparison with standard pixel-level segmentation.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Many areas of biomedical research rely 
on cell imaging to obtain information 
about the phenotypic response of cells 
to different growth factors and drugs. 
A common task is the quantification of 
spatial colocalization between fluores-
cently labeled species since the proteins 
under study are usually related to known 
subcellular markers.
Squassh is a subcellular shape 
analysis tool based on a segmentation 
technique that corrects for micro-
scope blur, detector noise, and uneven 
background (1,2). It enables the gener-
ation of large amounts of data on the 
features of subcellular objects. Once 
the objects of interest are distinguished 
from the background, object features 
such as size, intensity, or shape, as well 
as colocalization between fluorescence 
channels, are calculated and then written 
to comma-separated value (CSV) files.
Squassh comes with basic R function-
alities for data analysis, figure generation, 
and statistical tests. However, the investi-
gation of data generated for a particular 
problem often requires customized 
analysis, which then requires learning 
the R programming language, a prohib-
itive investment of time for many cellular 
biology researchers who lack training 
in software programming. Moreover, 
analysis of more than two fluores-
cence channels or of live-cell imaging is 
even more complex since specific data 
processing steps are necessary.
Here we present an updated version 
of Squassh called Squassh3C that works 
in combination with SquasshAnalyst, a 
new interactive web program written in 
the statistical programming environment 
R. This allows for the analysis of images 
(single images or movies obtained from 
fixed- or live-cell imaging) having up 
to three fluorescence channels that 
can be obtained, for example, with the 
co-expression of fluorescently tagged 
sensors (3) or with immunostaining. 
R is a free software and programming 
language (www.r-project.org) providing 
a wide variety of data processing, statis-
tical, and graphical tools. SquasshAnalyst 
brings these tools to non-programmers 
by providing an easy-to-use graphical 
interface made with the R package Shiny 
(www.rstudio.com/shiny).
The workflow functions with image data 
files in any format supported by ImageJ. 
In contrast to Squassh, Squassh3C can 
analyze in batch mode different experi-
mental conditions separated into distinct 
subfolders by selecting the parent folder. 
Conditions can then be compared and 
tested for statistical significance in the 
SquasshAnalyst user interface. It is also 
possible to compare conditions from 
separate Squassh3C computational runs.
Squassh3C is implemented as a 
plugin for the image processing program 
ImageJ (4,5). It provides a user interface 
for input selection, segmentation param-
eters, setting the microscope objective 
characteristics, and output options 
(Figure 1A). SquasshAnalyst is a web 
application with user interface tabs 
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Quantitative image analysis plays an important role in contemporary 
biomedical research. Squassh is a method for automatic detec-
tion, segmentation, and quantification of subcellular structures and 
analysis of their colocalization. Here we present the applications 
Squassh3C and SquasshAnalyst. Squassh3C extends the func-
tionality of Squassh to three fluorescence channels and live-cell 
movie analysis. SquasshAnalyst is an interactive web interface for 
the analysis of Squassh3C object data. It provides segmentation 
image overview and data exploration, figure generation, object and 
image filtering, and a statistical significance test in an easy-to-use 
interface. The overall procedure combines the Squassh3C plug-in 
for the free biological image processing program ImageJ and a web 
application working in conjunction with the free statistical environ-
ment R, and it is compatible with Linux, MacOS X, or Microsoft 
Windows. Squassh3C and SquasshAnalyst are available for down-
load at www.psi.ch/lbr/SquasshAnalystEN/SquasshAnalyst.zip.
Benchmarks
METHOD SUMMARY
Here we describe the image analysis applications Squassh3C, a method for automatic segmentation and quantification of 
subcellular structures and analysis of their co-localization in up to three fluorescence channels, and SquasshAnalyst, an 
interactive web interface for the analysis of Squassh3C segmentation data.
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Figure 1. Squassh 3C. (A) Squassh3C interface showing segmentation parameters panel. A higher regularization parameter should be used for noisy 
images. Minimum object intensities are set separately for each channel. Further description of the parameters is available by clicking on the help 
button. (B) A COS cell transiently expressing EYFP-RAB5a (green) and mCherry-RAB11a (blue) is shown 30 min after stimulation with EGF-Cy5 
(red). A z-axis projection of the fluorescence image is shown to the left of the Squassh segmentation (right). Lookup table values ranging from white 
(background) to color (maximum signal) produce a printer friendly colormap.
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Figure 2. SquasshAnalyst. (A) SquasshAnalyst interface showing analysis tab with settings for a comparison of the percentages of early endosome marker EEA1 
colocalizing with RAB7a, RAB11b, RAB5a, and RAB4a. (B) Venn diagram showing the average colocalization of five fluorescence images containing three fluo-
rescence channels: RAB5a (green), RAB11a (blue), and EGF (red). (C) PAE cells expressing VEGFR-2 and NRP-1 receptors were transiently infected with a virus 
expressing mTFP1-RAB7a and mCherry-RAB11a and then stimulated with Cy5-labeled VEGF165a. The graph displays the change over time of the amount of VEGF 
colocalizing with RAB7a or RAB11a. We provide all microscopy images needed to reproduce these figures with SquasshAnalyst at tinyurl.com/squasshanalystdata.
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for data input selection, an overview of 
Squassh3C generated segmentation, 
and data analysis (Figure 2A). Figures 
generated by SquasshAnalyst can be 
live-previewed while their graphical, 
processing, and analysis options are 
tuned, and can then be exported as PDF 
or PNG files.
Squassh3C and SquasshAnalyst form an 
automated workflow for the analysis of up to 
thousands of fluorescence images. However, 
for correct analysis, it is important to check 
that the intermediate steps, such as segmen-
tation of individual images or filtering of outliers, 
are done properly. SquasshAnalyst therefore 
generates a contact sheet view containing 
thumbnails of the segmented images to facil-
itate inspection of Squassh3C segmentation 
analysis. Each thumbnail displays the original 
image and the segmented objects side-by-
side. The original image is displayed with all 
channels merged, automatically enhanced 
contrast with 0.05% of the pixels saturated, 
and maximum z-axis projection in the case 
of 3-D images (Figure 1B). When a cell mask 
of positively transfected cells is computed by 
Squassh3C, the outline of the mask is overlaid 
in white on the image. It is possible from 
the contact sheet view to exclude selected 
images from further analysis.
The visual comparison of an image feature 
(colocalization, object count, cell size, mean 
object volume, mean object intensity, mean 
object sphericity) between image sets is 
achieved with bar plots, boxplots, or strip 
charts. Figure 2A compares colocalization 
of the EEA1 marker for early endosomes 
with four different RAB GTPases. The lesser 
colocalization of EEA1 with RAB11b and 
RAB7a compared with RAB4a and RAB5a 
reflects the maturation of early endosomes to 
recycling and degradation vesicles, respec-
tively. Colocalization quantified after segmen-
tation as done with Squassh3C was shown to 
yield better results compared with pixel-based 
approaches such as Pearson correlation (1,2). 
An option allows switching between colocal-
ization-based on object count, overall overlap 
size, or overall signal colocalization.
Fast visualization of all colocalization 
channel subsets in a given image set is 
achieved by displaying them as a Venn 
diagram (Figure 2B).
Quantitative analysis of movies from 
live-cell imaging is done by separate 
analysis of the movie frames. Results are 
then combined to display the progression 
over time of the colocalization of selected 
channel subsets or of any mean image 
feature. A rolling average over time frames 
with a parameterizable time window can be 
used to smooth any noise. As an example, we 
quantified the localization of VEGF165a-Cy5 
with mTFP1-RAB7a and mCherry-RAB11a 
in PAE cells stably expressing VEGFR-2 
and NRP-1 receptors (Figure 2C) in order to 
monitor, respectively, the degradation and 
recycling of VEGF165a after VEFGR2 stimu-
lation. (See Reference 6 for a description of 
the results.)
Statistical analysis to compare multiple 
conditions at a time and for pairwise multiple 
comparisons are done, respectively, with 
one-way ANOVA and Tukey-Kramer tests or 
with the nonparametric Kruskal-Wallis and 
Dunn tests. The most representative image 
of a condition is automatically detected and 
displayed. It is possible to remove objects 
from the analysis based on intensity or shape 
criteria thresholds. Removing objects with 
low intensity from the analysis is useful, for 
instance, to remove non-specific fluores-
cence in immunostaining experiments.
Squassh3C and SquasshAnalyst 
constitute a complete workflow from 
segmentation to data analysis that is based 
on the state-of-the-art segmentation method 
Squassh (1,2). A tutorial and installation 
instructions for the workflow are available 
in the SquasshAnalyst manual at www.psi.
ch/lbr/SquasshAnalystEN/SquasshAnalyst_
manual.pdf. An included toy example allows 
testing of the entire procedure in less than 
15 minutes. Finally, the manual showcases 
further possible uses of SquasshAnalyst with 
the image data sets corresponding to Figure 
2 containing more than 300 images in total.
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ultigene  delivery  systems  have  gained  significant  attention  in  biological  research  
in   both   academia   and   industry.   Projects   in   biological   research   benefit   directly  
from   these   systems   notably   in   fields   such   as   genome   editing,   regenerative  
medicine  and  biotechnological  product  development.  Therefore,  developing  novel   transduction  
systems  with  high  delivery  efficiency  and  simplicity  of  application  is  of  high  interest  for  biologists.  
Until   recently,   a   multitude   of   strategies   have   been   developed   to   genetically   modify   cells.   A  
couple   of   years   ago,   our   group   developed   MutiLabel,   which   is   a   plasmid-­based   multigene  
expression   system   for   mammalian   cells.   In   contrast   to   classical   co-­transfection   procedures  
using  several  plasmids,  which  resulted  in  heterogeneous  cell  populations,  MultiLabel  allowed  to  
simultaneously   transduce   and   successfully   express   a   large   number   of   genes   into   transfected  
cells.   Although   the  MultiLabel   system  works   well   with   easy   to   transfect   established   cell   lines  
such   as  HEK293,   other,   in   particular   primary   cells   are   difficult   to   efficiently   transfect   with   the  
current   established   procedures.   In   order   to   overcome   this   shortcoming   of   MultiLabel,   I  
developed   a   highly   efficient   baculovirus-­based  multigene   delivery   system   for   eukaryotic   cells.  
We  termed  this  system  “MultiPrime”  because  it   is  particularly  well  suited  for  multigene  delivery  
to   primary  mammalian   cells.  MultiPrime   relies  on  a   set   of   customized  DNA  plasmid  modules,  
called   acceptor   and   donor   plasmids   that   can   be   combined   through   in   vitro   Cre/loxP  
recombination.  A  fused  acceptor-­donor  plasmid  can  then  be  inserted  into  a  specially  engineered  
baculoviral   genome.   During   my   thesis   I   have   prepared   a   collection   of   MultiPrime   vectors  
carrying  specific  regulatory  sequences  such  as  distinct  promoters,  or  transcriptional  terminators.  
Antibiotic   resistance   genes   for   subsequent   cell   selection   or   fluorescent  marker   genes   for   cell  
monitoring  were  introduced  as  additional  tools  to  make  the  procedure  generally  applicable  and  
easy  to  use.    
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To   document   the   potential   of  MultiPrime,   I   delivered   and   simultaneously   expressed   up   to  
five   different   expression   cassettes   in  mammalian   cells   including   both   primary   and   stem   cells.  
Our   system   thus   opened   the   door   for   introducing   a   multitude   of   genes   into   hard-­to-­transfect  
cells.   Our   baculovirus   constructs,   especially   the   VSV-­G   protein   pseudotyped   versions,   were  
shown  to  successfully  transduce  a  wide  range  of  eukaryotic  cells  both  in  vivo  and  in  vitro.    
I  also  validated  a  range  of  mammalian  promoters  that  can  be  introduced  into  the  MultiPrime  
system.   This   feature   allows   to   fine-­tune   the   level   of   transgene   expression   according   to   user  
requirment.   In   addition,   we   engineered   two   dual-­host-­specific   promoters   for   multigene  
expression  in  both  mammalian  and  insect  cells  using  a  single  MultiPrime  virus.  The  use  of  these  
promoters  eliminates  additional  steps   for   re-­cloning  of   the  genes  of   interest   from   insect  cell   to  
mammalian   vectors   or   vice   versa.  For   example,   I   converted   three   scFvs   to   full   length   human  
antibodies   and   expressed   them   in  mammalian   and   insect   cells   using   a   dedicated  MultiPrime  
virus.  I  also  used  MultiPrime  to  convert  mouse  embryo  fibroblasts  to  neural  cells  through  forced  
expression   of   three   redifferentiation-­promoting   transcription   factors   which   are   required   for  
somatic   cell   reprogramming.   MultiPrime   baculovirus   is   thus   an   excellent   vehicle   for  
reprogramming   of   cells   represent   thus   a   transient   and   non-­integrating   expression   system   for  
safe   application   not   only   in   cells   but   also   in   whole   organisms.   To   document   this   I   applied  
MultiPrime   to   transduce   zebrafish   with   fluorescent   protein   markers.   Finally,   MultiPrime   was  
applied   for   efficient   CRISPR/Cas9-­mediated   genome   editing   in   primary   cells.  MultiPrime   thus  
allows  not  only  RNA  polymerase  II  dependent  transcription  but  can  also  be  used  for  U6-­driven  
expression  cassettes.  When  expressed  together  with  a  homology  construct  such  a  virus  allows  
for  genome  editing  through  CRISPR/Cas9.    
In   all   the   applications  mentioned  above,   reliable   and   reproducible   production   of   functional  
MultiPrime   virus   stocks   is   crucial.   I   therefore   developed   a   detailed   step-­by-­step   protocol   for  
implementation  of  our  technique  in  a  standard  laboratory  environment.  
Taken   together,   I   developed   and   validated   MultiPrime   as   powerful   vehicle   for   multigene  
delivery,  multi-­protein  expression  and  genome  editing.  I  anticipate  that  numerous  methodologies  
in   contemporary   research   and   drug   discovery,   which   rely   on   efficient   multigene   delivery,   will  
considerably  benefit  from  MutiPrime.    
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